ACG 2024 Meeting News

OCTOBER

CME / MOC

All ACG 2024 courses will offer MOC points.

16

HANDS-ON

Endoscopy School

Hands-On Workshop Center sessions run from Sunday through Tuesday.

MEETING NEWS

19

FELLOWS EVENTS

Learn about the GI Jeopardy Finals and other Fellowsfocused events.

Interview with ACG President: JONATHAN A. LEIGHTON, MD, FACG

2023-2024 ACG PRESIDENT

It has been a very busy year for you. As your term as ACG President is winding down, how are you feeling about your service to the organization and what have you learned?

My year as ACG President has been busy but very gratifying. I feel that it has been an amazing experience to lead such a prestigious organization. The ACG staff are exceptional and so impressive to work with. I have had the opportunity to spend time with many of them in the new ACG office. The design of the office offers a collaborative atmosphere, and it was wonderful to see the teamwork involved in everything we do. I also was fortunate to work with our extraordinary Board of Trustees whose dedication to making ACG successful is always their priority. In addition, our Board of Governors and our Committee Chairs are incredibly dedicated to the mission and vision of our organization. I have learned so much this year about the importance of servant leadership and working collaboratively with everyone to focus on what is most important to the College and its membership.

During your past year as ACG President, you had the opportunity to represent the College in a wide variety of capacities. What are some of the memorable experiences you care to share with the membership?

This year has been filled with so many memorable experiences. The Fight Colorectal Cancer 2024 United in Blue Rally on the National Mall in Washington, DC, was particularly gratifying, as was my participation in the North American Conference of Gastroenterology Fellows. Another superb event was the ACG Fly-In and Advocacy Day. Collaborating with the Board of Governors and the Early Career Leadership cohort was a wonderful experience. In addition, I have been fortunate to participate in all of our Regional Meetings this year. Interacting with the Course Directors, the Faculty, and our members was particularly satisfying. We also have an incredible Board of Trustees and leading the Board Meetings this year has been extremely rewarding. I am so proud of the commitment by all for making ACG such a powerful organization for its members.

You helped set the course for a full-scale review of the ACG Strategic Plan this year. What are some of the things you have learned and what can you say about the plan and the direction it sets for the College?

Having the opportunity to update our ACG Strategic Plan is one of the exciting goals of my Presidency. Under the talented leadership of Costas Kefalas and Aasma Shaukat, the intent is to be as transformative as possible. As we all know, the ACG has been amazing in terms of its programming throughout the years. But we also know that the healthcare landscape is changing and evolving very quickly. There are many issues impacting how we practice medicine. We know that our workforce will be changing dramatically over the next few years. In addition, there is a huge surge in technological advances that will impact gastroenterology and hepatology over the next several years. The world is also becoming even more diverse and global. We want to be prepared for all of these changes over the next several years. Our new Strategic Plan will reflect these changes and prepare us for the future so that all of our members will benefit from our education, leadership, research, and

20 NEW MASTERS HONORED

Seven members earn the distinction of MACG.

24

EXHIBIT HALL

Opens at 3:00 pm on Sunday. The Exhibit Hall Opening Reception begins at 5:15 pm.

A Conversation with ACG’s Next President: AMY S. OXENTENKO, MD, FACG 2024-2025 ACG PRESIDENT

On Monday evening at the 6:00 p.m., ACG Business Meeting, Amy S. Oxentenko, MD, FACG, will become the next President of the ACG. We asked Dr. Oxentenko to share with us some of her experiences as well as her ideas and aspirations for the coming year.

As you begin your Presidency, what are your goals and what do you believe are the biggest challenges facing ACG this year?

The biggest challenges that I see facing ACG and the College’s members are: 1) workforce shortages on a number of levels that will continue to impact our practices; 2) clerical and administrative work that challenges an already stretched clinical workforce; 3) ensuring access for patients most in need of GI care; and 4) retaining our current workforce by addressing issues leading to burnout. In terms of workforce shortages, this will require a multi-pronged assessment and approach. We have had a progressive shortage of allied staff since the pandemic, including technicians, assistants, and nursing support, which has affected capacity, flow, and efficiency within our clinical and endoscopic practices. Similarly, we have all felt the impact of changes in anesthesia support for endoscopic practices, and without thinking of new ways to administer this level of sedation, it will get progressively more challenging to perform the level of advanced endoscopic procedures we do now and on those with even more medical comorbidities than in the past. Finally, we need advanced modeling to predict the number of gastroenterologists needed to serve our future population so we can anticipate workforce shortages given retirement eligibility, premature dropout from clinical practice, and other factors. Reimaging training paradigms for each of these groups will be required.

There are many days in practice we have all wished for the “easy” button to help us perform mundane or clerical tasks that preclude us from spending more time doing the things we are ideally trained to do – care for GI patients. Our Board of Governors are the ears of the College, getting feedback from members of every state and region on how we can provide tools and resources that can be akin to that “easy” button. As a College, investing in ways to automate in clinical practice will allow us to do the work that is meaningful to all of us while serving more patients in need of GI care. By leveraging artificial intelligence, predictive analytics, and data sets, this can facilitate triaging and care modeling for our patients in new ways that save time yet deliver the highest level of care.

If we address the workforce shortages and the excessive clerical work through automated processes, it will go a long way to addressing the other two challenges, namely, patient access and clinician burnout.

I have and always will continue to push efforts within diversity, equity, and inclusion within our field. The time leading up to this year has hopefully demonstrated that. In addition, with my background of years in both education and practice leadership, I hope that together, we can tackle the challenges of today to ensure a bright and

DON’T MISS THE LATEST CLINICAL PRACTICE UPDATES from

this year’s POSTGRADUATE COURSE

YOU WON’T WANT TO MISS THE LATEST CLINICAL UPDATES FROM THIS YEAR’S ACG POSTGRADUATE COURSE, where leading gastroenterology experts will discuss a variety of relevant and timely topics including colorectal cancer, hepatology, endoscopy, inflammatory bowel disease, obesity, esophageal disorders, pancreaticobiliary diseases, and more. World-renowned faculty will deliver scientific presentations followed by question-and-answer sessions, optional bonus session “Learning Lunches,” and a choice of simultaneous symposia that will offer the latest clinical practice updates in gastroenterology and hepatology.

SATURDAY PRESENTATIONS

The course will begin with Session 1A: “GI Bleeding: Detection and Correction.” Moderated by Neena S. Abraham, MD, MSc (Epid), MACG, this session will include presentations on peri-procedural management of antithrombotic agents - how to minimize unintended bleeding and clotting; non-variceal upper GIinject, cauterize, clip, or spray?; small bowel bleeding - how to locate, treat, and improve quality of care; and lower GI bleeding - tips for optimal localization and treatment by Neil Sengupta, MD, FACG, Jonathan A. Leighton, MD, FACG, Loren A. Laine, MD, FACG, and Dr. Abraham. The session will conclude with a question-and-answer panel. Session 1A will be followed by the David Sun Lecture.

 THE DAVID SUN LECTURE - Creating a Manageable Cockpit for Physicians by Christine A. Sinsky, MD, MACP

Following the David Sun Lecture will be Session 1B: “What’s New in the Management of Liver Disease,” moderated by Jasmohan S. Bajaj, MD, MS, FACG, and featuring presentations by Vijay H. Shah, MD, FACG, Paul Martin, MD, FACG, Dr. Bajaj, and Atoosa Rabiee, MD, FACG, on alcohol-associated liver disease - recommendations from the guidelines; making sense of the alphabet soup - updates in non-hepatitis C viral hepatidities; managing complications of cirrhosis; and optimizing outcomes in acute and acute-on-chronic liver failure.

Saturday Learning Luncheons Bonus Sessions (separate registration required) Twelve (12) Learning Luncheon Bonus Sessions will be offered on key

topics including hepatitis C - far from over; perfecting your clinical consultreflections from a master clinician; autoimmune enteropathy and eosinophilic enteritis; hereditary GI cancers and gastrointestinal polyposis syndromes - who to screen, how to surveil, and what resources are available; management of an ileal pouch - from symptoms to cancer surveillance; evaluation and management of benign anorectal disorders; keeping you out of trouble when endoscopic complications happen; role of diet in the management of IBD; introduction to the GI hospitalist program; drug-induced liver injury - how to diagnose and prevent; healthcare maintenance in IBD; and all you ever wanted to know about dyspepsia and eructation.

Three simultaneous symposia will follow the Learning Luncheons:

Symposium A: “Battling the Bulge: From Metabolic-Associated Liver Disease to Obesity: What’s in My Clinical and Endoscopic Toolbox?” moderated by Linda Anh B. Nguyen, MD, FACG, and featuring presentations by Dr. Nguyen, Nancy S. Reau, MD, FACG, and Reem Z. Sharaiha, MD, MSc, on medical therapies for obesity and their GI side effects; metabolic dysfunction-associated steatotic liver disease - causes, prevention, and treatment; and bariatric endoscopywhat’s new?

Symposium B: “Incidentalomas: What to Do With Unexpected Findings” moderated by Vanessa M. Shami, MD, FACG, and featuring presentations by Dr. Shami, Vivek Kaul, MD, FACG, and Anjana A. Pillai, MD, FACG, on submucosal lesions of the GI tract; evaluation and management of biliary strictures; and focal liver lesions - an imaging primer from the guidelines.

Symposium C: “Evaluation and Management of Disorders of the GutBrain Axis” moderated by William D. Chey, MD, FACG, and featuring presentations by Jill K. Deutsch, MD, MA, Dr. Chey, and Brian E. Lacy, MD, PhD, FACG, on evaluation and management of chronic abdominal pain and suspected IBS; constipation - pharmacologic and non-pharmacologic therapies; and functional diarrhea - what’s in my toolbox?

Following the simultaneous sessions will be Session 1C: “Managing Pancreatic Disorders: What You Need to Know Now” moderated by Jodie A. Barkin, MD, FACG, and featuring presentations by Dr. Barkin, Santhi Swaroop Vege, MD, MACG, and Anne Marie Lennon, MD, PhD, FACG, on management of acute pancreatitis - updates from the guidelines; chronic

pancreatitis - managing pain, exocrine, and endocrine dysfunction; and pancreatic cysts - drain it, surveil it, or leave it alone?

Saturday will conclude with Course Directors Jodie A. Barkin, MD, FACG, and Jill K. J. Gaidos, MD, FACG, summarizing the day’s key learning points with “TakeHome Pearls: What Did We Learn Today?”

Each session will offer time for questionand-answer periods with the faculty.

SUNDAY PRESENTATIONS

Day two of the Postgraduate Course will begin with Session 2A: “Esophageal Disorders,” moderated by Nicholas J. Shaheen, MD, MPH, MACG, with presentations by Christine Y. Hachem, MD, FACG, Dr. Shaheen, Jennifer Horsley-Silva, MD, and Evan S. Dellon, MD, MPH, FACG, on NERD, GERD, and everything in between; Barrett’s esophagus - screening, surveillance, ablate, or resect?; esophageal motility disorders - common presentations, testing modalities, and treatments; and eosinophilic esophagitisupdates from the ACG guidelines.

Jill K. J. Gaidos, MD, FACG, will moderate Session 2B: “Personalizing IBD Therapy to Improve Outcomes” featuring presentations by David T. Rubin, MD, FACG, Miguel D. Regueiro, MD, FACG, Millie D. Long, MD, MPH, FACG, Dr. Gaidos, and Samir A. Shah, MD, FACG, on positioning IBD therapies for UC - where to start and when to switch; management of complex Crohn’s disease; risks of adverse side effects with new IBD therapies - selecting treatment based on safety; role of therapeutic drug monitoring in today’s IBD practice; and colonic dysplasia in IBD - surveil or resect?

Sunday Learning Luncheons Bonus Sessions (separate registration required) Twelve (12) Learning Luncheon Bonus Sessions will be offered on Sunday on topics including health disparities among patients with chronic liver diseases; how do I approach the patient with diarrhea?; evaluating elevated LFTs; gastric premalignant conditions - updates from the guidelines; elevated pancreatic enzymes - incidental, drug-induced, pathogenic, or autoimmune?; cannabis for gastrointestinal disorders - everything you wanted to know, but were afraid to ask; gut dysbiosis and the role of fecal microbiota transplantation in GI disorders; advancing your colonoscopy skills - integrating EMR, water colonoscopy, and CO2 into your everyday practice; optimizing diagnosis and therapy of H. pylori - an ACG guidelines-based approach; management of intra-abdominal and perianal abscesses and fistulae in Crohn’s disease - antibiotics, biologics, drainage, or surgery?; revenge

of the cheesesteak - foreign bodies, food impactions, and other fun middle of the night calls; and ERCPs - how to make difficult biliary cannulations easier and minimize your pancreatitis risk.

Three simultaneous symposia will be offered on Sunday afternoon featuring: Symposium D: “New Innovations in Endoscopy” moderated by Seth A. Gross, MD, FACG, and including presentations by Dr. Gross, Peter V. Draganov, MD, FACG, and Amrita Sethi, MD, on integrating artificial intelligence into CRC screening to improve visualization and characterization; splitting the wallupdates on submucosal and full-thickness endoscopy; and punching through the wall - lumen-apposing metals stents— where can we go?

Symposium E: “Abdominal Distention: Dysmotility, Dysbiosis, or Diet?” moderated by Baharak Moshiree, MD, MSc, FACG, and including presentations by Dr. Moshiree, Brooks D. Cash, MD, FACG, and Amy S. Oxentenko, MD, FACG, on gastroparesis - diagnosis, medical and endoscopic therapies; SIBO, disaccharidase deficiencies, foods, and functional – what do I do?; and celiac disease – what’s new and what’s on the horizon.

Symposium F: “Non-IBD Infectious and Inflammatory Colidities” moderated by David J. Hass, MD, FACG, and featuring presentations by Neil H. Stollman, MD, FACG, Dr. Hass, and Shilpa Grover, MD, MPH, on diagnosis and treatment of Clostridioides difficile and recurrent infection; diverticulitis, SCAD, and epiploic appendagitis - what’s new?; and when immunotherapy goes wrong - management of gastrointestinal, pancreatic, and hepatic toxicities.

Following a break will be Session 2C: “Colon Cancer Screening and Management of Colon Polyps” moderated by Aasma Shaukat, MD, MPH, FACG, and featuring presentations by Dr. Shaukat, Douglas K. Rex, MD, MACG, and Shivangi T. Kothari, MD, FACG, on CRC screening - when to start, what modality to use, when to stop; optimizing colonoscopy performance - tips and tricks to improve quality; and resecting colon polyps - snare, EMR, or ESD?

To conclude the Postgraduate Course, Course Directors Jodie A. Barkin, MD, FACG, and Jill K. J. Gaidos, MD, FACG, will review the “Take Home Pearls: What Did We Learn Today” and discuss the practical take-home messages.

We innovate with purpose

Patients will always inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we will continue to confidently address the most complex healthcare challenges of our time and unlock the potential medicines and technologies of tomorrow.

Visit us at Booth 201 to learn more.

ACG 2024

ANNUAL SCIENTIFIC MEETING HIGHLIGHTS the Latest in Clinical

ACG 2024 has set another record for abstract submissions and attendees will benefit with 80 exceptional oral presentations and over 5,100 poster presentations The oral presentations are in addition to the simultaneous symposia, "GI Ignite - Meet the Experts" breakfast sessions, featured lectures, and hands-on sessions that will be offered.

MONDAY, OCTOBER 28

Monday morning kicks off with “GI Ignite - Meet the Experts” Breakfast Sessions. Faculty from Annual Scientific Meeting Bonus Sessions A-H will be available to discuss their topics and continental breakfast will be served. These “Meet the Experts” sessions are open to all Annual Scientific Meeting attendees. (The Bonus Sessions are an optional add-on to an Annual Scientific Meeting registration. Visit the ACG Registration Desk in Philadelphia to purchase access or visit acgmeetings. gi.org.)

The “GI Ignite - Meet the Experts” sessions will be followed by 2 Presidential Plenary sessions. Between the plenary sessions, ACG President Jonathan A. Leighton, MD, FACG, will deliver the ACG 2024 President’s Address. Don’t miss it! The Exhibit Hall opens at 10:00 am on

Monday where you can visit with exhibitors, attend an Exhibitor Theater presentation, or participate in an Endoscopy School Hands-On Workshop session. Posters will be on display from 10:30 am to 4:15 pm so stop by to see the latest in scientific advancements and meet the authors from 1:00 pm - 2:15 pm

Three simultaneous symposia are also offered on Monday morning, including the ACG Past Presidents’ Symposium (1A), How to Prevent and Manage Adverse Events During Endoscopy (1B), and Caught in the Middle – Management of Small Bowel Disorders (1C). Join the experts as they discuss these hot topics!

Two additional simultaneous plenary sessions featuring Colorectal Cancer Prevention (1A) and Interventional Endoscopy (1B) abstracts are offered on Monday afternoon from 2:15 pm – 3:00 pm.

 THE AMERICAN JOURNAL OF GASTROENTEROLOGY LECTURE

 Monday, October 28

 3:05 PM – 3:35 PM

Learn how clinicians can participate in research that moves the fields of gastroenterology and hepatology forward when Naga P. Chalasani, MD, FACG, presents The American Journal of Gastroenterology Lecture on “Drug-Induced Liver Injury as an Example for Leveraging Networks for Clinical Research.”

The AJG Lecturer is chosen by the co-editors of The American Journal of Gastroenterology with approval from the ACG Educational Affairs Committee and the ACG Board of Trustees.

If you have burning questions about how to get your research published, there will be a special Monday afternoon session from 3:45 pm – 4:45 pm on How to Get Published: An ACG Journal Editors’ Roundtable featuring Jasmohan Bajaj, MD, MS, FACG, Millie D. Long, MD, MPH, FACG, Brian C. Jacobson, MD, MPH, FACG, Prateek S. Harne, MBBS, MD, and Muhammad N. Yousaf, MD. This session is free to all and perfect for GI fellows or anyone new to publishing.

Three simultaneous sessions will begin at 4:45 pm on Monday afternoon: Complex Pancreaticobiliary Challenges (2A), Clinical Updates in the Management of Hospitalized IBD Patients (2B), and Live From Philly!

The 12th Annual Endoscopy Video Forum (2C). Attendees at the Endoscopy Video Forum will be able to vote, along with the moderators and a panel of judges, for the winning video at the end of the session.

Following the educational agenda on Monday, ACG will hold its Annual Business Meeting at 6:00 pm. All members and Fellows (FACG) of the ACG are invited to attend.

TUESDAY, OCTOBER 29

Tuesday will again begin with “GI Ignite - Meet the Experts” Breakfast Sessions.

Faculty from Annual Scientific Meeting Bonus Sessions I-P will be available to discuss their topics and continental breakfast will be served. These Meet the Expert sessions are open to all Annual Scientific Meeting attendees.

The “GI Ignite - Meet the Experts” sessions will be followed by simultaneous plenary sessions with presentations of Small Intestine/Functional/Liver (2A) and Colon/

General Endoscopy/GI Bleed/Practice Management (2B) abstracts. After the plenary sessions, Michelle A. Anderson, MD, MSc, will deliver the J. Edward Berk Distinguished Lecture entitled, “Exploring New Frontiers: Innovations Shaping the Future of Gastrointestinal Endoscopy.”

The Exhibit Hall opens at 10:00 am on Tuesday, so plan to visit with exhibitors, attend an Exhibitor Theater presentation, or participate in an Endoscopy School Hands-On Workshop session. Posters will again be on display from 10:30 am to 4:00 pm. Stop by to see the latest in scientific advancements and meet the authors from 1:00 pm - 2:15 pm.

Three simultaneous symposia are offered on Tuesday morning, including sessions on: Challenges in Cirrhosis Management (3A), Management of Obesity in 2024: The Role of the Gastroenterologist (3B), and Beyond PPIs: New Treatments for GERD and EoE (3C). Join the experts as they discuss these popular topics!

In the afternoon, two additional simultaneous plenary sessions will take place with presentations of Esophagus/ Stomach/Practice Management (3A) and Obesity/Biliary-Pancreas (3B) abstracts.

After these plenary sessions, Leonard L. Berry, PhD, MBA, will present the Emily Couric Memorial Lecture entitled, “Kindness-Influenced Trust and Healing." Be sure to visit the Exhibit Hall one last time before it closes at 4:30 pm on Tuesday! Then plan to attend one of two afternoon simultaneous symposia sessions that begin at 5:10 pm: How to Address Abdominal Pain (4A), or Tackling Advanced Colon Polyps (4B). Don’t miss these important practical topics.

WEDNESDAY, OCTOBER 30

Wednesday kicks off with two simultaneous plenary sessions focusing on Liver (4A) and IBD (4B) abstracts. After the plenary sessions, David E. Fleischer, MD, FACG, will deliver the David Y. Graham Lecture entitled, “Africa - Opportunities for You and for the ACG.”

Two simultaneous symposia wrap up the educational agenda for the meeting—When Should We Use These Medications? Clinical Roundtable Discussion With the IBD Experts (5A), and Hepatology Potpourri (5B). Be sure to arrange your schedule so you can stay and hear the latest information on these great closing topics.

JOIN US IN THE LEVEL 5 BALLROOM SALONS G, K, AND L TACKLING INEQUITIES IN IBD

Inclusive Solutions for Elevated Patient Care

Discover the latest insights and updates on how health care disparities are affecting patient outcomes in inflammatory bowel disease (IBD). Stay informed about the cutting-edge developments in nonbiologic small-molecule drugs that are poised to revolutionize the diagnosis and management of Crohn’s disease and ulcerative colitis. Learn how to develop effective, collaborative strategies within multidisciplinary teams to improve long-term management of IBD. Together, we can elevate the standard of care and ensure better outcomes for all patients.

PROGRAM CHAIR

Sandra Quezada, MD, MS, AGAF

Associate Dean for Admissions

Associate Dean for Faculty Diversity and Inclusion

Associate Professor of Medicine

Division of Gastroenterology and Hepatology University of Maryland School of Medicine Baltimore, MD

LEARNING OBJECTIVES

• REVIEW the evolving epidemiology of IBD

• APPLY diagnostic algorithms to identify IBD early in a variety of patient populations

Saturday, October 26, 2024

Dinner and Registration: 7:30–8:00 pm ET

Scientific Session: 8:00–9:30 pm ET Philadelphia Marriott Downtown • Philadelphia, PA

• ASSESS health disparities in the treatment of IBD

• FORMULATE collaborative multidisciplinary strategies for the equitable management of patients with IBD

To learn more, scan here or visit the link below

go to per.com/guideibd24

Interview with ACG President Jonathan A. Leighton, MD, FACG

advocacy programs. It is our intent to not only prepare for the future but also to be proactive and anticipate the changes ahead of us. It is my hope the new ACG Strategic Plan will be a “living document” for years to come.

Among the roles you served in prior to joining the ACG Board of Trustees was as Chair of the Educational Affairs Committee. Having participated in so many programs this year, how do you assess the state of ACG’s educational programming?

The ACG does so many things well from leadership programs to advocacy to research funding. But I think our educational programming has always stood out as a beacon of our success. The Educational Affairs Committee will always mean something special to me because that is the first committee I served on and then led at the ACG. It is a testament to our commitment to education. Having attended all of the Regional Meetings this year, I have seen first-hand what our amazing ACG staff do to make all of these programs come to life. The organization and followup of our staff is incredible and contributes to the success of these programs. In addition, I have been impressed with all of the Course Directors and Faculty. I think the true value of these programs is reflected in the course attendance by our members. The state of ACG’s educational programming is as strong as ever!

You have held a variety of administrative roles at Mayo Scottsdale over the years. One of the most recent was as Director of Mayo Clinic Experience for all of Mayo. Indeed, you invited the Emily Couric Memorial Lecturer, Leonard Berry, PhD, MBA, who has done a great deal of research in this area. What lessons have you learned personally that are most relevant to the membership and what do you hope people will take from the Couric Lecture?

In my role, I have learned that staff and patient experience go “hand in hand.” I call it the Experience Loop. Happy employees lead to happy patients. It is critical that practices, large groups, or hospital systems not only support and empower their staff but are generous as well. The goal is to inspire and unleash the creative potential of our team to deliver the best experience possible for our patients and their families. We can accomplish this through efficient workflows, collaboration, coordination, and the development of highly functioning care teams that support each other and their patients. It is important that we focus on trust, belonging, and hope. This in turn builds trusted and loyal relationships with our patients. Finally, it is critical that we elevate and engage the voice of our patients and their caregivers to co-design healthcare delivery of the future. Ultimately, we must preserve the human connection in healthcare. If we all work together, the future will be bright.

Though you didn’t have the privilege of serving on the ACG Board of Governors, you have made it a point to find opportunities for engagement with them and to promote their work. Can you share your perceptions of this unique group and the role they play on behalf of the membership at large?

The Board of Governors is one of the most unique and powerful aspects of the ACG. The Governors are an incredibly dedicated and passionate group of gastroenterologists that represent all regions of

the United States as well as international countries. They are our liaisons with our membership and local healthcare organizations and GI societies. Through this relationship, they keep us informed of important healthcare issues at the local and regional level. It has been truly an honor to serve with them and participate in their meetings, especially the April FlyIn where we worked together to communicate with our representatives in Washington, DC. The Board of Governors are dedicated to addressing key issues in healthcare that impact our membership and along with our Legislative and Public Policy Committee work together to effect change. They play an incredibly important role in the College.

Your practice is centered around IBD, an area that is directly impacted by a number of major public policy challenges that the College is working to address, such as prior authorization and step therapy. What has your engagement as President shown you this year about the College’s efforts in public policy activities?

The ACG has a very important role in advocacy for our members and their patients. The Legislative and Public Policy Council works very closely with our Board of Governors and Board of Trustees to identify important public policy issues that impact the practice of gastroenterology and hepatology. Issues like physician reimbursement, prior authorization, and step therapy are challenges that impede the ability to adequately care for our patients. In addition, they impede access to quality care. The College’s efforts in this arena of public policy have been extremely effective in promoting positive change for the benefit of our members. As President, I am very proud of what we have accomplished this year.

You serve as chair of the World Gastroenterology Organisation (WGO) Scientific Program Committee and have long had an interest in international engagement. With a membership that is mostly U.S.-based, talk about the ways the College can most effectively impact clinical gastroenterology internationally.

We live in an extremely exciting era of healthcare, where the practice of medicine has become more global than ever. There are incredible opportunities for the ACG to have an impact on healthcare, not only in the U.S. but around the world. While we are an organization based in the United States, we have a unique opportunity to collaborate internationally with our colleagues and sister GI societies, not only in the arena of education and research but also in improving the delivery of healthcare throughout the world. It is a wonderful opportunity for our members to interact internationally if they are so inclined. As President this year, it has been my goal to foster new international relationships and programs that will increase our presence internationally in a way that benefits our members and colleagues.

Endoscopy education has been a focus for the College over the past decade or more, including expanded hands-on education, Endoscopy School, and this year the updated quality metrics for endoscopy, which were developed jointly with colleagues at ASGE, not to mention GIQuIC. How do you view the role of the College in this important area?

At the ACG, we excel in so many areas, including research, advocacy, and education. Endoscopy

education is at the core of what we do best through so many of our programs that you mention above. The majority of our members are practicing gastroenterologists who perform endoscopy on a daily basis. It is critical that the ACG provide cutting-edge education to our members who desire it. The future is very bright for gastroenterology and technology is advancing at warp-speed. Artificial intelligence, robotics, and advanced imaging techniques, just to name a few, are rapidly evolving. It is our intent to stay ahead of this exciting technology and bring these innovative techniques to our membership through advanced training programs.

The nature of clinical practice has been changing significantly in recent years, with increased pressures on physicians and other members of the clinical care team, both in private practice and academics. Physician well-being has been a major theme of your Presidency. What are some ways the College can help address these issues?

Healthcare is undergoing seismic shifts that will change where care is delivered, who delivers it, and how it is paid for. Ecosystems are evolving and technology will become a central member of the care team and restructure clinician roles. At the same time, there are many headwinds facing gastroenterology as we speak, including increased regulation, declining reimbursement, workforce shortages, and sicker, more complex patients. This, in turn, has led to increased burnout, early retirement, and the emergence of a variety of practice models. This is exacerbated by less leisure time, increased isolation, and an increasing sense of loneliness. Physician well-being practices have never been more important to counteract these forces. The College can help address many of these issues. Building a professional community at ACG through networking, building relationships, and enhancing communication can benefit all of us. The College can aid in individuals’ self-care, which in turn can support collective well-being of our friends and colleagues. Getting involved in the ACG can lead to increased meaning and purpose and it can grow your community and build relationships. Networking can lead to an exchange of ideas and creative thinking, career opportunities, leadership positions, and enhanced social well-being, to name a few. Healthcare is deeply personal; medicine is an art, and we must ensure that caregivers are able to do what only humans can do. The ACG will continue to stay focused on physician well-being as we plan our future strategies.

Are there any words of wisdom you would like to share with Dr. Oxentenko as she prepares to take up the role of ACG President for the next year?

I would say that my involvement in the ACG has been one of the most gratifying experiences in my career. I have learned so much and the friendships I have built over the years mean so much to me. My year as President has been particularly special and meaningful, but the time goes so very quickly. Dr. Oxentenko is a dear friend and colleague. We have worked closely together for many years. I have no doubt that she will be an amazing President. My words of wisdom to Dr. Oxentenko are to savor and appreciate every moment as President and enjoy the journey because “now” is all you have for certain…so enjoy it!

NP/PA Award for Clinical Excellence

 THE NP/PA AWARD FOR CLINICAL EXCELLENCE recognizes a distinguished nurse practitioner or physician assistant who is an ACG Advanced Practice Provider member and has shown longstanding contributions to advancing clinical practice in the field of gastroenterology and hepatology. These efforts are demonstrated by the awardee’s substantial contributions in the areas of practice expertise, leadership, mentoring, and collaborative activities that have an impact at the state, regional, national, or international level. This award was given for the first time in 2022.

NP/PA Award (Community Practice)

Christie L. Morrison, NP

Christie L. Morrison, NP, is a Board-Certified Adult Advanced Practice Nurse and Lead APP at Oshi Health, a digital digestive health practice. She strives to improve the lives of patients with chronic gastrointestinal conditions through a multidisciplinary approach. She has worked in various roles as a GI advanced practice provider, including inpatient, outpatient clinic, and telehealth since 2015.

Mrs. Morrison is currently an active member of the Texas Society of Gastroenterology and Endoscopy, where she serves on its APP and membership committees. She is also a member of several GI societies, including the American College of Gastroenterology, American Society for Gastrointestinal Endoscopy, and Gastroenterology & Hepatology Advanced Practice Providers. She collaborates with industry partners and GI colleagues to enhance education and engagement for APPs working in gastroenterology.

Mrs. Morrison is particularly passionate about enhancing the treatment and quality of life for patients with inflammatory bowel disease. She completed an advanced practice provider preceptorship sponsored by the Crohn’s and Colitis Foundation and volunteers in her local chapter, organizing and participating in patient education conferences.

NP/PA Award (Academic)

Mary S. Vetter, ANP-BC

Mary S. Vetter, ANP-BC, is a Senior Nurse Practitioner at the University of Rochester (UR) Medical Center (URMC). She graduated from the Nurse Practitioner program at the University of Rochester in 2007, after 22 years as a Registered Nurse.

Ms. Vetter began her career as an advanced practice provider in the Solid Organ Transplant program at UR, with a focus on liver transplant, live liver donation, and hepatology. In 2013, she transitioned to a non-transplant hepatology and gastroenterology role with a focus in pancreaticobiliary. She has interests in education, mentoring, research, and APP professional development, and has multiple publications, case studies, and has presented at various conferences.

Ms. Vetter served as the first Chair of the American College of Gastroenterology Advanced Practice Providers Committee from 20182022. She is passionate about working for APPs in gastroenterology. Most recently, she has co-authored an ACG Practice Management Toolbox article about incorporating advanced practice providers into GI practice.

Distinguished NP/PA Teaching Award

 The intent of the DISTINGUISHED NP/PA TEACHING AWARD is to recognize a distinguished nurse practitioner or physician assistant who has shown long-standing contributions to educating and mentoring NPs/PAs in the field of gastroenterology and hepatology. The candidate has made meaningful contributions in teaching by demonstrating mentorship, preceptorship, curricula development, and/or other activities that have an impact in educating and developing future NPs/PAs in the field. This award is being given for the first time in 2024.

Andrea E. Wagner, CNP, is a nurse practitioner at Mayo Clinic in Rochester, Minnesota. Her clinical focus and interests include esophageal disorders, including Barrett’s esophagus, achalasia, and eosinophilic esophagitis.

Ms. Wagner has been dedicated to education throughout her career as a clinical preceptor for the Mayo Clinic Nurse Practitioner and Physician Assistant Clinical rotations, coDirector for the Mayo Clinic Physician Assistant Board Review Course, and co-founder of the Mayo Clinic enterprise wide GIH APP Education Day. She collaborated with the Mayo Clinic School of Health Sciences in the creation and establishment of the Mayo Clinic Nurse Practitioner/ Physician Assistant Gastroenterology and Hepatology Fellowship program. She has served as the program director since its inception.

Ms. Wagner has participated in institutional education initiatives, including the formation of NP/PA Quality Standards for all Mayo Clinic School of Health Sciences NP/PA Fellowship Programs. She serves on her Division’s Education Committee and has lectured both locally and nationally. As a member of the American Gastroenterological Association, she was nominated to participate on the AGA’s Education and Training Committee. She appreciates that educating future clinicians has a farreaching impact on more patients than could ever be seen by one clinician alone.

TEXT YOUR QUESTIONS to the Moderators!

Do you have a question for the moderator of a course you’re attending?

SUNDAY

TUESDAY OCTOBER 29

PG Course Simultaneous Session D

WEDNESDAY OCTOBER 30

1. FIND THE CODE for your session below

2. TEXT THE CODE AND YOUR QUESTION TO 22333 during the session

3. You MUST TEXT "LEAVE" to 22333 AT THE END OF EACH SESSION in order to participate in subsequent sessions.

FOR EXAMPLE: if you have a question during Saturday’s Postgraduate Course Session 1A: Inflammation you would send a text to 22333 with the code ACGPG1A and your question.

- 3:00

PG Course Simultaneous Session E 1:45 pm - 3:00 pm

Ballroom 1 Code:

Ballroom 2-3 Code: ACGPGSSE PG Course Simultaneous Session F 1:45 pm - 3:00 pm

Plenary Session 2

Simultaneous Symposia 1A

Ballroom 4 Code: ACGPGSSF

am - 12:45 pm Terrace Ballroom 1 Code: ACGAM1A

Simultaneous Symposia 1B 11:30 am - 12:45 pm Terrace Ballroom 2-3 Code: ACGAM1B

Simultaneous Symposia 1C 11:30 am - 12:45 pm Terrace Ballroom 4 Code: ACGAM1C

ACG-FDA Related Matters and Innovation & Technology Joint Symposium 12:45 pm - 2:15 pm 119AB Code: ACGFDA

Plenary Session 1A 2:15 pm - 3:00 pm Terrace Ballroom 1 Code: ACGPL1A

Plenary Session 1B 2:15 pm - 3:00 pm Terrace Ballroom 2-3 Code: ACGPL1B

Journal Editors Roundtable 3:45 pm - 4:45 pm 119AB Code: ACGJER

Simultaneous Symposia 2A 4:45 pm - 6:00 pm Terrace Ballroom 1 Code: ACGAM2A

Simultaneous Symposia 2B 4:45 pm - 6:00 pm Terrace Ballroom 2-3 Code: ACGAM2B

Simultaneous Symposia 2C 4:45 pm - 6:00 pm Terrace Ballroom 4 Code: ACGAM2C

Plenary Session 2A 8:30 am - 10:00 am Terrace Ballroom 1 Code: ACGPL2A

Plenary Session 2B 8:30 am - 10:00 am Terrace Ballroom 2-3 Code: ACGPL2B

Simultaneous Symposia 3A 11:30 am - 12:45 pm Terrace Ballroom 1 Code: ACGAM3A

Simultaneous Symposia 3B 11:30 am - 12:45 pm Terrace Ballroom 2-3 Code: ACGAM3B

Simultaneous Symposia 3C 11:30 am - 12:45 pm Terrace Ballroom 4 Code: ACGAM3C

Plenary Session 3A 2:15 pm - 3:45 pm Terrace Ballroom 1 Code: ACGPL3A

Plenary Session 3B 2:15 pm - 3:45 pm Terrace Ballroom 2-3 Code: ACGPL3B

Simultaneous Symposia 4A 5:10 pm - 6:25 pm Terrace Ballroom 1 Code: ACGAM4A

Simultaneous Symposia 4B 5:10 pm - 6:25 pm Terrace Ballroom 2-3 Code: ACGAM4B

Plenary Session 4A 8:30 am - 10:15 am Terrace Ballroom 1 Code: ACGPL4A

Plenary Session 4B 8:30 am - 10:15 am Terrace Ballroom 2-3 Code: ACGPL4B

Simultaneous Symposia 5A 11:00 am - 12:15 pm Terrace Ballroom 1 Code: ACGAM5A

Simultaneous Symposia 5B 11:00 am - 12:15 pm Terrace Ballroom 2-3 Code: ACGAM5B

A Conversation with ACG’s Next President, Amy S. Oxentenko, MD, FACG

sustainable future for GI that we can all be excited about!

You have been extremely active in training and clinical education within the College as well as in your various roles at Mayo Clinic, including both internal medicine and gastroenterology and hepatology. As the nature of clinical practice evolves and organizations like the ACGME and ABIM try to keep up, what is your evaluation of the current state of training in medicine in general and in our specialty in particular? The most rewarding experiences I have had thus far in my career have been those that have helped to shape the workforce of the future. There is nothing more gratifying than to see those you have recruited, trained, and mentored go on to successful careers. Healthcare is rapidly transforming, and how we train the workforce of the future also needs to transform. It was not long ago that simulation training was novel in gastroenterology, and yet now our trainees need to understand responsible use of artificial intelligence, how to incorporate new data streams from wearables and other inputs into a patient’s care plan, and need to know the nuances of practicing medicine in a virtual world. If programs are relying on traditional curricular paradigms, they are not equipping trainees for what lies ahead. Also, as trainees have sought to become even more specialized in their future practices, this has resulted in more years in training. As we look to the future and can predict where we will have greater workforce shortages, we need to have undergraduate and graduate medical education accreditation bodies empower programs to innovate and show what is really needed, cutting out redundancy, to help bridge those gaps. We have seen this successfully piloted with transplant hepatology, and the ACGME has had an open call out for AIRE (Advancing Innovation in Residency Education) proposals – which includes all of GME – where specialties can propose new models that may shorten training, yet ensures competency. Does core GI fellowship plus an advanced year really need to be four years in length? Does internal medicine plus GI really need to be 6 years in length? These are the types of questions we need to consider as we evaluate our future workforce needs in gastroenterology.

It also goes without saying that as we become more specialized in our care of patients who are getting more complex over time, there needs to be customization of our ongoing learning and assessment to satisfy ABIM maintenance of certification needs. We

all are learning every day in practice, such as reading the most updated ACG guideline or reviewing the side effects of a novel therapy we want to consider for our patients. This just-in-time selfdirected learning needs to be translated into just-in-time credit.

In light of your comments, can you share your thoughts about the College’s role as an educationfocused organization and the keys to successful educational programming and resources in 2025?

ACG has had the educational needs of our members as a highest priority, whether that be the experiences for trainees through programming, panels, webinars; and mentorship programs; for program directors and educators through curricular tools within ACG Universe and Train-the-Trainers programs; for all in clinical practice through courses, guidelines, podcasts, Virtual Grand Rounds; and so much more. The educational content put out by ACG is phenomenal given the due diligence in making sure every product best meets the needs of those who will be using it - all of you! There is so much that goes on behind the scenes to ensure delivery on that high bar. The ACG staff work tirelessly on meeting the educational needs of our members, and they are the engine that keeps it all running so efficiently and effectively. Our educational programming has and will remain relevant for the changing landscape of practice, incorporating new content and programming to meet the needs of our practicing members.

Your practice has focused on celiac disease and conditions of the stomach and small bowel. What led you down that path and what are some of the most interesting developments you think are coming in the near-to-medium future?

I got interested in proximal bowel luminal diseases as early as my medical school physiology course. It fascinated me that the small bowel could so rapidly respond (e.g., secretion, absorption) based on ingested contents and the health of the underlying bowel. As a distance runner from my high school years onward, fueling and hydration was always an exercise in trial and error – and let me tell you – one learns a lot about GI physiology very quickly if there is an error! Realizing how to take advantage of small bowel physiology to replace losses can be a game changer for endurance athletes. To be able to apply those learnings into real-life situations with patients who have small bowel diseases was incredibly gratifying, noting how slight changes in someone’s diet could make an extraordinary difference in their GI symptoms. I have

found that taking a careful dietary history in patients who present with diarrhea or bloating, for example, can be key to symptom improvement. I had great mentorship during my residency years working on celiac disease projects with Dr. Joe Murray, which further fueled my passion for small bowel diseases.

We are learning so much on what we can do for patients with the development of cellular, molecular, and bispecific therapies, so it is only a matter of time before we find even more ways that we can reprogram our body’s response to antigenic or other stimuli, completely changing the face of diseases that we treat now.

At last year’s Annual Scientific Meeting, there was a display illustrating the history of women leadership within the College. This is now on display at the ACG headquarters. After years of concerted efforts, the percentage of women in in key roles such as service on the Board of Trustees, Board of Governors, as well as Committee membership and course directors has grown to meet or exceed the percentage of women across the membership. Why do you think this is important for the College and clinical gastroenterology and hepatology at large?

The efforts of the College to ensure equitable representation by women in key roles have been remarkable and commendable. We have barely reached a critical mass of women in our specialty, yet we are attracting more women into GI, as evidenced by the demographics of those in our training programs. If we show women trainees and junior faculty that there will be opportunities for them and a place at the table, we will be able to attract and retain top talent. There has been compelling data that has shown that diversity in the workforce that reflects the diversity in the patients we serve will lead to better outcomes. The College has supported numerous initiatives aimed to recognize the diverse backgrounds and experiences of our members, and by ensuring that sense of belonging in our membership, we will be able to accomplish far more together. I feel incredibly grateful for the many individuals within ACG who opened doors for me, so my mission is to continually find ways to pay it forward.

One of the paths to leadership in the College is through committee service. You served for some time as a member and as Chair of the Women in GI Committee at a time when its activities expanded considerably. Can you offer your impressions of the work of this committee and its unique

role within the College?

Being a prior member and Chair of the Women in GI Committee was an incredible honor, and this committee has worked steadfastly over the years to meet the needs of College members, as well as the patients that we serve given the evolving demographics of those groups. This committee has created resources to address unique challenges and barriers that women may face throughout their training, child-bearing years, and throughout career and leadership pursuits. With programming and platforms for such issues to be openly and candidly addressed, it has allowed a proactive approach to ensuring we maintain the pipeline of talented women interested in GI. The Women in GI Committee has also been involved in a number of initiatives that have provided resources for the care of women as patients within our specialty. The ACG Monograph in GI Diseases and Endoscopy in Pregnancy and Postpartum Period that was published in The American Journal of Gastroenterology is one fantastic example of that. The overwhelming interest expressed by College members to join the Women in GI Committee is a testament to its ongoing essence. You balance extensive institutional clinical and administrative responsibilities at the Mayo Clinic Rochester. How do you anticipate adding new responsibilities and the demands of the ACG presidency over the coming 12 months?

I love this question, and it is great to hear that we ask this of all incoming presidents, given its importance! To lead within a society like ACG, one should have demonstrated leadership within their own institution or practice. Therefore, we will continue to call upon those who are remarkably busy in their clinical and administrative roles to serve in this important College capacity, so this is a pertinent question for everyone stepping into this role. Essential leadership skills that include planning, organizing, and delegating have served me well in the past and will be paramount going into this year. In leadership talks and workshops I have presented at, I talk about the proverbial “plate,” avoiding the comparison game to the plates of others, and knowing when your plate is full, how to move things off your plate, and the consequences of not managing your plate well. I try to practice what I preach. In addition, I know what I need to maintain my wellness and avoid burnout, so I do not sacrifice when it comes to my own self-care. So, the simple answer to this question is that I will be redistributing things on my

plate for the next year. There is no doubt this year will be a busy one, and lands at a time when my husband and I will become “empty nesters” for the first time as we send all three of our kids off to college this fall. This will free up the many hours I have spent as an unofficial Uber driver and cheering at baseball tournaments, football games, crosscountry courses and around tracks. In recent years, and in conjunction with my role as Vice Dean of Practice for Mayo Clinic - serving on numerous practice committees across our organization – I have maintained a busy inpatient and outpatient clinical practice that has nearly half of my FTE. I value this time in patient care because I can best lead in the practice and in the College by experiencing first-hand the challenges members are similarly experiencing. You are quite well known for your commitment to strong mentorship. How can the College best assist in facilitating mentorship?

My strong commitment to mentorship stems from the fact that I had incredible and unwavering mentorship and sponsorship throughout my training and career, so it feels like a prioritized personal responsibility to pay it forward so others who are coming up in the field have the same positive experience and the chance for opportunity. The College has been dedicated to its mentoring program for many years, and I feel so fortunate to have been paired with mentees who have gone on to lead within various aspects of the College and within their own practices or institutions – there is nothing more rewarding. We can continue to encourage formal mentoring programs, not only for trainees and junior faculty, but also extend such programs to those who are mid-career and are looking for a change or pivot – a time when mentoring and advice is critical. We have so many talented individuals in the College, at all levels and depths of experience, and every single member of our society can serve as a mentor to another, formally or informally. I would love to see the College showcase these “mentorship moments” so that everyone can see the true impact that small acts of mentorship can play in one’s future.

In the spirit of being a good mentor, do you have any comments or advice for those interested in starting down the path toward engagement with and a potential future leadership position in the College?

The advice I would give others is that engagement is like dipping your toe in the water – you can get a good feel of the landscape and your future part in it before committing on a deeper level. If there is any reluctance to engage given concerns about the time commitment or other aspects, find something manageable to start that excites you. It

is far better to take on one or two small things and do them very well, rather than overcommitting to something that you cannot deliver on. With hard work and follow-through, more opportunity is likely. If someone from the College reaches out with an opportunity, it is likely that they have seen that drive and determination demonstrated. Early on in one’s career, I would not focus on a future “leadership position.” Instead, focus on cultivating great leadership skills (shameless plug here for the ACG leadership programs!), as strong leadership in general showcases who would be a great leader in the College. Focus on the journey – the experiences, the networking, the relationships –and focus less on the destination.

You have worked very closely with ACG President Jonathan Leighton for many years, both at the Mayo Clinic and within the life of the College. Together, you helped oversee the updates to the College’s strategic plan. What would you like the membership to know about these experiences?

It has been such a joy to work with Dr. Leighton, not only in our work over the years spanning Mayo Clinic sites, in my brief time at Mayo Clinic in Arizona, but also in our time in ACG leadership. Dr. Leighton is a trusted friend, colleague, and leader, and he has been an incredible mentor and sponsor to so many across Mayo Clinic sites and within the College.

The Board of Trustees thought it was timely to update the strategic plan given the healthcare landscape has changed enough over the last 5 years, and this will ensure the College’s new and ongoing initiatives align. Many leaders contributed to the updated strategic plan, under the oversight of Drs. Costas Kefalas and Aasma Shaukat, which has provided a broad lens to scope priorities and future activities.

Dr. Leighton and I reviewed the content as

it was being developed and will use the strategic plan to guide us in upcoming years. It is clear to me that Dr. Leighton has the interest of members and patients at the forefront of his decisions, and that is a legacy I look forward to carrying on.

There is more that I could share on Dr. Leighton, including his special interests, but you will need to listen to his Presidential introduction to learn some of those gems!

Are there any final thoughts you would like to share with the membership as you embark upon this exciting new leadership role?

I could never have imagined when I attended my first ACG as a second-year

resident, giving an oral presentation on celiac disease, that one day I would have the incredible honor of leading the College. I do not take the responsibility lightly. It is critically important to me that every one of our members feels that they are welcome, their voices are heard and that their society needs are being met. I look forward to partnering with all of you to ensure that ACG continues to serve your practice, education, research, and personal needs! There is a place for everyone at the ACG table! #BOOM

CONNECT

CME & MOC for ACG 2024

The maximum total CME credits for this activity assumes attendance at all sessions throughout the live meeting (in-person or virtual), as well as review of all recordings of sessions not attended live. Participants should claim credit for time spent engaged in both the live meeting and session recordings. Submit your meeting evaluation and claim CME only after you have completed the content you want. You should only claim the amount commensurate with your time spent in this activity. Evaluations cannot be reopened once submitted. Do not claim CME until you have completed all intended content (including on-demand).

The American College of Gastroenterology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Gastroenterology designates these other activities (blended learning) for a maximum number of AMA PRA Category 1 Credits™ as noted below. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

Successful completion of each CME activity, which includes participation in the evaluation component, enables the participant to earn Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) and MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) programs. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM and ABP MOC credit.

An equal number of CME credits and MOC points will be awarded for each course, as reflected in the maximums listed below. Please note, claiming CME and MOC are TWO DIFFERENT processes, and you cannot make changes or adjust your CME credits after you submit your course evaluation.

No MOC credit will be awarded after April 30, 2025 for these

How to Claim CME and MOC for ACG 2024

 Complete your evaluations: evals.gi.org/AM/2024

Your certificate will be available to you on the site once your evaluation has been successfully submitted.

U.S.-licensed physicians will then be directed to the MOC submission page to obtain MOC points.

ABIM Board Certified physicians need to complete their MOC activities by December 31, 2024 in order for the MOC points to count toward any MOC requirements that are due by the end of the year. No MOC credit may be awarded after April 25, 2025 for this activity.

Please allow 2-3 business days for your MOC credit to appear on your ABIM account.

ABP diplomates can NOT use the MOC link on the evaluation site to claim MOC points. AFTER completing your CME evaluation and submitting for CME credits for an individual course, ABP MOC can be claimed by emailing education@gi.org.

CME/MOC FOR ACG 2024 COURSES Contact ACG: education@gi.org AWARDED POINTS OR MOC STATUS Contact ABIM: 1-800-441-ABIM | ABP: 919-929-0461

FEATURED LECTURES

CREATING A MANAGEABLE COCKPIT FOR PHYSICIANS

Christine A. Sinsky, MD, MACP

 Saturday, October 26

 10:00 am – 10:30 am ET

 Terrace Ballroom

\ DAVID SUN LECTURE

Saturday, October 26

\ THE AMERICAN JOURNAL OF GASTROENTEROLOGY LECTURE

Monday, October 28

\ J. EDWARD BERK DISTINGUISHED LECTURE

Tuesday, October 29

\ EMILY COURIC MEMORIAL LECTURE

Tuesday, October 29

\ DAVID Y. GRAHAM LECTURE

Wednesday, October 30

Join colleagues as Dr. Christine Sinsky presents the David Sun Lecture on “Creating a Manageable Cockpit for Clinicians.” For many clinicians, the work of health care has become undoable. The “cockpit” where physicians and other health professionals work now consists of a cacophony of warning alerts, pop-up messages, mandatory tick boxes, a Sisyphean inbox, and maddening documentation. Paradoxically, many interventions intended to improve quality, safety, or value, when taken in totality, may in fact contribute to health system dysfunction by virtue of the cumulative impact on workload and consequent burnout.

Christine A. Sinsky, MD, MACP, is Vice President of Professional Satisfaction at the American Medical Association. A general internist, she practiced at Medical Associates Clinic in Dubuque, Iowa, for 32 years. Dr. Sinsky is a former Director for the American Board of Internal Medicine and a former Chair of the ABIM Foundation Board of Trustees. She currently serves on the National Academy of Medicine’s Action Collaborative on Clinician Well-Being.

Dr. Sinsky leads initiatives at the American Medical Association to improve opportunities for joy, purpose, and meaning in work for physicians and their teams. Publications on “The Quadruple Aim,” “Joy in Practice,” “Texting While Doctoring,” and “Creating a Manageable Cockpit for Clinicians,” have contributed to the national conversation. She has also contributed to research regarding the prevalence, drivers, and solutions to burnout among physicians and to resources for individual physicians and for health systems to improve practice efficiency and organizational culture.

 The David Sun Lecture, held during the Postgraduate Course, was established by Mrs. Sun in memory of her husband, Dr. David Sun, an outstanding gastroenterologist and investigator. Each year, a lecturer with a distinguished background in gastroenterology or an allied field is chosen by the ACG President subject to the approval of the ACG Educational Affairs Committee and the Board of Trustees.

DRUG-INDUCED LIVER INJURY

AS AN EXAMPLE FOR LEVERAGING NETWORKS FOR CLINICAL RESEARCH

Naga

 Monday, October 28

 3:05 pm – 3:35 pm ET

 Terrace Ballroom 2-3

Join Dr. Naga P. Chalasani as he discusses drug-induced liver injury and how to leverage networks for clinical research during Monday’s The American Journal of Gastroenterology Lecture.

Naga P. Chalasani, MD, FACG, is currently the David W. Crabb Professor of Medicine and Vice President for Academic Affairs at Indiana University School of Medicine and Indiana University Health. He previously served as the Director of the Division of Gastroenterology and Hepatology (2007-2020) and interim Chair of the Department of Medicine (2020-2021) at IU School of Medicine. He received his MBBS at Kakatiya Medical College (1981-1987) and completed his internal medicine residency (1991-1994) and gastroenterology and hepatology fellowship (1994-1997) at Emory University in Atlanta.

His research is focused on nonalcoholic fatty liver disease (NAFLD) and druginduced liver injury (DILI), two highly significant public health problems. His research has been continuously funded by the National Institutes of Health since 1999. He is a founding principal investigator of the NIDDK-funded NASH CRN and is the PI for the HIV NASH CRN. He was the lead author for the practice guideline on the Diagnosis and Management of Nonalcoholic Fatty Liver Disease by multiple societies (AASLD, ACG, and AGA) in 2012 which was updated in 2022 by the AASLD. He is the founding PI for the NIDDK-funded Drug-Induced Liver Injury Network and is the lead author for the ACG Practice Guideline on the Diagnosis and Management of Drug-Induced Liver Injury.

Dr. Chalasani was the first author on the 2021 ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. He has authored over 400 original papers during his career, and has received over $60 million of extramural funding from the National Institutes of Health and other sponsors. He is an elected member of Alpha Omega Alpha, American Society of Clinical Investigation (ASCI), and the American Association of Physicians (AAP). He is a former trustee of the ACG Board of Trustees.

EXPLORING NEW FRONTIERS: Innovations Shaping the Future of Gastrointestinal Endoscopy

Michelle

 Tuesday, October 29

 10:05 am – 10:35 am ET

 Terrace Ballroom 2-3

At this year’s J. Edward Berk Distinguished Lecture, Dr. Anderson will discuss the challenges and opportunities that exist in adopting emerging technology in gastrointestinal procedures.

Dr. Michelle Anderson is Associate Professor and Senior Associate Consultant at Mayo Clinic Arizona. Her research and clinical career is focused on gastrointestinal disease with a specific concentration on pancreatic diseases including chronic pancreatitis and pancreatic cancer. Using advanced endoscopy techniques, including endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography, she cares for the full spectrum of benign and malignant pancreatic disorders. Dr. Anderson successfully completed an NIH-sponsored study centered on the discovery and validation of minimally invasive clinical biomarkers for the diagnosis of pancreatic cancer.

On a national level, Dr. Anderson is an active member of the ASGE Governing Board and currently serves as the Secretary-Elect. She is the Co-Director of the ASGE EUS Diagnostic Course. Dr. Anderson speaks regularly on topics of biliary and pancreatic diseases and teaches advanced endoscopic techniques nationally and internationally. In the arena of chronic pancreatitis, Dr. Anderson led the development of national guidelines in the care of patients with painful chronic pancreatitis. Additional work in this field includes the publication of three peer-reviewed papers focused on pain, chronic pancreatitis, and EUS, two of which involved a multi-center prospective cohort study of patients with chronic pancreatitis.

 The AJG Lecturer was chosen by the co-editors of The American Journal of Gastroenterology with approval from the ACG Educational Affairs Committee and the Board of Trustees.

 The J. Edward Berk Distinguished Lecturer is awarded to individuals prominent in gastroenterology or a related area. The lecturer is nominated by the ACG President, and the appointment is subject to approval by the Board of Trustees. The lectureship was established in recognition of the significant contributions made by J. Edward Berk, MD, MACG, to clinical gastroenterology during his long and distinguished clinical and academic career.

P. Chalasani, MD, FACG

A. Anderson, MD, MSc

KINDNESS-INFLUENCED TRUST AND HEALING AFRICA – Opportunities for You and

for the ACG

Leonard L. Berry, PhD, MBA

 Tuesday, October 29

 4:30 pm – 5:00 pm ET

 Terrace Ballroom 2-3

Attend Dr. Berry's Emily Couric Memorial Lecture and gain a better understanding of how kindness is a behavior with multiple dimensions that not only influences patients’ trust and healing but benefits clinicians as well.

Dr. Leonard L. Berry is University Distinguished Professor of Marketing, Regents Professor, and holds the M.B. Zale Chair in Retailing and Marketing Leadership in the Mays Business School at Texas A&M University. He is also a Presidential Professor for Teaching Excellence. As a Visiting Scientist at Mayo Clinic in 2001-2002, he conducted an in-depth research study of healthcare service, the basis for his book, Management Lessons from Mayo Clinic (2008). He also has done in-residence field research at Gundersen Health System, ThedaCare, and Bellin Health System, all in Wisconsin, and at Henry Ford Health in Detroit, Michigan. Dr. Berry is a Senior Fellow of the Boston-based Institute for Healthcare Improvement, studying service improvement in cancer care, and is an Adjunct Professor, Faculty of Health Sciences, at the University of Southern Denmark.

Professor Berry has published 13 books including: Discovering the Soul of Service, On Great Service, Marketing Services: Competing Through Quality, and Delivering Quality Service. He is the author of numerous academic articles and an invited lecturer throughout the world.

Professor Berry’s teaching and research contributions have been widely recognized with honors that include the Sheth Gold Medal, the American Marketing Association (AMA) William Wilkie “Marketing for a Better World” Award, the Paul D. Converse Award, the AMA/McGraw-Hill/Irwin Distinguished Marketing Educator Award, the AMA Career Contributions to Services Marketing Award, and the Academy of Marketing Science Outstanding Marketing Educator Award. He is a Fellow of both the American Marketing Association and the Academy of Marketing Science. In 2024, he received Texas A&M’s Southeastern Conference Faculty Achievement Award. He also has received the University’s Distinguished Achievement Award in Teaching and the Distinguished Achievement Award in Research. Dr. Berry is the most frequently cited author in the Texas A&M University System. He is a former national president of the American Marketing Association.

David E. Fleischer, MD, FACG

 Wednesday, October 30

 10:20 am – 10:50 pm ET

 Terrace Ballroom 2-3

Join Dr. Fleischer as he delivers the David Y. Graham Lecture and discusses personal and professional opportunities that exist in Africa, as well as ways that ACG can facilitate opportunities for its members to participate in clinical, educational, and research activities there.

Dr. Fleischer is currently a staff physician at Mayo Clinic Arizona and a Professor of Medicine at Mayo Clinic College of Medicine. He graduated from Vanderbilt University School of Medicine. He did his residency at Cleveland Metropolitan General Hospital/Case Western Reserve University and at Wellington Hospital in New Zealand. He completed his GI fellowship at Harbor General UCLA. He served in the United States Army at Fort Belvoir, Virginia. He was on the staff at the VA Medical Center in Washington, DC, the Cleveland Clinic Foundation, Georgetown University (where he was a Professor of Medicine), and Mayo Clinic Arizona (where he served as Chair of the Division of Gastroenterology until 2006). He is a member of ASGE (for which he served as President), AGA, and ACG. He is also an honorary member of the Swiss Gastroenterology Society and Italian Gastroenterology Society. Dr. Fleischer has been given the Schindler Award by the ASGE, its highest honor, and he has been an invited lecturer for the society. He is a Master in the American College of Physicians and served as a Robert Wood Johnson Health Policy Fellow in the United States Senate. He has published more than 250 original articles and edited several books. He has lectured throughout the United States and internationally and has spoken on all seven continents, most recently in Antarctica.

His main interests are innovations in endoscopy, esophageal cancer, and Barrett's esophagus. He has been involved in projects for screening, prevention, and treatment of esophageal cancer in China, Iran, South Africa, and Kenya. Dr. Fleischer is married to Karen Samuel, and they have three children - Ruben, Lucas, and Mara. He enjoys golf, hiking, hat collecting, writing low doggerel poetry, making scrapbooks, playing ladder golf, and both country and western music.

 The Emily Couric Memorial Lecture—developed by the ACG, the Virginia Gastroenterological Society, and the Old Dominion Society of Gastroenterology Nurses and Associates—is in honor of Virginia State Senator Emily Couric, who died of pancreatic cancer in October of 2001. Senator Couric was a strong advocate for health care issues, particularly in her instrumental work to pass the nation’s first legislation mandating health insurance coverage for colorectal cancer screening.

 The Graham Lecturer is chosen by the ACG President and is subject to approval by the ACG Board of Trustees. Established in 2004 in recognition of the many contributions to clinical gastroenterology made by David Y. Graham, MD, MACG, this named lectureship was made possible through a donation by Otsuka Pharmaceutical Co., Inc., and Meretek Diagnostics, Inc.

Endoscopy School

HANDS-ON WORKSHOP CENTER

Workshop Directors: Christine Y. Hachem, MD, FACG, and Ronald K. Hsu, MD, FACG

GAIN INSIGHT FROM LEADING EXPERTS and learn about the latest tools and techniques when you participate in one or more of the numerous sessions to be offered.

\ GI Fellows-only sessions will be offered on Monday, October 28

\ Resident Training sessions will be offered on Sunday, October 27, Monday, October 28, and Tuesday, October 29.

SUNDAY, OCTOBER 27, 2024

3:45 pm – 6:45 pm

4:00 pm – 7:00 pm

10:15 am – 12:55 pm

10:30 am – 1:05 pm

1:55 pm – 4:30 pm

2:05 pm – 4:40 pm

10:05 am – 12:45 pm

10:20 am – 12:55 pm

1:45 pm – 4:20 pm

1:55 pm – 4:30 pm

 Please note: All Hands-on Workshop registration will be done via the meeting app; registration for a session will open in the app the day before the session. Space is limited.

New Ultrasound Technology (Liver Elastography & IBD US)

Faculty Leader: Bincy P. Abraham, MD, MS, FACG

Foreign Body Removal

Faculty Leader: Kavya Reddy, MD

Hemostasis

Faculty Leader: Fouad A. Otaki, MD

MONDAY, OCTOBER 28, 2024

ERCP

Faculty Leader: Immanuel K.H. Ho, MD, FACG

EMR/Polypectomy

Faculty Leader: Nikila C. Ravindran, MD, FACG

Advanced Technology (Stenting/POEM)

Faculty Leader: Shivangi T. Kothari, MD, FACG

Hemostasis

Faculty Leader: Julie T. Yang, MD

EUS

Faculty Leader: Vivek Kaul, MD, FACG

ESD with the Experts

Faculty Leader: Galen Leung, MD

Mucosal Ablation

Faculty Leader: Michael S. Smith, MD, MBA

Hemorrhoid Therapy

Faculty Leader: Jessica L. McKee, DO

TUESDAY, OCTOBER 29, 2024

ERCP

Faculty Leader: Jodie A. Barkin, MD, FACG

Small Bowel (Capsule Endoscopy/Enteroscopy)

Faculty Leader: Tanya Bruckel, MD

EMR/Polypectomy

Faculty Leader: Linda S. Lee, MD, FACG

Mucosal Ablation

Faculty Leader: Nicholas J. Shaheen, MD, MPH, MACG

Hemorrhoid Therapy

Faculty Leader: Waqar A. Qureshi, MD, FACG

Foreign Body Removal

Faculty Leader: Linda C. Cummings, MD, FACG

Esophageal / Anorectal Manometry / Sacral Neuromodulation

Therapy for Fecal Incontinence / Endoluminal Functional

Lumen Imaging Probe

Faculty Leader: Scott L. Gabbard, MD, FACG

Hands-On Endoscopy Sessions do not offer CME.

7:45 am9:30 am

ERCP

Faculty Leader: Ronald K. Hsu, MD, FACG

EMR/Polypectomy

Faculty Leader: Lauren G. Khanna, MD, MS

Foreign Body Removal

Faculty Leader: Saurabh Chawla, MD, FACG Hemostasis

Faculty Leader: Wissam Kiwan, MD

RESIDENT TRAINING SESSIONS BACK BY POPULAR DEMAND!

• Sunday, October 27, 2024 | 4:00 pm – 5:50 pm

Faculty Leader: Jeffrey Z. Ko, MD

• Monday, October 28, 2024 | 10:30 am – 12:20 pm

Faculty Leader: Folasade P. May, MD, PhD, MPhil

• Monday, October 28, 2024 | 2:45 pm – 4:35 pm

Faculty Leader: Milena G. Suarez, MD, FACG

• Tuesday, October 29, 2024 | 2:00 pm – 3:50 pm

Faculty Leader: Kamran Qureshi, MD

ERGONOMIC ASSESSMENTS

Learn how to identify and limit potential work-related injuries related to performing endoscopies. 15-minute sessions will be offered. All Endoscopy School Hands-on Workshop registration will be done online, and registration for a session will open the day before the session. Pre-registration will be required, and a limited number of spaces are available for each session. In-person attendees are limited to a single time slot and space is extremely limited.

Sunday, October 27, 2024 3:30 pm - 6:45 pm Monday, October 28, 2024 10:30 am - 4:45 pm

The 12th Annual ENDOSCOPY VIDEO FORUM

 Monday, October 28 |  4:45 pm   –

Cases Demonstrate Interesting Endoscopic Findings and Techniques Encountered in Daily Clinical Practice

The Endoscopy Video Forum Symposium will feature the best video presentations submitted by colleagues from across the U.S. and around the world. Submitted during the Call for Abstracts and peer-reviewed and selected for oral presentation, the cases will feature interesting endoscopic techniques and challenging or unique cases encountered in daily clinical practice. At the end of the session, the audience, along with the judges, will vote to select the best video of ACG 2024.

Moderators:

Jodie A. Barkin, MD, FACG

Vivek Kaul, MD, FACG

Judges:

Sean Bhalla, MD

Laith H. Jamil, MD, FACG

Pichamol Jirapinyo, MD, MPH

Lauren G. Khanna, MD, MS

Vanessa M. Shami, MD, FACG

C. Roberto Simons-Linares, MD

Guilerme G. Macedo, MD, PhD, MACG

Presenting Authors are UNDERLINED

V1. The Runaway Bowel: Endoscopic Tethering for Management of a Delayed EUS-Guided Gastroenterostomy Dehiscence

Ali Lahooti, BS1, Anam Rizvi, MD1, Muhammad Usman Baig, MBBS1, Kate E. Johnson, BS1, SriHari Mahadev, MD2, Kartik Sampath, MD1, David L. CarrLocke, MD, FACG1, Reem Sharaiha, MD1; 1Weill Cornell Medicine, New York, NY, 2New York-Presbyterian / Weill Cornell Medical Center, New York, NY

V2. Lost in the Biliary Maze: A Rare Case of TIPS Stent Misplacement Successfully Treated With EDGE

Alejandra Vargas, MD1, Michael Saadeh, MD2, Steve D'Souza, MD3, Ana Vilela, MD1, Adam Lustig, MD1, Parth Parekh, MD1; 1Eastern Virginia Medical School, Norfolk, VA, 2University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH, 3Case Western Reserve University / MetroHealth, Cleveland, OH

V3. Endoscopic Ultrasound-Guided Ileo-Colostomy Creation to Manage Distal Small Bowel Obstruction

Brysen Keith, DO, MSBE1, Shria Kumar, MD, MSCE2, Jodie A. Barkin, MD, FACG3, Sunil Amin, MD, MPH1, Sean Bhalla, MD1; 1University of Miami Miller School of Medicine, Miami, FL, 2University of Miami, Miami, FL, 3University of Miami Miller School of Medicine, Boca Raton, FL

V4. Building Bridges: NOTES Salvage for EUS-Guided Gastroenterostomy

Carter E. Edmunds, MD1, Dalton A. Norwood, MD2, Babusai Rapaka, MD3, Jessica McCreight,3, Rachel Mitchell,c3, Shajan Peter, MD3, Ali Ahmed, MD3, Kondal Kyanam, MD3, Ramzi Mulki, MD3, Sergio A. Sánchez-Luna, MD3; 1University of Alabama at Birmingham Hospital, Birmingham, AL, 2UAB Minority Health & Health Equity Research Center, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL, 3Basil I. Hirschowitz Endoscopic Center of Excellence, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL

V5. Suture Traction-Assisted Bearclaw Fistula Closure: A Case Series Describing a Novel Endoscopic Technique for Fistula Closure

Joelle Sleiman, MD, Mohammad Abureesh, MD, Jean M. Chalhoub, MD, Sherif Andrawes, MD, Youssef El Douaihy, MD; Staten Island University Hospital, Northwell Health, Staten Island, NY

V6. Endoscopic Intermuscular Dissection for Large, Obstructing Subepithelial Tumor of the Transverse Colon Using the Novel Dynamic Rigidizing Overtube

Marina Kim, DO1, Tamadar Abdulrhman Al Doheyan, MD2, Roshan Raza, MD2, Mohamed Othman, MD2; 1Saint Louis University, St. Louis, MO, 2Baylor College of Medicine, Houston, TX

our Cutting-Edge IBD Clinical Decision Support Tool to make a difference in Treatment Selection and RMEI will Donate in Your Honor

FREE ONGOING ACCESS

The IBD CDST was developed by Parambir Dulai, MD in conjunction with the US Health Outcomes Consortium, a collaboration of leading IBD centers across the US. RMEI Medical Education provides ongoing oversight, content development, and accreditation for related CE activities. ArcheMedX provides platform development, optimization, and data tracking.

This CDST is supported by educational grants from Takeda Pharmaceuticals U.S.A., Inc. and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC both Johnson & Johnson Companies.

*The $1 donation is solely funded by RMEI Medical Education, LLC. No external funding was used for this expense. Connect, Collaborate, and Elevate IBD Treatment Together Visit us at Booth 575 to learn more! For every sign-on, RMEI will Donate $1 to an IBD related non-profit* Access the CDST

DIVERSITY, EQUITY, AND INCLUSION AWARD FOR DEDICATION TO HEALTH

EQUITY

AND DIVERSITY IN

GI, SONALI PAUL, MD, FACG, Receives the Diversity, Equity and Inclusion Award

Sonali Paul, MD, FACG, is awarded the 2024 ACG Diversity, Equity, and Inclusion Award for her passion for health equity, specifically for sexual and gender minorities, for both professionals and patients in the GI and hepatology community. Dr. Paul has been a leader in supporting LGBTQI+ physicians and conducting research to increase awareness of the unique challenges of LGBTQI+ patients in GI and hepatology.

Sonali Paul, MD, FACG, is Assistant Professor of Medicine in the Section of Gastroenterology, Hepatology, and Nutrition at the University of Chicago. She obtained her medical degree from Tufts University School of Medicine and completed her residency at Massachusetts General Hospital and advanced fellowships in gastroenterology and transplant hepatology at Tufts and MGH, respectively. She joined the University of Chicago in 2016 and has worked at the grassroots level to promote diversity and health care equity in the workplace, not just for patients but also for colleagues.

While establishing her academic and clinical niches in metabolic dysfunction-associated steatotic liver disease and obesity medicine as a transplant hepatologist, Dr. Paul has been working on her other passion to promote health care equity, particularly in the LGBTQI+ population. She has increased awareness on health disparities in the LGBTQI+ population in the realms of gastroenterology, hepatology, and liver transplantation through national presentations and publications.

ACG is offering BAG STORAGE during ACG 2024

Dr. Paul is currently Associate Vice Chair of Diversity, Equity, and Inclusion for the University of Chicago's Department of Medicine and Associate Program Director in the Internal Medicine Residency Program. In these roles, Dr. Paul continues to lead efforts to support the Internal Medicine Inclusion and Diversity curriculum, recruit and retain diverse residents and faculty, promote an inclusive environment, and foster engagement within the Southside Chicago patients and community. She is also a previous member of the AASLD and AGA diversity committees and has served on ACG’s Diversity, Equity and Inclusion Committee since 2021.

Dr. Paul is the Co-Founder and Executive Director of Rainbows in Gastro, a newly formed nonprofit organization that brings LGBTQI+ medical trainees and physicians together. This organization is guided by the mission statement of CHARM: Community, Healing, Advocacy, Research, and Mentorship. Dr. Paul has been recognized for her work through various awards. She was the recipient of the University of Chicago Department

CHECK YOUR BAG and continue participating in the ACG conference before you depart Philadelphia.

Located Near ACG Registration in the BROAD

of Medicine’s 2022 Diversity Award, 2023 ACG Edgar Achkar Visiting Scholar in Equity, Diversity, and Ethical Care, and was awarded the 2023 Rising Disruptive Innovator at the 5th Annual Healio Gastroenterology Disruptive Innovator Awards. Dr. Paul is also the incoming Chair of the ACG Diversity, Equity, and Inclusion Committee, and Chair of the Intersociety Group on Diversity, a collaboration between ACG, AASLD, AGA, ASGE, and NASPGHAN.

 THE DIVERSITY, EQUITY AND INCLUSION AWARD

The Diversity, Equity and Inclusion Award is awarded to an ACG member, in recognition of outstanding work in the areas of clinical practice, research, teaching and/or leadership which has demonstrated an emerging or sustained commitment to the values of diversity, health equity and inclusion.

GI FELLOWS-IN-TRAINING EVENTS

 These sessions are available for in-person attendees only

NAVIGATING, NETWORKING, AND NEGOTIATING YOUR FIRST JOB WORKSHOP

Friday, October 25 | 5:45 pm - 9:00 pm | Room 121A

The ACG Women in GI Committee is hosting a program geared toward senior GI fellows and junior faculty, addressing the specifics of both the private practice and academic job search. Discussions will focus on details of private practice versus academics, contract analysis, networking skills, negotiating skills, and work-life balance.

Advance registration is required, and space is limited. There is a $25 fee for this workshop. Light fare will be provided. Visit the ACG Registration Desk to register, however this event may be sold out.

CAREER OPPORTUNITIES FOR WOMEN IN GI LUNCHEON

Saturday, October 26 | 12:20 pm - 1:35 pm | Room 117

The ACG Women in GI Committee is hosting a program geared toward residents, trainees, and junior faculty who are facing difficult decisions regarding the future of their medical careers. Female gastroenterologists from a variety of medical backgrounds will address the issues of being a female subspecialist, balancing career and family, and opportunities for women in medicine, and more specifically, gastroenterology. This program is free for ACG 2024 attendees.

Visit the ACG Registration Desk to register, however this event may be sold out.

GI JEOPARDY: BUZZ IN FOR YOUR TRAINING PROGRAM

Saturday, October 26 | 5:15 pm - 7:00 pm | Room 120AB

GI Jeopardy will return in 2024! Join a lively audience and attend the competitive final round of GI Jeopardy, a spirited GI version of the television classic. The programs competing this year are: Cleveland Clinic Foundation, National Capital Consortium, Naval Medical Center (San Diego), UCLA David Geffen School of Medicine/ UCLA Medical Center, and University of Missouri - Columbia.

TRAINEES LOUNGE

Saturday, October 26 - Tuesday, October 29 8:00 am - 5:00 pm | Room 123

The Training Committee invites ACG residents and GI fellows to network with peers, meet leaders in the GI field, and learn about engagement opportunities within the College at the inaugural ACG Trainee Lounge. Light refreshments will be available.

TRAINEES LUNCHEON

Sunday, October 27 | 12:20 pm - 1:35 pm | Room 116

A special luncheon program exclusively for fellows-in-training will be offered during the Postgraduate Course. This year's luncheon focus will be Scoping Out Your Future: From Fellow to Frontline.

Advance registration is required and space is limited. This luncheon is available to all trainees in gastroenterology and hepatology, and has a fee of $25. Visit the ACG Registration Desk to register, however this event may be sold out.

ENDOSCOPY

SCHOOL

HANDS-ON WORKSHOP CENTER

RESIDENT-ONLY SESSIONS

Sunday, October 27 | 4:00 pm - 5:50 pm | Exhibit Hall

Monday, October 28 | 10:30 am - 12:20 pm | Exhibit Hall

Monday, October 28 | 2:45 pm - 4:35 pm | Exhibit Hall

Tuesday, October 29 | 2:00 pm - 3:50 pm | Exhibit Hall

Residents will be able to get hands-on endoscope training during our residents-only sessions. Experts will be available to guide residents on the use of the scopes as they navigate tasks using the Thompson Endoscopic Skills Trainer (T.E.S.T.). Pre-registration is required. See page 16 for details.

ENDOTITANS HANDS-ON CHALLENGE

Sunday, October 27 | 5:30 pm - 7:00 pm | Exhibit Hall

The EndoTitans Challenge is an opportunity for fellows to demonstrate both their knowledge and technical abilities in endoscopy. The challenge begins over the summer with a preliminary knowledge round open to all secondand third-year fellows. The top scoring fellows from each year are then invited to participate in a skills challenge in Philadelphia. Winners will take home both bragging rights and a travel grant for ACG 2024. Join us in the Endoscopy School Hands-On Workshop Center of the Exhibit Hall to cheer on the competitors.

ENDOSCOPY SCHOOL

HANDS-ON WORKSHOP CENTER TRAINEE-ONLY SESSIONS

Monday, October 28 | 7:45 am - 9:30 am | Exhibit Hall

A special hands-on workshop session just for trainees will be offered. Expert faculty will demonstrate techniques using a wide variety of equipment and products. Attendees will then have an opportunity to practice using the equipment. Pre-registration is required. See page 16 for details.

RESIDENTS SESSION: NAVIGATING THE GI MATCH - TIPS AND TRICKS FOR APPLICANTS

Monday, October 28 | 10:30 am - 11:30 am | Room 119AB

Gastroenterology and hepatology fellowship continues to be one of the most competitive internal medicine subspecialties. This session will focus on answering questions that prospective GI fellowship applicants may have. In addition, a panel of GI fellowship program directors and current GI fellows will share their experiences and tips regarding the application process. This free session is open to all residents attending the Annual Scientific Meeting. No preregistration is required.

FIRESIDE CHAT WITH ACG LEADERSHIP

Monday, October 28 | 10:30 am - 11:30 am | Room 123

Join College leadership and Board of Trustees members for an informal Q&A exclusively for ACG fellows-in-training!

HOW TO GET PUBLISHED: AN ACG JOURNAL EDITORS ROUNDTABLE

Monday, October 28 | 3:45 pm - 4:45 pm | Room 119AB

ACG’s journal editors discuss the most common questions they receive about the publication process and share pearls of wisdom about what works—and what doesn’t work—when submitting papers for publication. If you want to start or improve your publishing career, then don’t miss this valuable opportunity to hear directly from the editors who are eager to help! Free and open to all attendees.

FLASH MENTORING FOR GI FELLOWS

Monday, October 28 | 3:35 pm - 4:35 pm | Room 123

The ACG Training Committee invites fellowsin-training to participate in a Flash Mentoring session with faculty experts on topics such as advanced fellowships, work-life integration, and leadership in the GI field.

To join the waitlist, please visit https:// acgmeetings.gi.org/flash-mentoring-for-gifellows

ASK THE FELLOWS

Tuesday, October 29 | 10:35 am - 11:35 am | Room 123

The ACG Training Committee will host “Ask the Fellows” in the Trainee Lounge. This exciting opportunity for residents hoping to match into GI fellowship will be led by Dr. Joseph Sleiman. Residents will network and ask questions in an informal gathering with GI fellows.

Seven Members to be HONORED AS MASTERS of

THE AMERICAN COLLEGE OF GASTROENTEROLOGY

 Distinguished careers in gastroenterology and contributions to the College through service, leadership, and education have earned seven colleagues the distinction of Master of the American College of Gastroenterology (MACG).

CAROL A. BURKE, MD, MACG

Carol A. Burke, MD, MACG, is a past ACG President and a past president of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer. She is former Vice-Chair of the Department of Gastroenterology, Hepatology, and Nutrition at Cleveland Clinic. She holds joint appointments in the Taussig Cancer Center and Department of Colorectal Surgery. She leads the section of Polyposis in the Sanford R. Weiss, MD, Center for Hereditary Colorectal Neoplasia and is the Program Director of the Carol A. Burke, MD-Sheetz Family Endowed Fellowship in Hereditary Gastrointestinal Cancer Syndromes. Her clinical expertise is in the management and GI cancer risk mitigation of patients in the general population as well as those with hereditary GI cancer syndromes.

Dr. Burke’s research career has focused on the prevention of GI neoplasia including the discovery and use of chemoprevention and has been funded through the NCI, NIH, USDA, and industry. She has authored over 270 manuscripts including guidelines, is a visiting professor, and an invited speaker at national and international conferences.

She is the humble recipient of the Cleveland Clinic “George W. Crile Founders Professional Staff Award for Research” which recognizes a professional staff member who demonstrates outstanding dedication to research throughout their career and recognizes an individual’s body of human subject research, and the ACG Berk/Fise Clinical Achievement Award which recognizes distinguished contributions to gastroenterology over a significant period of time, including patient care, clinical science, and education.

Dr. Burke is the ACG representative to the U.S. Multi-Society Task Force on Colorectal Cancer and a member of the National Comprehensive Cancer Network (NCCN) Guideline task force on Familial/Genetic High-Risk Assessment: Colorectal, and a graduate of the Intensive Course in Genetic Cancer Risk Assessment through the City of Hope Division of Clinical Cancer Genomics. She is past associate editor for The American Journal of Gastroenterology, reviewer for many journals including Lancet, BMJ, Gut, Gastroenterology, Gastrointestinal Endoscopy, PLOS One, and The American Journal of Gastroenterology, to name a few.

ANDREW D. FELD, MD, JD, MACG

Andrew D. Feld, MD, JD, MACG, is part of the Washington Permanente Medical Group and a Clinical Professor of Medicine at the University of Washington. He is a graduate of Harvard University and Emory University School of Medicine and was admitted to the Alpha Omega Alpha Honorary Medical Society. He attended the University of Washington for internal medicine residency and gastroenterology fellowship, where he worked with the endoscopic research group (led by Dr. Cyrus Rubin and Dr. Fred Silverstein) which developed an ulcer model and prototypes of the heater probe, monopolar probe, and bipolar probe. Later, while still working as Chief of the Gastroenterology Clinic at Group Health Cooperative, he attended and graduated from the University of Washington Law School. Upon graduation, he passed the Washington State Bar exam, and was admitted to the Washington State Bar. Dr. Feld served two terms as ACG Governor for Washington state, has been a past Chair and longtime member of

the ACG Professionalism Committee, and past Chair of the ACG Constitution and Bylaws Committee. He also received fellowship status in ASGE and AGA. He has been elected to serve as the At-Large Representative for the Executive Council of the Health Law Committee of the Washington State Bar (the first MD, JD, in that role) and his primary focus in this is on collaboration between physicians and health law attorneys.

Dr. Feld has a unique niche, as one of the few practicing gastroenterologists who is also a licensed attorney. Much of his professional gastroenterology society work has focused on using insights gleaned from his medical practice and dual degrees to inform gastroenterologists about legal issues and risk management in gastroenterology. He often lectures to national professional societies, has published extensively on related topics, and participated in crafting legal aspects of some professional white papers. These have included white papers on social networking, transportation barriers preventing needed endoscopic procedures, and multi-society endoscopic sedation curricula.

He was fortunate to work with Ann Zauber, PhD, and Sidney J. Winawer, MD, MACG, on the Steering Committee of the National Colonoscopy Study, which investigated screening for colon cancer. Dr. Feld has also been involved for many decades in research activities on functional GI disorders with the Behavioral Medicine Research Group at the University of Washington, under the direction of Rona L. Levy, MSW, PhD, MPH.

Dr. Levy, who is also Chair of the psychosocial chapter of the Rome Committee, is Dr. Feld’s life partner, and parent with him to three daughters, two of whom are physicians, and one an attorney. So those apples did not fall far from this tree! Finally, Dr. Feld notes he is gratified to see research and leadership development in areas including ethics and law by of one of these daughters, a University of Massachusetts Medical Center Assistant Professor of Gastroenterology/Transplant Hepatology, Lauren D. Feld, MD, whom he also credits with markedly improving his PowerPoint presentations ever since she was eight years old!

HARISH K. GAGNEGA, MD, MACG

Harish Gagneja, MD, MACG, is Chief Medical Officer at Austin Gastroenterology. He serves as Chair of the South Texas Clinical Governance Board and member of the Physician Executive Board for GI Alliance. Before joining Austin Gastroenterology in 2004, Dr. Gagneja was Assistant Professor of Medicine and Co-Director of the GI fellowship program at University of Texas MD Anderson Cancer Center, Houston, TX, where he was also a lead interventional endoscopist. He has published multiple abstracts, manuscripts, and book chapters, and has also presented at many national meetings.

Since 2017, Dr. Gagneja has served as the ACG Governor for Southern Texas and in 2019 received the Junior Governors Award. He has also served on the ACG Credentials Committee, Educational Affairs Committee, and Practice Management Committee, and was the Practice Management Course CoDirector in 2019 and 2020.

He is a proud member of regional and national professional societies, including Travis County Medical Society, Texas Medical Association, ACG, American Gastroenterological Association, American Society for GI Endoscopy, and Texas Society of Gastroenterology and Endoscopy (TSGE), where he served as President from 2014-2016. He is President of the American Association of Gastroenterologists of Indian Origin (AAGIO) from 2022-2025.

Since 2018, Austin Monthly has recognized Dr. Gagneja as a Top Doctor, an annual recognition of the best physicians in the Austin area, as chosen by their peers. In 2022, Dr. Gagneja was awarded the TSGE Marcel Patterson - Robert Nelson Award (highest honor of the society) for his outstanding contributions to the field of gastroenterology. He has been voted to the Texas Super Doctors list yearly since 2012. He taught medical students and residents at the Dell Medical School at UT Austin and was voted Consultant of the Year for 2003/2004.

Dr. Gagneja provides cutting-edge care in a patient-centered environment. He is an expert communicator and is known for his ability to break down the complex world of medical jargon into simple terms that his patients can easily understand,

and for working with his patients to create a personalized treatment plan to achieve their health goals. Dr. Gagneja has a keen interest in evaluating newer endoscopy/ GI technologies and incorporating them in his practice to help take care of his patients, and frequently presents these emerging technologies at national meetings. He also has a special interest in screening colonoscopies and the prevention of colorectal cancer, Barrett’s esophagus, non-surgical resection of large/complex polyps, avoiding expensive surgeries and associated short term and long-term complications, IBD, officebased and hospital-based hemorrhoid treatment avoiding painful surgery, and practice management issues.

When he is not busy taking care of his patients, he enjoys traveling, photography, hiking, watching sports, playing golf and pickle ball, spending time with his family, and enjoying fine food coupled with wine. He is a foodie and has traveled extensively sometimes just to enjoy fine food at famed Michelin-starred restaurants.

LUCINDA A. HARRIS, MD, MS, MACG

Lucinda A. Harris, MD, MS, MACG, is a Professor of Medicine at the Mayo Clinic School of Medicine and Consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic Scottsdale. At Mayo she served as Co-Director of the Motility Group and led a patient support group for IBS. She is a current member of the GI fellowship committee and serves as the Department of Education coordinator for gastroenterology, supervising visiting GI fellows and medical students. She has been actively involved in mentoring medical students, residents, and fellows over the years.

Dr. Harris’s interest in medicine started at a young age and it was an honorable mention from the Westinghouse Science Talent Search for her high school project on “The Electrical Communication Patterns of the Black Ghost Knifefish” that led to an invitation to apply to Barnard College. She was accepted and majored in Biochemistry and then went on to get a master’s degree in Community Health and later an MD from the University of Connecticut.

She completed her internship at Columbia Presbyterian Hospital and was influenced to appreciate GI by her Chairman at the time, Dr. Robert Glickman, as well as Dr. Peter Green. She did her gastroenterology fellowship at The New York Hospital/Weill Medical College of Cornell University and tried her hand at bench research in fatty acid uptake. From that experience, she learned that she much preferred human patients to lab rats. She remained on staff there in academic practice until 2004, when she decided that she wanted to develop her interests further in motility and IBS and was enticed to join Mayo Clinic in Scottsdale by Dr. David Fleischer

and Dr. Kevin Olden. She also continued her practice in celiac disease and credits Dr. Jonathan Leighton with inviting her to learn to read small bowel video capsules. Dr. Harris is active in the ACG and has served on the FDA-Related Matters, Research, and Women in GI Committees. She is also a Fellow of the American Gastroenterological Association and the American College of Internal Medicine. She is a member of the International Foundation for Functional Gastrointestinal Disorders and the American Neurogastroenterology and Motility Society and was most recently appointed to the Rome V CommitteePatient Experience, Race, Gender, and Social Determinants of Health. Her special clinical and research interests are in IBS, gastroparesis, chronic constipation, and pelvic floor disorders, as well as celiac disease and autonomic disorders. She has also written and lectured extensively on these topics.

Although she loved NYC, moving to Scottsdale provided a great opportunity to have her mom enjoy the beauty of Scottsdale in her last years. She also met her husband, the love of her life, Scott Helmkamp there in 2013. They were married in 2015 and are the proud parents of a four-year-old chocolate labrador, Danielle, named in honor of her dad. Dr. Harris and her husband enjoy entertaining and cooking for their friends (Scott is a grill master) as well as traveling all around the world.

SUNANDA V. KANE, MD, MSPH, MACG Sunanda (Susie)

V. Kane, MD, MSPH, MACG, is a Professor of Medicine at the Mayo Clinic in Rochester, MN. Her career with ACG started when she was training in GI as a fellow and became an instant fan of the College when she participated in the North American Conference of GI Fellows. It was there that she met some long-time close friends, including Dr. Neena S. Abraham. She was so engaged in that program that she became a faculty member and quickly rose to Chair. She served on the Educational Affairs Committee and served on and became Chair of the Women in GI Committee. After serving six years as an ACG Trustee, she was tasked to be the inaugural Chair of the ACG Quality Council. She then was nominated to be an Officer of the College and served as President from 2018-2019. Dr. Kane regularly attends ACG’s Annual Scientific Meetings and was a recipient of an ACG/Wyeth Gender-Based Research Award for her research. She is a passionate teacher of peers, trainees, and patients. For the Annual Scientific Meeting, she reviews abstracts, leads poster tours, moderates sessions, and speaks at the Postgraduate Course and at clinical symposia. She has been the Edgar Achkar Visiting Professor at several institutions over the years as well. Her clinical expertise is in IBD and

she has helped develop the ACG IBD School with Dr. David T. Rubin, is CoChair of IBD 101 under Dr. Lisa Malter, and is the Co-Chair of the ACG-Crohn’s and Colitis Foundation IBD Circle with Dr. Jean-Paul Achkar.

Noting an opportunity in leadership development, Dr. Kane solicited funding to develop and teach at the Navigating, Networking, and Negotiating Workshop, a program favorite offered Friday night of the ACG Annual Scientific Meeting, going on for 16 years and run by the Women in GI Committee. She has been a member of the ACG Mentoring Program since its inception, served as an author on the ACG Guideline in Preventive Care in IBD, and an Editor of the Pregnancy Monograph. For her clinical excellence, she was bestowed the honor of being awarded the Berk/Fise Clinical Achievement Award in 2022.

Outside of the ACG she remains an active member of other medical societies including the American Gastroenterological Association, American Society for Gastrointestinal Endoscopy, and the Crohn’s and Colitis Foundation. She was the first female Associate Editor for Alimentary Pharmacology and Therapeutics. Amongst other leadership positions that she holds within Mayo Clinic, she is the Assistant Chair of Patient Experience within the Division of Gastroenterology and Hepatology, Physician Chair of the Mayo Quality Academy Fellow Subcommittee, and was recently named the Chief Patient Experience Officer for Mayo Clinic.

CAROLL D. KOSCHESKI, MD, MACG

Caroll D. Koscheski, MD, MACG, began his career in gastroenterology with a multispecialty group in Hickory, North Carolina, in 1991 after completing his GI fellowship at LSU New Orleans. After a few years in the group practice, he and his fellow gastroenterologist Dr. John Meier started their own private practice, Gastroenterology Associates of Hickory, North Carolina. They served the four-county area of western North Carolina providing general GI care for the community.

As the practice grew, they were able to receive certificate of need approval for a two-room ambulatory surgical center, which quickly grew to a third suite. The practice has continued to grow and now includes 10 physicians, along with NP and PA providers, to meet the increased demand. He served on medical staff positions of both hospitals in Hickory, serving eventually as Chief of Staff at Frye Regional Medical Center, as well as leadership positions at Catawba Valley Regional Medical Center.

In 2008, he began involvement in advocacy efforts at the federal level at the urging of Dr. William Cassidy, a

former mentor who was newly elected as Representative in his district in Louisiana. Dr. Koscheski was elected ACG Governor for North Carolina in 2010. While on the Board of Governors (BOG), he served on the Nominating Committee, Membership Committee, and Credentials Committee as the BOG representative on these committees. He was recognized by the BOG as the Freshman Governor of the Year in 2010. He was also the recipient of the William D. Carey Award in 2018.

Given his involvement in advocacy work on Capitol Hill, he was a member of the National Affairs Committee and served as Chair of the committee from 2013-2015. He also served on the ACG Board of Trustees from 2015-2021.

Dr. Koscheski has also served on the Board of Trustees of the Digestive Diseases National Coalition (DDNC) and now serves as its President. Other advocacy work at the state level has included involvement with leadership with the North Carolina Society of Gastroenterology and board membership on the North Carolina Colorectal Cancer Roundtable, working to make screenings available for underserved populations under the supervision of the North Carolina Department of Health and Human Services.

WAQAR A. QURESHI, MD, MACG

Waqar A. Qureshi, MD, MACG, is a Professor at Baylor College of Medicine in Houston, Texas. Following medical school graduation from the University of London’s Royal Free Hospital School of Medicine, he completed a residency in OB/GYN in the UK prior to immigrating to the U.S., where he pursued a fellowship in gastroenterology.

Although he started as an advanced endoscopist, it became clear to him that managing anorectal disease was not part of most GI fellowship training in the U.S. Most anorectal disease does not require surgery, and there is little reason for gastroenterologists not to diagnose and treat these conditions. ACG has had a major impact in bringing about awareness and opportunities for hands-on training in anorectal disease.

Dr. Qureshi has made anorectal disease management his raison d'être and written a textbook, peer-reviewed articles, and guidelines for patients, including pregnant patients. Anorectal disease management is now increasingly being taught in fellowship programs in the U.S.

He has served on the ACG Educational Affairs Committee and Practice Parameters Committee and is a frequent faculty member at ACG’s Endoscopy School Hands-On Workshops.

In his free time Dr. Qureshi plays the drums, fishes, and is a keen photographer.

 INDUSTRY-SPONSORED SATELLITE SYMPOSIA PROVIDE ADDITIONAL EDUCATIONAL OPPORTUNITIES FOR ATTENDEES. These programs are independent of the ACG 2024 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs, unless otherwise noted. For more information, see the company sponsor.

FRIDAY, OCTOBER 25

The Medscape IBS-C Report: Breaking News on Clinical Data and Expert Perspectives

TBD

 6:00 pm – 7:30 pm |  Philadelphia Marriott – Salon Ballroom H-J

This innovative symposium format includes 2 faculty 'anchors' and a video-based guest appearance by a patient. The content agenda for the Newscast-Style symposium will include 'Breaking News on IBS-C', 'The Patient Viewpoint on IBS-C', 'Current Concepts in IBS-C Pathophysiology and Targets for Therapy', 'Perspectives From the Street' (a roving reporter in the audience), 'Walking Through Cases' and ending with 15 minutes of Q and A.

Supported by an independent educational grant from Ardelyx.

SATURDAY, OCTOBER 26

Exclusive from Philadelphia - Recent Updates on Ulcerative Colitis Treatment: Exploring IL-23 Inhibitors

Bruce E. Sands, MD, MS, FACG; Adam C. Ehrlich, MD, MPH, FACG  5:30 pm - 7:30 pm |  Philadelphia Marriott - Salon H-J

Join us for an engaging, case-based presentation by Dr. Bruce Sands and Dr. Adam Ehrlich where they will delve into the mechanisms of action, efficacy, safety, and long-term data for IL-23 inhibitors in the treatment of ulcerative colitis.

This event is sponsored by Eli Lilly and Company.

VELSIPITY (etrasimod): Come learn about an Rx treatment option from Pfizer

Asher Kornbluth, MD

 5:30 pm - 7:30 pm |  Philadelphia Marriott - Salon C-E

Don't miss an exciting presentation from an expert about a prescription treatment option from Pfizer. Join us for a deep dive into efficacy and safety data, identifying appropriate patients, how to get started, and other clinical treatment considerations.

This activity is sponsored by Pfizer.

Advances in the Treatment and Management of MASH: More Options, More Decisions

Mazen Noureddin, MD, MHSc, Naga Chalasani, MD, FACG, Mary E. Rinella, MD, FACG

 7:30 pm - 9:30 pm |  Philadelphia Marriott, Salon ABF

This symposium will help you fine-tune your practice by providing practical, interactive discussions of early identification and risk stratification, advances in treatment, monitoring for disease progression, and long-term medical management.

This activity is provided by Prova Education and supported by an independent educational grant from Madrigal Pharmaceuticals.

Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care

Sandra Quezada, MD, MS

 7:30 pm - 9:30 pm |  Philadelphia Marriott - Salon GKL

Join us for a dynamic continuing education symposium designed for health care professionals treating patients with IBD. Discover vital insights into the growing impact of health care disparities on patient outcomes and stay ahead with the latest advancements in non-biologic small-molecule drugs, poised to revolutionize the diagnosis and management of Crohn’s disease and ulcerative colitis. Engage with expert speakers, network with

peers, and learn collaborative strategies to enhance multidisciplinary teamwork and improve long-term care for patients with IBD.

This activity is supported by educational grants from Takeda and Eli Lilly and Company.

SUNDAY, OCTOBER 27

How Low Can You Go? Targeting of Deep Remission in the Management of Crohn’s Disease

Bruce E. Sands, MD, MS, FACG (Moderator) ; Marita Kametas, MSN, APN, FNP-BC, CMSRN, COCN; Millie D. Long, MD, MPH, FACG  5:30 am - 7:30 am |  Pennsylvania Convention CenterRoom 113AB

In this CME Outfitters live symposium, expert faculty will guide learners on how to integrate knowledge of the heterogeneity of CD in severity and manifestation into patient assessment and treatment. Learners will be instructed on utilizing alternative diagnostic and evaluation tools beyond colonoscopy for evaluating symptoms in patients with CD. Faculty will model incorporation of histopathologic treatment targets as an objective measure of inflammation in CD to inform clinical decision-making.

This activity is supported by an educational grant from Eli Lilly and Company.

How Does Inflammation Drive Assessment in Crohn’s Disease? The Evolution Continues

Miguel D. Regueiro, MD, FACG; Vipul Jairath, MBChB, DPhil, FRCP, FRCPC

 7:30 pm – 9:30 pm |  Philadelphia Marriott - Salon H-J

Join us for an insightful presentation by Dr. Miguel Regueiro and Dr Vipul Jairath as they explore the inflammatory mechanisms underlying Crohn’s disease and the evolution of its assessment.

This event is sponsored by Eli Lilly and Company.

Managing Gastroesophageal Reflux Disease: Who is in the Waiting Room?

Philip O. Katz, MD, MACG; C. Prakash Gyawali, MD, MRCP, FACG; Rena H. Yadlapati, MD, MSHS, FACG

 7:30 pm – 9:30 pm |  Philadelphia Marriott - Salon C-E Gastroesophageal reflux disease (GERD) is one of the most common reasons for visits to gastrointestinal (GI) specialists in the United States. Up to half of patients with reflux symptoms do not get adequate relief from empiric therapy with proton pump inhibitors and require more advanced management. In this live, interactive symposium, expert faculty will discuss the latest clinical evidence regarding the diagnosis and management of GERD, erosive esophagitis (EE), and nonerosive reflux disease (NERD), including the evidence for newly approved acid suppressive medications. Faculty will present real-world patient cases to help learners contextualize important clinical information on GERD evaluation and management that they can apply in their own practices.

Supported by an independent educational grant from Phathom Pharmaceuticals.

MONDAY, OCTOBER 28

Next-Level Eosinophilic Esophagitis Care – Embracing Novel Therapies and Strategic Management Solutions

Evan S. Dellon, MD, MPH, FACG; Mirna Chehade, MD, MPH; Glenn Furuta, MD; Kristle L. Lynch, MD

 5:30 am – 7:30 am |  Philadelphia Marriott - Salon LK Eosinophilic esophagitis (EoE) is a prevalent condition associated with a significant disease burden, largely due to prolonged delays in accurate diagnosis and undertreatment. When left unmanaged, EoE can severely affect a patient’s ability to eat, leading to food impaction, nutritional deficits, and increased healthcare costs. This educational program aims to equip clinicians with the knowledge and skills necessary to optimize diagnosis and management of EoE. Expert faculty will review the latest guideline recommendations and clinical data, highlighting the importance of individualized, evidence-based therapy and interprofessional

collaboration for improved patient outcomes. This symposium features Curbside Consults, an interactive and dynamic case-based discussion of best practices for diagnosis and management of EoE in pediatric and adult patients.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi.

What’s

IL-23 Got to Do With It? Targeted Therapies in the Management of IBD

Marla Dubinsky, MD (Moderator), David P. Hudesman, MD, FACG, Corey A. Siegel, MD, MS  7:00 pm – 8:30 pm |  Philadelphia Marriott - Salon H-J

In this CME Outfitters hybrid educational symposium, expert faculty will review the functions of Fc gamma receptors, CD64 and its connection with interleukin (IL)-23, the molecular attributes of anti–IL–23 therapies, in vivo data on expression of CD64 monocytes, and the most recent clinical trial data differentiating the anti–IL-23 agents. To demonstrate these concepts, animated 3-D models will be included in the educational program and available to attendees.

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.

Health Maintenance in Inflammatory Bowel Disease

Bruce E. Sands, MD, MS, FACG; Aline Charabaty, MD, FACG  7:00 pm – 9:00 pm |  Philadelphia Marriott - Salon C-E

This symposium will provide an overview of health maintenance in IBD, review primary and secondary preventative care, and present care considerations for special populations.

This program is sponsored by Pfizer.

TUESDAY, OCTOBER 29

Unmasking Gastrointestinal Manifestations of IgG4RD: Autoimmune Pancreatitis and Beyond

Emma L. Culver, BSc, MD, PhD (Activity Chair); Phil A. Hart, MD; Arezou Khosroshahi, MD; Vikesh Singh, MD  7:00 pm – 9:00 pm |  Philadelphia Marriott - Salon H-J Immunoglobulin G4-related disease (IgG4-RD) is an immune-mediated systemic fibroinflammatory condition that can involve the gastrointestinal (GI) system, leading to substantial organ dysfunction, decreased quality of life, and increased mortality. Gastroenterologists must be vigilant about the GI manifestations of this disease, which can include autoimmune pancreatitis and cholangitis, among others. The varied clinical presentations of IgG4-RD often result in underrecognition and misdiagnosis, leading to potentially avoidable organ damage. This educational activity is designed to raise awareness of IgG4-RD and its management. The program will emphasize differential diagnosis as well as current and emerging treatment options for this disease. Patient perspectives, a case presentation, and RapidFire Roundtable panel discussions will enhance learning opportunities for attendees.

This activity is supported by educational funding provided by Amgen.

Managing Eosinophilic Esophagitis: Take the Case Challenge

Evan S. Dellon, MD, MPH, FACG; Gary W. Falk, MD, MS, MACG; Amanda Muir, MD, MTR

 7:00 pm – 9:00 pm |  Salon Ballroom GKL

Patients with eosinophilic esophagitis (EoE) frequently experience extensive delays in the diagnosis of their disease, often suffering for years with debilitating symptoms. Until recently, there were no FDA approved treatments for EoE. That changed recently with the approval of 2 new therapies, 1 topical and 1 systemic. In this interactive, case-based symposium, expert faculty will review the latest evidence for new and emerging treatments for EoE. Clinical cases will provide context and instruction for the stepwise approach to EoE diagnosis and selecting therapies based on the latest data and clinical guidelines.

This activity is supported by Takeda Pharmaceuticals U.S.A., Inc.

 OPEN TO ALL IN-PERSON ACG 2024 ATTENDEES. These presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations. The Exhibitor Product Theater is located in booth 1171 in the Exhibit Hall.

SUNDAY, OCTOBER 27

Exploring Treatment Options for UC

Miguel D. Regueiro, MD, FACG

 5:15 pm - 6:00 pm

Join Dr. Miguel Regueiro on Sunday, October 27th at 5:15 PM in a presentation sponsored by AbbVie. Dr. Regueiro will explore endoscopic outcomes and remission in a first-line treatment for adults with moderately to severely active ulcerative colitis. This program is sponsored by AbbVie.

Adding on Second-Line Therapy to Help Change the Course of Treatment in PBC

Steven Flamm, MD, FACG

 6:15 pm – 7:00 pm

Join us for an informative presentation that discusses liver health and taking treatment for Primary Biliary Cholangitis (PBC) a step further. Learn about an approved therapy for patients with PBC.

This program is sponsored by Intercept Pharmaceuticals, Inc.

MONDAY, OCTOBER 28

Optimizing Management of Constipation and Abdominal Symptoms in Adult IBS-C Patients. Time to have a deeper conversation with your adult patients with IBS-C

Brooks D. Cash, MD, FACG

 10:30 am – 11:15 am

Constipation and abdominal symptoms are the hallmark symptoms of IBS-C, a chronic and burdensome condition. Come to a clinical review to learn more about management of IBS-C in adults.

This program is sponsored by AbbVie.

All About ENTYVIO® (vedolizumab)

Subcutaneous Pen

Asher Kornbluth, MD

 11:30 am – 12:00 noon

This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

Discover a Treatment Option that is Available for Patients with NASH with Liver Fibrosis

Kimberly A. Brown, MD and Anthony Martinez, MD

 12:15 pm – 12:45 pm

Please join us for an engaging and highly anticipated educational presentation focusing on this treatment option for patients with NASH, including the clinical data. This program is sponsored by Madrigal Pharmaceuticals, Inc.

Head-to-Head in CD

Remo Panaccione, MD

 1:00 pm – 1:30 pm

Join Dr. Remo Panaccione on Monday, October 28th at 1:00 PM EST for a presentation sponsored by AbbVie. Dr. Panaccione will review the results of 2 biologics in a head-to-head clinical trial evaluating moderate to severe Crohn’s disease.

This program is sponsored by AbbVie.

Spotlight on Eosinophilic Esophagitis: Perspectives on defining control and optimizing disease management

Joshua B. Wechsler, MD, MSCI

 1:45 pm – 2:15 pm

Join us as we explore how and why eosinophilic esophagitis management strategies should evolve with our increased understanding of disease pathogenesis.

This program is sponsored by Sanofi and Regeneron.

Integrating a Different Mechanism of Action, A Different Class of Therapy Into the Treatment of Adults with IBS-C

Darren M. Brenner, MD, FACG

 2:30 pm – 3:00 pm

This program is sponsored by Ardelyx.

Introducing A First-in-Class Acid Suppressant for Adults With Erosive and Non-Erosive GERD

Brooks D. Cash, MD, FACG

 3:45 pm – 4:30 pm

Join Brooks D. Cash, MD, FACG for an engaging session on therapeutic options for the treatment of GERD (gastroesophageal reflux disease) in adults.

This program is sponsored by Phathom Pharmaceuticals

TUESDAY, OCTOBER 29

What's Next for Patients with Moderately to Severely Active UC

Miguel D. Regueiro, MD, FACG and Jessica R. Allegretti, MD, MPH, FACG

 10:35 am – 11:30 am

Discuss the role of inflammation in UC, review relevant clinical data and the importance of various clinical outcomes.

This program is sponsored by Johnson and Johnson

Learn About Omvoh: Some Discoveries Are Too Urgent to Ignore

Bincy P. Abraham, MD, MS, FACG and Kim Kearns, APRN

 12:30 pm – 1:00 pm

This presentation includes an overview of disease symptoms/burden and the efficacy and safety data from relevant clinical studies. The facilitator will provide clinical insights and be available for a live Q&A session following the presentation. This program is sponsored by Lilly.

Eosinophilic Esophagitis: A Treatment Option for Your Appropriate Patients

Nirmala Gonsalves, MD, FACG

 1:15 pm – 1:45 pm

Join us to discover how inhibition of 2 key cytokines can impact your patient’s disease. An expert will walk through the efficacy and safety of a treatment option, leaving you with a better understanding of the effect of dual inhibition in EoE.

This program is sponsored by Sanofi and Regeneron.

Finding high-risk progressors from nondysplastic Barrett's esophagus patients

Phillip Woodworth, MD and Jay N.Yepuri, MD, MS, FACG

 2:00 pm – 2:30 pm

Recent AGA guidelines recognized a subset of patients with NDBE that progress at a rate similar to higher grades of dysplasia. Clinical case discussions of how to identify high risk patients using a personalized, precision medicine prognostic assay to prevent progression to HGD/EAC. This program is sponsored by Castle Biosciences.

Attention on MASH: Exploring the Role of Metabolic Dysfunction in a Chronic Liver Disease

Eric J. Lawitz, MD  2:45 pm – 3:15 pm

This presentation will review the underlying metabolic dysfunction in patients with MASH (metabolic dysfunction-associated steatohepatitis) and the impact of this dysfunction on disease progression. We will also review current AGA guidelines regarding patient identification, screening, and disease management. This program is sponsored by Novo Nordisk.

ProfessionalHead Shot Station

Located in the Terrace Ballroom Foyer

Saturday, October 26 12:30 pm - 1:45 pm

Sunday, October 27 12:30 pm - 1:45 pm

Monday, October 28 10:30 am - 11:30 am 12:45 pm - 2:15 pm 3:45 pm - 4:45 pm

Tuesday, October 29 10:30 am - 11:30 am 12:45 pm - 2:15 pm 3:45 pm - 4:45 pm

EXHIBITOR PRODUCT THEATER EVENTS

EXHIBIT HALL Special Events & Exhibitors

There is always plenty to see and do on the exhibit hall floor, including:

OPENING RECEPTION

Join colleagues at the largest social event of the meeting, Sunday, October 27, from 5:15 pm – 7:00 pm. Explore the Exhibit Hall while you enjoy hot and cold hors d’oeuvres, beer, wine, and non-alcoholic beverages. ACG thanks AbbVie for their support.

EXHIBIT HALL PRODUCT THEATER PRESENTATIONS

Open to all ACG 2024 attendees, Exhibitor Theaters are provided by ACG exhibitors. These presentations offer additional educational opportunities for attendees. See page 23 for the list of presentations. No CME is provided for Theater presentations.

POSTER SESSIONS: IN-PERSON AND VIRTUAL

View the latest in clinical research at the ACG 2024 poster sessions! Colleagues will share their latest research as well as interesting cases/clinical vignettes. Browse and visit with authors during the Exhibit Hall Opening Reception on Sunday, and the lunch breaks on Monday and Tuesday. In addition, both in-person and virtual attendees will have access to the virtual ePoster Hall during and after the meeting. ACG’s ePoster Hall allows poster authors to share their research and interesting clinical cases virtually, and visitors can submit questions directly to them. No CME is provided for poster sessions.

THE ENDOTITANS CHALLENGE

Join us in the Hands-On Workshop area of the Exhibit Hall to cheer on the competitors. Winners will take home both bragging rights and a travel grant for ACG 2025.

ENDOSCOPY SCHOOL HANDS-ON WORKSHOP CENTER

Hone your technical skills at one of the more than 40 hands-on sessions to be offered. Experts will lead demonstrations using the latest tools and techniques. Get hands-on experience and participate in Q & A with the experts. No CME is provided for hands-on sessions.

Sunday, October 27 3:45 pm - 7:00 pm

Monday, October 28 (Fellows-in-training only) 7:45 am – 9:30 am

Monday, October 28 10:15 am – 4:40 pm

Tuesday, October 29 10:05 am – 4:30 pm

• 3-D Matrix

• AbbVie

• Abivax

• Acaria Health Specialty Pharmacy

• Actial Nutrition - VSL#3 Probiotic

• Adler Micromed, Inc.

• Advanced Pathology Solutions

• AdventHealth

• Allied Digestive Health

• Ambu, Inc

• American College of Gastroenterology

• American Society for Gastrointestinal Endoscopy

• Amgen

• AMN Healthcare

• Ankr Health

• AnX Robotica

• APFED

• Ardelyx

• Aya Locums

• Banner Health

• Baptist Health Medical Group

• Bausch Health Companies Medical Affairs

• Baylor Scott & White Health

• Billings Clinic

• Boston Scientific

• Braintree - A Part of Sebela Pharmaceuticals

• Cairn Diagnostics

• CapsoVision, Inc.

• Cardinal Health

• Castle Biosciences

• CDx Diagnostics

• Celltrion Inc.

• ChiRhoClin, Inc.

• Colorectal Cancer Alliance

• ColoWrap

• Commonwealth Diagnostics International, Inc.

• Community Liver Alliance

• CompHealth

• CONMED

• Cook Medical

• CRH Medical - Well Health USA

• Dartmouth Health

• Delta Locum Tenens

• Digestive Care, Inc.

• Echosens

• Eckert Wordell

• Eli Lilly and Company

• Endo Surgical Source

• Endo Tools Therapeutics U.S. Corp

• EndoGI-Medical Inc.

• EndoSoft

• EndoSound, Inc

• Endo-Therapeutics, Inc.

• Enterra Medical

• Epic Physician Staffing

• Era Locums, LLC

• ERBE USA

• Erlanger

• Evoke Pharma

• Exact Sciences Corp

• F-CAL

• Ferring Pharmaceuticals

• FoodMarble Digestive Health

• Freenome Holdings Inc.

• FUJIFILM Healthcare Americas Corporation

• Gastro Concepts

• Gastro Health

• Gastroenterology & Endoscopy News

• Gastroenterology & Hepatology; The Independent Peer-Reviewed Journal

• Gastroenterology Consultants

• Gemelli Biotech

• Genentech

• Geneoscopy, Inc.

• Genesis Laboratory Management, LLC

• GHAPP (Gastroenterology & Hepatology Advanced Practice Providers)

• GI Alliance

• Gifthealth

• Gilead Sciences Inc.

• GIQuIC

• Global Medical Staffing

• Hackensack Meridian Health

• Haemoband Surgical Ltd

• Happitum™

• Healio

• HealthWell Foundation

• HISKY Medical Technologies Co., Ltd.

• Hoskinson Health & Wellness Clinic

• IFFGD

• Indiana University Health

• Intercept Pharmaceuticals, Inc.

• Interpace Diagnostics

• Intra-Sana Laboratories

• IntroMedic America, Inc.

• Ipsen Biopharmaceuticals, Inc.

• Ironwood

• Johnson & Johnson

• Kiwi Biosciences (FODZYME)

• Konsyl Pharmaceuticals, Inc.

• KORB Health Group

• Laborie Medical Technologies

• Lilly, USA

• LocumTenens.com

• Lucid Diagnostics

• Madrigal Pharmaceuticals

• Mallinckrodt Pharmaceuticals

• Mayo Clinic

• mBIOTA Elemental

• McFarland Clinic

• Medicus Healthcare Solutions

• Medspira, LLC

• Medtronic

• Merck & Co., Inc.

• Merit Medical Endotek

• Merit Medical Systems, Inc

• Micro-Tech Endoscopy

• Mindset Health

• ModMed

• Mommy's Milk: Human Research Biorepository

• Mosaic Life Care

• Motilent

• MPLT Healthcare

• Naturlax

• Neptune Medical Inc.

• Nestlé Health Science I US Pharmaceuticals

• Nestle Health Science

• Nextservices

• Northern Health Authority

• Northwell Health

• Novo Nordisk, Inc.

• Olympus America Inc.

• Optum

• Orbita AI

• Orlando Health Digestive Health Institute

• Orphalan, Inc.

• Ovesco

• Owlstone Medical

• PENTAX Medical

• Pfizer Inc.

• Phathom Pharmaceuticals

• Piedmont Healthcare

• Practical Gastroenterology

• PracticeLink

• Prisma Health

• Prometheus Laboratories Inc.

• Provation

• Provider Solutions & Development

• QUAD A

• Quest Healthcare Solutions

• QuinTron Instrument Company

• Redhill BioPharma

• Reid Health

• RMEI Medical Education, LLC

• Rocky Mountain Gastroenterology

• RosmanSearch

• RWJBarnabas Health

• Salix Pharmaceuticals

• Sanofi and Regeneron Pharmaceuticals, Inc

• Sanofi NextGen Immunology

• Singing River Health System

• Sonic Incytes Medical Corp.

• Spatz Medical

• St. Luke's University Health Network

• STERIS

• Stryker

• Sutter Health

• Synapse, LLC

• Takeda Pharmaceuticals U.S.A., Inc.

• Teva Pharmaceuticals, Inc.

• The Permanente Medical Group

• Tidelands Health

• TLS Global Group

• TrueHLTH

• UNC Health

• United Digestive

• UPMC

• US Digest

Thank you

SPONSORS

AbbVie

Ardelyx

Celltrion Inc.

FUJIFILM Healthcare Americas

Corporation

Intercept Pharmaceuticals, Inc.

Ipsen Biopharmaceuticals, Inc.

Ironwood

Johnson and Johnson

Lilly, USA

Madrigal Pharmaceuticals

Medtronic

Novo Nordisk, Inc.

PENTAX Medical

Pfizer Inc.

Phathom Pharmaceuticals

Salix Pharmaceuticals

Sanofi and Regeneron Pharmaceuticals, Inc

Takeda Pharmaceuticals

U.S.A., Inc.

OFFICIAL MEDIA PARTNER OF ACG 2024

VIRTUAL EXHIBIT HALL

In addition to the in-person Exhibit Hall in Philadelphia, ACG 2024 added a Virtual Exhibit Hall component with new, dynamic features designed to enhance your experience, whether it’s in-person or online-only!

 Visit the virtual exhibitor booths on the ACG 2024 Virtual Conference Platform. All attendees will have access to the Virtual Exhibit Hall until October 30, 2024.

EXHIBIT HALL HOURS

Sunday, October 27

3:00 pm – 7:00 pm Monday, October 28

10:00 am – 4:45 pm Tuesday, October 29

10:00 am – 4:30 pm

POSTER SESSIONS

POSTER SESSIONS

POSTER SESSIONS

The College takes great pride in the GI community’s passionate and unwavering commitment to support colorectal cancer (CRC) prevention. In 2015, ACG introduced a prize to annually recognize innovative, creative, and impactful CRC awareness efforts: SCOPY – Service Award for Colorectal Cancer Outreach, Prevention & Year-Round Excellence.

THE JUDGES AWARDED A TOTAL OF 26 SCOPY AWARDS TO AN EXCEPTIONAL GROUP OF CRC AWARENESS CHAMPIONS.

This year’s initiatives include strategies that are low-cost and high-impact and reach specific populations that are underserved and underscreened. We thank all applicants for their commitment to CRC awareness and prevention, and the time and effort they have dedicated to these important projects.

SCOPY AWARDS FOR 2024 2024 SCOPY AWARD WINNERS ACG Announces

Best Community Collaboration: NYU Langone Health, Memorial Sloan Kettering Cancer Center & NYC Colorectal Cancer Coalition; New York, NY; Your Guide to Screening for Colorectal Cancer

Best Coordinated Community Campaign/Health Intervention: VA Caribbean Healthcare System; San Juan, PR; Storming Through Colon Cancer: A Multi-Task and Bilingual Approach to Screen for Colon Cancer after Hurricane Maria and COVID-19

TIED FOR THE WIN

Best Culturally Sensitive Outreach & Education: Fnu Vikash, MD, M.Med & Sindhu Vikash, MD; Bronx, NY; Colorectal Cancer Awareness Campaign Among Underprivileged Southeast Asian Community (Pakistani) in New York

Best Culturally Sensitive Outreach & Education: One Brooklyn Health; Brooklyn, NY; Screen, Detect, Prevent

Best High Impact Community Event: Kadirawel Iswara, MD, FACG & Detective Roxanne Joseph; Colon Cancer Awareness and Prevention Event in the African American Community of Brooklyn South

Best High-Impact Media Initiative: Gemma Rolle, MD; Nassau, Bahamas; In the Shadow of Risk: A Live Colonoscopy

Best Initiative Serving American Indian and Alaska Native Populations: Kaiser Permanente Center for Health Research, Great Plains Tribal Leaders Health Board & South Puget Intertribal Planning Agency; Portland, OR; Creating Meaningful Colorectal Health Messages in American Indian and Alaska Native Communities

Best Initiative to Achieve a Clean Colon: Johns Hopkins Hospital-Endoscopy; Baltimore, MD; March Madness: Colon Cancer Awareness & Bowel Prep Bash

Best International Effort: Guatemalan Initiative for Colorectal Cancer Awareness (IGUAC) Guatemala City, Guatemala; Guatemalan Initiative for Colorectal Cancer Awareness/Iniciativa Guatemalteca contra el Cáncer Colorrectal (IGUAC)

Best Multi-Channel Colorectal Cancer Awareness

26 winners were selected by the 2024 SCOPY Awards judges: Reezwana Chowdhury, MD, FACG Chair, ACG Public Relations Committee

Assistant Professor of Medicine, Johns Hopkins University; Baltimore, MD

Rashmi Advani, MD, ABOM-D

Assistant Professor of Medicine, Icahn School of Medicine at Mount Sinai; Director of Bariatric Endoscopy, Mount Sinai South Nassau; New York, NY

Carl Kay, MD

Gastroenterologist, Carl R. Darnall Army Medical Center; Assistant Professor, Uniformed Services University of the Health Sciences; Fort Cavazos, TX

Campaign by GI Fellows: Mayo Clinic Gastroenterology and Hepatology Fellowship Program; Rochester, MN; Illuminating Colorectal Cancer Awareness: A Mayo Clinic Media Initiative

Best Resident Initiative in Improving Screening: Sanya Goswami, MD; SUNY Downstate Health Sciences University; Brooklyn, NY; The Unique Role of Residents as Patient Care Navigators on CRC Screening Rates in the Primary Care Clinic

Best Social Media Campaign by GI Fellows & Residents: American College of Gastroenterology Evidence-Based GI (EBGI) Social Media Ambassadors; #EBGIvsCRC Colorectal Cancer Awareness Campaign

Best Spanish Language Colorectal Cancer Awareness Campaign: Nicolas Restrepo, MS; Betsy Escobar, MD; Milena Gould Suarez, MD; Jane Montealegre, PhD; Maria Jibaja-Weiss EdD; Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX; Like, Retweet, Save Lives: Colorectal Cancer Awareness Campaign

Best Virtual Education Event: The Association of Black Gastroenterologists and Hepatologists (ABGH); Culver City, CA; Real Talk: Why are So Many Young Black People Getting Colorectal Cancer?

Grand SCOPY: Veterans Health Administration National Colorectal Cancer Screening Program; Washington, DC; The Department of Veterans Affairs’ Cancer Moonshot Colorectal Cancer Screening Awareness Campaign

SCOPY Advancing Quality Award: Mount Sinai Morningside/West Residents; New York, NY; Increasing Colorectal Cancer Screening Rates Among Patients at a Federally Qualified Health Center

SCOPY CRC Mythbuster Award: Allegheny Health Network; Pittsburgh, PA; Colonoscopy “MythBusting”

SCOPY Insights & Inspiration Award: Dawn Baker; Darwin Conwell, MD, FACG; Erica Duh, MD; Katie Farah, MD, FACG & Sudha Pandit, MD, FACG; Community Outreach on Colorectal Cancer: Lessons & Pearls from ACG’s SCOPY Award Winners

SCOPY Inspiration & Impact Award: American Cancer Society, Kaiser Permanente Center for Health Research, Centers for Disease Control and Prevention (CDC),

and the African Methodist Episcopal Church – Atlanta East District; Atlanta, GA; Promoting Colorectal Cancer Screening in the African Methodist Episcopal Church Community

TIED FOR THE WIN

SCOPY Music and CRC Awareness Maestro Award: Ronald Hsu, MD, FACG & Angelo Moreno; University of California Davis School of Medicine & Davis Senior High School Orchestra; Bridging Medicine and Music, Colon Cancer Awareness - ACG Outreach and Rock & Roll Concert 2024

SCOPY Music and CRC Awareness Maestro Award: Benjamin H. Levy, III, MD; University of Chicago Medicine; Tune It Up: A Concert To Raise Colorectal Cancer Awareness

SCOPY MVP: Aasma Shaukat, MD, MPH, FACG; New York, NY; Busting Myths and Raising Awareness about Colon Cancer in South Asian Communities in the US

SCOPY Putting CRC Screening to the Test Award: Best Clinical Trial of A Community-Based Mass Media Campaign: Charles R. Rogers, PhD, MPH, MS, MCHES; Men's Health Inequities Research Lab, Milwaukee, WI; #CRCandMe: A Pre-Post Quasi-Experimental Study of a Mass Media Campaign to Increase Early-Onset Colorectal Cancer Awareness in Utah and Wisconsin

TIED FOR THE WIN

Spirit of SCOPY Award: Mount Sinai Hospital, Icahn School of Medicine; New York, NY; “Passport to Your Health” – Mount Sinai “Get Your Rear in the Clear” Colorectal Cancer Awareness Events in March 2024

Spirit of SCOPY Award: Pooja Singhal, MD, FACG; Oklahoma Gastro Health and Wellness; Oklahoma City, OK; Lakeside Goes Blue Colorectal Cancer Awareness Event

SCOPY Social Media Visibility & Vision Award: Wendi LeBrett, MD; UCLA Health; Los Angeles, CA; GI Doctors Share What You Need to Know About Colorectal Cancer – A Social Media Initiative

Community Service Award Presented to ASAD ALI CHOUDHRY, MBBS, MRCP (UK), FRCP (EDIN)

For Playing A Pivotal Role In Establishing A Subsidized Clinic For Liver Disease, Raising Awareness About Hepatitis B And C, Developing Human Resources, And Fostering Research Collaborations

Asad Ali Choudhry, MBBS, MRCP (UK), FRCP (Edin), graduated from the prestigious King Edward Medical College in Lahore, Pakistan. He proceeded to the UK immediately after completing his house job in pursuit of specialist training. In 1998, he moved back to his hometown of Gujranwala, where he has served as a renowned gastroenterologist ever since.

In the early years of his practice, hepatitis C was highly prevalent, creating havoc and affecting almost every family in parts of Gujranwala. Trained specialists were few and far between and generally beyond the reach of the under-resourced majority. Recognizing the dire need for affordable care, Dr. Choudhry joined the Gujranwala Liver Foundation (GLF) in 2006. GLF introduced a “subsidy and facility” model with free treatment for those who cannot afford subsidized treatment. Under his leadership, the foundation helped train doctors and nurses to manage hepatitis in local communities. The center boasted up to 60% SVR with interferon in a region with limited resources.

In 2017, Dr. Choudhry founded PARSA Trust with the help of friends and philanthropists, driven by a vision of a hepatitis-free Pakistan. PARSA Trust has collaborated with Project ECHO to launch a hugely successful hepatitis ECHO for primary care physicians; it is now the first SuperHub representing the ECHO movement in Pakistan. PARSA Trust aims to scale the community model of free and subsidized treatment of hepatitis to a larger population regionally and to build capacity in the shape of ECHO hepatitis clinics in primary care across Pakistan. You can find Dr. Choudhry every Friday at PARSA Trust Liver Clinic and devoting most of his evenings to coordinating outreach efforts with the Project ECHO team. Today, besides having practiced gastroenterology for over two decades, Dr. Choudhry serves as the Vice-Chairman of PARSA Trust, Director of PARSA ECHO Pakistan, President of the Pakistan Society of Hepatology, Board member of The Health Foundation Karachi, and member of the Technical Advisory Group for National Hepatitis Elimination Program. He has also authored dozens

2024-2025

2024

of scientific posters and papers, especially on hepatitis elimination.

In his spare time, Dr. Choudhry loves reading, watching sports and movies, and spending time with his wife, Noshi, whom he has been married to since 1995, and their four lovely children: Rabiah, Arham, Hafsa, and Haris.



The Community Service Award is bestowed upon an ACG Allied Health Member, Resident Member, Trainee Member, Member, Fellow, or Master who has initiated or has been involved in volunteer programs or has provided extensive volunteer service posttraining. The service must have been performed on a completely voluntary basis and not for the completion of training or position requirements. Such service may include but is not limited to the following: community education programs (e.g., colon cancer awareness); working in free clinics; mentoring advocacy groups or local government committees; teaching in under-served schools related to health education; and political work on committees for comprehensive health insurance or other issues.

ACG REGIONAL COURSE CALENDAR

ACG FUNCTIONAL GI & MOTILITY DISORDERS SCHOOL & SOUTHERN REGIONAL POSTGRADUATE COURSE

 December 6–8, 2024

 Renaissance Nashville Hotel | Nashville, TN

2025

ACG’S NEW ESOPHAGUS SCHOOL & WESTERN REGIONAL POSTGRADUATE COURSE

 January 24-26, 2025

 Mandalay Bay | Las Vegas, NV

ACG’S IBD SCHOOL & ACG/FGS ANNUAL SPRING SYMPOSIUM

 March 7-9, 2025

 Naples Grande Beach Resort | Naples, FL

ACG/LGS REGIONAL POSTGRADUATE COURSE & ACG’S LEADING WITH GUTS COURSE

 March 14-16, 2025

 DoubleTree by Hilton New Orleans | New Orleans, LA

ACG'S ENDOSCOPY SCHOOL & EASTERN REGIONAL POSTGRADUATE COURSE

 June 6–8, 2025

 Washington Marriott Metro Center | Washington, DC

ACG’S FUNCTIONAL GI AND MOTILITY DISORDERS SCHOOL & MIDWEST REGIONAL POSTGRADUATE COURSE

 August 22–24, 2025

 Marriott IndyPlace | Indianapolis, IN

ACG’S NEW ESOPHAGUS SCHOOL & ACG/VGS/ MASGNA REGIONAL POSTGRADUATE COURSE

 September 5–7, 2025

 Williamsburg Lodge | Williamsburg, VA

ACG'S HEPATOLOGY SCHOOL & SOUTHERN REGIONAL POSTGRADUATE SCHOOL

 December 5-7, 2025

 Renaissance Nashville Hote | Nashville, TN

Defining and Transforming Quality in GI

When physicians decided they needed a reliable way to measure adenoma detection rate, the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE) worked together to create GIQuIC. Although it was built in collaboration with the two societies and continues to follow their recommended guidelines, GIQuIC is a separate entity and is guided by the leadership of its own physician board.

GIQUIC BOARD MEMBERS

Demonstrated to Improve the Quality of Patient Care

Since the registry’s inception, overall adenoma detection rate across all physicians has increased from 25% in 2011 to about 40% in 2019 through 2023. The registry currently captures data for colonoscopies and EGDs and provides measure reports in order to gauge, benchmark, and improve quality.

GIQuIC and the MIPS 2024 QCDR Reporting Option

For the eleventh year in a row, CMS has approved GIQuIC as a Qualified Clinical Data Registry (QCDR) for reporting to the Merit-based Incentive Payment System (MIPS). As a result, GIQuIC participants have the option of reporting to the Quality, Promoting Interoperability, and Improvement Activities (IA) performance categories to decrease negative payment adjustments and even increase payouts.

For more information about utilizing GIQuIC as a QCDR to report to MIPS or to inquire about the benefits of implementing GIQuIC as a performance benchmarking registry, visit our website at giquic.org.

Stay Tuned!

GIQuIC is adding new clinical modules, including inflammatory bowel disease (IBD), ERCP, endoscopic bariatric therapy (EBT), wireless capsule endoscopy (WCE), and endoscopic ultrasound (EUS).

Nominating Committee Proposes Slate of Officers and Trustees

The ACG Nominating Committee, composed of ACG Past Presidents Daniel J. Pambianco, MD, FACG, Samir A. Shah, MD, FACG, and David A. Greenwald, MD, FACG, and ACG Governors Vonda G. Reeves, MD, MBA, FACG, and Jay N. Yepuri, MD, MS, FACG, met by telephone conference call on May 28, 2024, and proposed the following slate of Officers for 2024 – 2025 and the following slate of Trustees for 2024 – 2026:

Nominating Committee Proposes Slate of Officers

OCTOBER 2024-2025

• President: Amy S. Oxentenko, MD, FACG

• President-Elect: William D. Chey, MD, FACG

• Vice President: Costas H. Kefalas, MD, MMM, FACG

• Secretary: Neil H. Stollman, MD, FACG*

• Treasurer: Nicholas J. Shaheen, MD, MPH, MACG

Nominating Committee Proposes Trustees for two-year terms

OCTOBER 2024-2026

• Jill K. J. Gaidos, MD, FACG

• David J. Hass, MD, FACG

• Vonda G. Reeves, MD, MBA, FACG

• Aasma Shaukat, MD, MPH, FACG

• Jay N. Yepuri, MD, MS, FACG

*The Board of Trustees has designated Dayna S. Early, MD, FACG, to fill out the final year of Dr. Stollman’s term as Trustee should this slate be approved by the membership and Dr. Stollman become Secretary.

 ACG’s Secretary, Nicholas J. Shaheen, MD, MPH, MACG, has announced that the College’s 2024 Annual Business Meeting will be held on Monday, October 28, 2024, at 6:00 pm at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. The Nominating Committee will present its proposed slate of officers and trustees at that time, and all Fellows and Members are encouraged to attend and to vote on this and all other items of business at the meeting.

Costas Kefalas, MD, MMM, FACP, FACG, FASGE, AGAF President and Director

Colleen Schmitt, MD, MHS, MASGE, FACG Vice President and Director

Brett Bernstein, MD, MBA, FASGE Secretary and Director

Jay Yepuri, MD, MS, FACG Treasurer and Director

Katie Farah, MD, CPE, FASGE Director

Joseph Vicari, MD, MBA, FACG, FASGE Director

Aasma Shaukat, MD, MPH, FACG, FASGE Director

#DiversityinGI Virtual 5K Run & Onsite Fun Runs

A Special Virtual Run / Walk to Benefit ACG Summer Scholars and Celebrate Diversity

JOIN YOUR ACG COLLEAGUES AND THE GI COMMUNITY FOR THE DIVERSITY IN GI VIRTUAL 5K to celebrate the diversity of the GI profession, shine a light on a critical issue in gastroenterology and medicine, and create a fun, healthy, and thoughtful event with potential for widespread social media visibility and engagement –not to mention enthusiasm from a vocal core constituency of ACG members who run!

Registrants run or walk on their own, log their activity online, take photos in race “swag” and celebrate via social media during the ACG 2024 Annual Scientific Meeting. The Virtual 5K is a chance for the entire GI community to show their support, get some exercise, and connect via social media in the weeks surrounding the ACG 2024 Annual Scientific Meeting.

There is a small registration fee, but thanks to a generous sponsorship from Ironwood Pharmaceuticals, proceeds of the event will benefit the ACG Summer Scholars mentorship program for medical students and residents from groups under-represented in medicine.

HOW IT WORKS: Registrants run or walk on their own, log their activity online, take photos in race “swag” and celebrate via social media using #DiversityinGI during the ACG 2024 Annual Scientific Meeting and through November 5, 2024.

SHARE ON SOCIAL MEDIA & CELEBRATE DIVERSITY

After you run/walk wearing your #DiversityinGI 5K race tee shirt, importantly, be sure to post photos on social media! Encourage your colleagues, friends, and family to participate and celebrate the diversity of the GI profession. Support this event by conveying with your words and actions how diversity drives excellence and innovation.

REGISTER: bit.ly/acg2024-diversityingi

FUN RUN MEETUPS IN PHILADELPHIA: CALLING ALL RUNNERS!

Plan to meet up with other avid runners for a morning run to support #DiversityinGI at the Lobby of Philadelphia Marriott Downtown (ACG 2024 Headquarters hotel) 1201 Market Street, Philadelphia, PA 19107.

• Saturday, October 26 at 6:45 am ET [Dr. Aasma Shaukat & Dr. Sara Goff, Leaders]

• Sunday, October 27 at 6:45 am ET [Dr. Sophie Balzora & Dr. Patrick Young, Leaders]

• Monday, October 28 at 6:45 am ET [Dr. Dana Lukin & Dr. Reezwana Chowdhury, Leaders]

• Tuesday, October 29 at 6:45 am ET [Dr. Grant Hutchins & Dr. Baha Moshiree, Leaders]

ACG’S COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION

Under the leadership of ACG DEI Committee Chair Dr. Sophie Balzora—and with inspiration and commitment from numerous College leaders—ACG continues to strengthen and deepen its longstanding commitment to diversity, equity, and inclusion. ACG offers "Health Equity and DEI in Gastroenterology" educational modules via the ACG Education Universe and collaborates with sister GI organizations as part of the Intersociety Group on Diversity. Through the ACG Institute, the College is proud to offer the Leonidas Berry Health Equity Research Award to fund research to produce actionable science that will translate to reducing health and/or healthcare disparities, thereby promoting health equity.

This virtual 5K event celebrates the sense of inclusion, representation, and community at the center of the life of the College and offers a dose of healthy activity as we gather for the ACG 2024 Annual Scientific Meeting.

Sophie M. Balzora, MD, FACG Outgoing Chair, ACG Diversity, Equity & Inclusion Committee; NYU Langone Health

VIRTUAL 5K CHAMPION AND DEI COMMITTEE CHAIR

The #1 GI-Specific EHR for 14 Consecutive Years*

VISIT US AT BOOTH #600

STOP SETTLING FOR LESS and enter to win our raffle for an Apple Watch Series 9!

Explore our cloud-based EHR, PM, ERW, Analytics and Patient Collaboration solutions

Still documenting after hours, struggling to do more with less, dealing with paper forms, multiple server-based systems and manual processes? There’s a reason why your peers have chosen gGastro® year after year — it helps them document faster, communicate better with patients and breathe easier.

MEET THE AUTHORS AND LEARN ABOUT THEIR RESEARCH IN THE POSTER AREA OF THE ACG 2024 EXHIBIT HALL

P0535. Esophageal Yolk Sac Adenocarcinoma Found Incidentally on Endoscopic Submucosal Dissection: A Rare Coexistence

P0551. A Case of Thoracogastric Airway Fistula: A Serious Complication 13 Years After Esophagectomy for Esophageal Cancer

P0552. Esophageal Histoplasmosis: A Rare Cause of Odynophagia

P0581. A Novel Approach for Managing Blown Out Myotomy After POEM or Heller Myotomy Using Endoscopic Bands

P0607. A Case of DysphagiaSecondary to Necrotising Autoimmune Myopathy Triggered by COVID-19

P0617. Reasons for Treatment Discontinuation in Patients With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

P0638. Variation of Stomach Shapes in Gastric Emptying Scintigraphy: Correlation with Gastric Emptying Results, BMI, and Symptoms

P0649. Lactulose-Induced Bowel Perforation

P0661. Head-to-Head Evaluation of Two Machine Learning Algorithms for Predicting Endoscopic Mayo Score in Ulcerative Colitis

P1074. Dual Endoscope: Endoscopic Submucosal Dissection (DE-ESD) for Rectosigmoid Colon TumorsA Potential Time Saver

P1082. Endoscopic Ultrasound-Directed Trans-Enteric ERCP (EDEE) in a Patient With Malignant Afferent Limb and Hepaticojejunostomy Stricture

P1084. A Rare Presentation of Bateman Purpura Following ERCP

P1090. The Unpredictable Migration of Biliary Stents

P1092. Colonic Stenting and EUS-Guided EnteroColostomy in Malignant Small Bowel Obstruction: A Case Report

P1103. Appendiceal Orifice Polyp Resection: Exploring Full-Thickness Endoscopic Technique - A Case Report and Discussion

P1104. Sugar Shortage: A Case of Insulinoma Managed by EUS-Guided Ethanol Ablation

P1110. Laser Lithotripsy: Innovative Solutions for Challenging Gallstones and High-Risk Patients

P1116. Hemostasis of Malignant Gastrointestinal Lesions With Over-The-Scope Clips: A Case Series

Learn about the latest clinical research from colleagues from across the U.S. and around the world when you visit the ACG 2024 Poster Hall. Posters will be presented beginning Sunday afternoon through Tuesday. Over 300 of the more than 5,100 posters presented this year have been honored with a Presidential Poster Award.

Determined by the ACG Abstract Selection Committee, approximately 7% of accepted abstracts annually receive this distinction for high-quality, novel, unique and interesting research. Listed below are this year’s Presidential Poster Award recipients, which will be recognized with a blue Presidential Poster ribbon pinned to the poster during the ACG 2024 poster sessions.

Additionally, all posters will be viewable online as ePosters on the ACG 2024 Conference Platform beginning at 12:00pm (Eastern time) on Sunday, October 27, 2024, until March 31, 2025 when the platform closes. Presidential Poster Award recipients will be recognized in the ePoster Hall with a blue ribbon icon.

ACG 2024 ACG PRESIDENTIAL POSTER AWARD RECIPIENTS

Sunday, October 27

Poster viewing time: 3:30 pm – 7:00 pm

P0054. The Severity of Exocrine Pancreatic Insufficiency by FE-1 Levels Correlates With Tumor Location and Stage, But Does Not Correlate With PDAC Survival

P0091. A Rare Complication of ERCP: Fibrin Cast of the Biliary Tree After Post-Sphincterotomy Bleeding

P0105. Rare Presentation of Eosinophilic Cholangitis in a 32-Year-Old Male: A Case Report

P0120. A Rare Case of Immune Checkpoint Cholangitis

P0164. Sump Syndrome - Diagnosis Dilemmas and Therapeutic Approaches: A Case Series

P0184. Suprainfected Heterotopic Pancreatic Tissue: A Rare Culprit of Recurrent Gastric Outlet Obstruction

P0198. Recognizing Cholecystocolonic Fistula: A Rare Gallbladder Disease Complication Discovered During Routine Colonoscopy

P0222. Investigating Fecal Calprotectin: Unmasking the Sneaky Subtypes of Non-IBD Colitis

P0232. Higher Nighttime Colonic Activity Measured by Wireless Patches Linked to Patient Reported Bowel Movement Satisfaction

P0266. A Case of Clostridium septicum Endophthalmitis as the First Presenting Sign of Colon Cancer

P0285. From Contagion to Containment: Tackling Multidrug-Resistant Shigella in MSM Community

P0293. Gastrointestinal Amyloidosis: An Unusual Cause of Mesenteric Ischemia

P0296. Unveiling Gastrointestinal AL Amyloidosis: A Rare Presentation of a Systemic Disease

P0307. Masquerading Malignancy: Metastatic Breast Cancer Mimicking Colitis

P0329. GI Highway, Wrong Exit: T-Fastener Retention Following Gastrostomy Tube Placement

P0356. The GIPP Never Lies: A Case of Refractory Ulcerative Colitis

P0359. Undiagnosed Polyposis Syndrome Preceded by Thyroid Cancer in Young Female

P0365. A Case of Severe Amebiasis in a Patient With Sarcoidosis on Low-dose Immunosuppressive Steroid Therapy

P0370. A Case of Endoscopic Full-Thickness Resection for a Known Colon Adenocarcinoma in a Patient With Decompensated Cirrhosis

P0376. Serum β-hCG as a Prognostic Marker for Colorectal Adenocarcinoma in Women of Reproductive Age: A Case Report and Literature Review

P0379. The Womb Wanders to the Bowel: An Uncommon Case of Large Bowel Obstruction Secondary to Intestinal Endometriosis

P0421. Impact of Racial Disparities and Socioeconomic Factors on Tumor Stage at Diagnosis in Early-Onset Colorectal Cancer: A SEER Database Study

P0434. Multi-Center, International Study of Colonoscopy Findings in Patients With CDH1 and CTNNA1 Germline Pathogenic Variants

P0441. Association Between Ring Finger Protein 213 (RNF213) Mutation and Increased Risk of Early Onset Colorectal Cancer

P0446. Geospatial Analysis of Preventative Resource Distribution and Colorectal Cancer Outcomes in Mississippi (MS): Emphasis on Disparities Between Rural and Urban Populations

P0450. Hidden Hazards: Desiccant Canister Ingestion During Sodium Sulfate Bowel Preparation – A Case Report and Safety Recommendations

P0479. Dupilumab Is Effective in Treating EoE in Patients Weighing ≥15 kg: Results From the Phase 3 KIDS Study

P0480. Dupilumab Efficacy in Children With Eosinophilic Esophagitis and Prior Use of or Prior Inadequate Response, Intolerance, or Contraindication to Swallowed Topical Corticosteroids: Results From the Phase 3 EoE KIDS Study

P0520. The Validation of CARS Score for Prediction of Patients With Achalasia

P0674. Efficacy of Topical Antimicrobials in Preventing Peristomal Infections Associated With PEG Tube Placement: A Systematic Review and Meta-Analysis

P0680. The Impact of GLP-1 Receptor Agonists on Bowel Preparation for Colonoscopy

P0711. Endoscopic Management of Foreign Body Perforating Through Hiatal Hernia Into Thoracic Cavity

P0730. Comparison of TC-325 Hemostatic Powder With Standard Endoscopic Treatments for Malignancy-Related Upper Gastrointestinal GI Bleeding: Meta-Analysis of Randomized Controlled Trials

P0735. Stress Ulcer Prophylaxis in Patients Requiring Mechanical Ventilation: A Meta-Analysis of Randomized Controlled Trials

P0746. Frailty Predicts Mortality and Procedural Performance in Patients With Non-Variceal Upper Gastrointestinal Bleed: Results From Nationwide Analysis

P0751. Outcomes of Same Day Computed Tomography Angiography (CTA) Followed by Urgent Colonoscopy versus Urgent Colonoscopy alone for Acute Diverticular Bleeding: A Propensity Matched Cohort Study

P0826. Efficacy and Safety of Guselkumab Maintenance Therapy Among Guselkumab Induction Week 24 Clinical Responders: Results From the Phase 3 QUASAR Maintenance Study

P0866. Complementary and Alternative Medicine Use Among Inflammatory Bowel Disease Patients Remains Prevalent, Diverse, and Warrants Multidisciplinary Collaboration

P0881. Trends in the Prevalence of Diagnosed Inflammatory Bowel Disease among Asian Subgroups in a Large Northern California Population

P0915. Inflammatory Bowel Disease (IBD)-Associated Peripheral Arthritis is Not Associated With Objective Markers of Luminal IBD Disease Activity - Results From the CHASE Cohort

P0957. Long-Term Outcomes of an Infliximab-First vs Vedolizumab-First Treatment Strategy in Biologic-Naive Patients With Ulcerative Colitis

P0958. Serum Protein Capillary Electrophoresis as a Biomarker for Endoscopic Disease Activity in Inflammatory Bowel Disease: A Prospective Pilot Study

P0964. IBD and Major Depression: Associated with Age, Sex, Smoking, Severity, and Extra-Intestinal Manifestations

P0975. At a Crossroad of Chronicity: Crohn's Disease and Endometriosis

P0990. Pyostomatitis Vegetans in a Young Adult with Crohn's Disease

P0994. A Case of Fungal Colitis in a Solid Organ Transplant Patient

P1002. A Rare Finding of Rectal Squamous Metaplasia in Crohn’s Disease

P1005. An Unexpected Extraintestinal Manifestation of Ulcerative Colitis: Seronegative Necrotizing Myositis

P1040. Accuracy of Intra-Operative Cholangiogram for Detection of Choledocholithiasis

P1054. Radiofrequency Vapor Ablation is Safe and Well-Tolerated for Duodenal Mucosal Ablation in the Treatment of Type 2 Diabetes: Six Month Results From the First-in-Human Dose Finding Study

P1122. Endoscopic Ultrasound-Guided Esophagojejunal Anastomosis: A Case Series on the Novel Technique and Our Experience

P1126. Single-Stage EUS-Guided Gastrogastrostomy Secured With Clips With Anchor Prongs to Treat Massive Gastrointestinal Hemorrhage in Roux-en-Y Gastric Bypass

P1144. Disparities in the Decision to Evaluate for Liver Transplant in Patients Referred With Underlying Alcohol-Associated Liver Disease (ALD)

P1146. GLP-1 Agonist Use is Associated With Lower Mortality and Improvement of Cardiovascular Outcomes in Patients With Obesity Who Have MAFLD and OSA: A Multi-Center Analysis

P1151. Hepatitis B Vaccination is Severely Underutilized in the United States

P1159. Mapping the Global Impact: Liver Cancer Attributable to Drug Use Across 204 Countries, 1990-2021:A Benchmarking Analysis

P1200. Incidence, Management, and Prognosis of Wilson’s Disease

P1205. Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in Post-Menopausal Women: NHANES 2017-2020

P1211. The Catch Up: Improving Hepatitis B Screening and Vaccination Rates Among High-Risk Ethnic Minorities

P1213. Lipid Lowering Therapies and Primary Sclerosing Cholangitis: A Mendelian Randomization Study

P1218. Trends in Incidence of Hepatocellular Carcinoma From 2000 to 2020: A SEER-Based Analysis

P1243. Efficacy of Mycophenolate Mofetil vs Standard Therapy for the Treatment of Autoimmune Hepatitis: An Updated Meta-Analysis

P1245. Improving Hepatitis B Screening Using EMR Hard-Stop Across Health System Enterprise

P1267. Isolated Polycystic Liver Disease Requiring Transplant- A Rare Indication for MELD Exception

P1277. Liver Transplantation After Successful Downstaging of Multifocal Hepatocellular Carcinoma With Marked AFP Elevation Using Interventional Immuno-oncology

P1355. A Rare Case of Spontaneous Regression of Hepatocellular Carcinoma

P1449. The Weight of the Future: Machine Learning Projections for Obesity Mortality in Young Americans(1999-2035)

P1462. Differences in Healthcare Utilizations Between Pediatric and Adult Inflammatory Bowel Disease: A National Inpatient Analysis

P1466. Metagenomic Analysis of Gut Microbiota in Phenylketonuria (PKU) Patients: A New Perspective From the Ecuadorian Population

P1467. Comparison of Trans Umbilical Laparoscopic-Assisted Appendectomy (TULAA) vs Conventional Laparoscopic Appendectomy (CLA) In the Pediatric Population: A Systematic Review and Meta-Analysis

P1503. ACG Summer Scholars Program and fastPACE: Results of a Program Designed to Develop the Next Generation of Gastroenterology Physician Innovators

P1504. A Head-to-Head Randomized Controlled Trial of Electronic Medical Record Text Messages vs Phone Call Reminders for Fecal Calprotectin Testing

P1507. A Standardized, Specialty-Specific Note Template Improves Inpatient Evaluation and Management

Coding Capture

P1518. Unveiling the Cost of Care: A Decadal Analysis of Emergency Department Visits and Hospital Billing Trends Using NEDS Database (2012 - 2021)

P1521. Safety and Tolerability of Once-Weekly Glucagon-Like Peptide-2 Analog Apraglutide in Patients With Short Bowel Syndrome and Intestinal Failure: Results From a Global, Phase 3, Randomized, Double-Blind Trial

P1528. Achieving Organoleptic Acceptability with Elemental Formula: A Prospective Single-Blind Comparative Study

P1545. A Former Dancer Regains Some Balance by Avoiding Gluten

P1565. Unlocking the Digestive Dilemma: Sevelamer's Trail in Gastrointestinal Dysfunction and Literature Review

P1583. Rare Presentation of Plesiomonas Shigelloides-Induced Partial Small Bowel Obstruction and Spontaneous Bacterial Peritonitis in a Healthy Patient

P1589. Refractory Diarrhea Related to EPHB4 Mutation in a Patient With Capillary Malformation-Arteriovenous Type 2 Syndrome

P1598. Real-Life Experience With Refractory Helicobacter Pylori: A Specialist’s Perspective

P1601. Development and External Validation of a Machine Learning-Based Gastric Cancer Prediction Model using Electronic Health Record Data

P1604. Response of Autoimmune Gastroparesis to Immunomodulation

P1620. Beyond the Snapshot: Multi-Day Motility Measurement Captures Day-to-Day Variation in Gastric Activity

P1636. Bridge the GAPPS: A Case Report of Rare Familial Gastric Cancer

P1647. Uncommon Encounter: A Massive Gastric Leiomyoma Masquerading as Refractory GERD

P1662. Rare Gastric Metastasis From Cervical Cancer: A Case Report

P1674. PEG, Slug, Bug: Once Seen Never Forgotten

P1692. Uninvited Guests: Gastric Anisakiasis Discovered During EGD

Monday, October 28

Poster viewing time: 10:30 am – 4:15 pm

P1729. Intratumoral Microbiome Associations With the Infiltration of Natural Killer Cells and Improved Patient Survival in Pancreatic Cancer

P1751. Surveillance of Low-Risk Pancreatic Cysts is not Beneficial in Older Patients: A Retrospective Cohort Analysis

P1753. Cost-Effectiveness of Modalities of Palliative Biliary Drainage in Malignant Extrahepatic Biliary Obstruction

P1756. Effect of Substance Use Counseling on Readmission Rates for Acute Alcohol-Associated Pancreatitis: A Prospective Cohort Study

P1764. Compliance to NCCN Tumor Gene Profiling Guidelines in Pancreatic Ductal Adenocarcinoma: A Large Multi-Center Study

P1796. Untangled Mystery: Peutz-Jeghers Syndrome Unmasked by Pancreatic Intussusception

P1825. FromAbdominal Pain to ICU: A Cascade of Stills Disease

P1833. Non-Surgical Ablation of a Large Intraductal Papillary Mucinous Neoplasm Using Tandem Endoscopic Ultrasound-Guided Radiofrequency and Chemoablation

P1850. Small Cell Carcinoma of the Gallbladder: A Rare Case of Aggressive Neuroendocrine Neoplasm in a 56-Year-Old Man

P1891. A Rare Case of Biloma and Subsequent Bilothorax Post Extracorporeal Shock Wave Lithotripsy of a Right Renal Stone

P1909. The First Reported Case of a Pseudosarcomatous Stromal Tumor: A Unique Benign Ampullary Tumor

P1931. AI-Assisted Colonoscopy May Increase ADR in Right Side of Colon in Gastroenterology Fellows: A Randomized Control Trial

P1935. First-Line Treatment of Fecal Microbiota Transplantation for Immune-Mediated Colitis

P1958. Outcomes of Endoscopic Submucosal Dissection for Large Colorectal Neoplasms: An International, Multicenter Perspective

P1976. Looking Beyond the Surface: An Exceedingly Rare Presentation of Metastatic Cutaneous Colorectal Adenocarcinoma

P1990. History Matters: A Rare Case of Rectosigmoid Endometriosis Disguised as Colorectal Malignancy

P1997. Metastatic Merkel Cell Carcinoma of Unknown

Primary Presenting as an Exophytic Colon Mass

P2000. A Case of Endometriosis in a Colon Polyp

P2080. A Case of Multiple NSAID-Induced Strictures of the Ascending Colon

P2084. Gangrenous Peri-Appendiceal Abscess

Uncovering a Diagnosis of Common Variable Immunodeficiency

P2087. Malignant Myopericytoma Involving the Colon Presenting as Occult Blood Loss

P2091. A Rare Case of Carbidopa-Levodopa Induced Colitis

P2092. Minimally Invasive Solutions: Endoscopic Resection of Appendiceal Orifice Polyps Versus Traditional Surgery

P2104. Comparative Outcomes of Pancreatic, Colon, and Liver Cancers in GLP-1 RA Treated Patients: A Retrospective Analysis

P2113. Very Low Rate of Post-Colonoscopy Colorectal Cancer in Individuals at Average-Risk for Colorectal Cancer

P2124. Long-Term Oncologic Outcomes in Patients With History of Non-Colorectal Cancer and Positive Multi-Target Stool DNA Test With Negative Diagnostic Colonoscopy for Advanced Colorectal Neoplasia

P2134. Glucagon-Like Peptide-1 Receptor Agonist (GLP1RA) Use Reduces Risk of Early-Onset Colorectal Cancer in Patients with Type 2 Diabetes-Mellitus (T2DM)

P2136. Colorectal Cancer in Heart Transplant Patients: Effect of Immunosuppressant Medications

P2143. Increasing Access to Colonoscopies for Under-Resourced Patients at Good Neighbor Health Clinic: Success of a Free Community Clinic and Academic Medical Center Partnership

P2149. Modification of the Fecal Immunochemical Test (FIT) Return Envelope Process Improves Lab Acceptance Rate

P2190. Safety of Esophageal Dilation Procedures in Patients on Antithrombotic Therapy: A US Collaborative Network Cohort Study

P2209. Pharmacokinetics and Local Tolerability of EP104GI, an Extended-Release Formulation of Fluticasone Propionate for Treatment of Eosinophilic Esophagitis, After Intra-Esophageal Injection in Mini-Pigs

P2217. Burden of Esophageal Cancer Attributable to Smoking in the United States and Its Trend from 1990-2021: A Benchmarking Systematic Analysis for the Global Burden of Disease Study 2021

P2220. Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease

P2226. Dupilumab Improves Multiple Histopathologic Endpoints in Children With Eosinophilic Esophagitis: 52-Week Results From the Phase 3 EoE KIDS Trial

P2249. Esophageal Obstruction Secondary to Gastric Intussusception of Hiatal Hernia: A Cathartic Reduction

P2266. Interplay of Hypereosinophilic Syndrome (HES) With Serosal Eosinophilic Gastroenteritis (EGE)

P2297. Russell Body Esophagitis Without Associated Barrett’s Esophagus: One of Two Reported Cases

P2298. Jackhammer Esophagus: An Unusual Presentation of Neuromyelitis Optics Spectrum Disorder

P2357. Hormone Replacement Therapy Is Associated With Increased Risk of Developing Irritable Bowel Syndrome in Post-Menopausal Women

P2362. A Multicenter, Sham-Controlled, Randomized Controlled Trial of Interferential Therapy for the Treatment of Chronic Constipation

P2364. Irritable Bowel Syndrome or Acute Intermittent Porphyria - The Clinical Conundrum in Healthy Young Individuals

P2372. Using Disruptive Innovation to Design Endoscopic Ligators for Resource-Challenged Health Settings

P2377. Gastric Biopsy: Deleterious Effects of a Central Needle Within Endoscopy Forceps

P2418. Using Biliary Stone Extraction Balloon Catheter for Relieving Esophageal Food Impactions

P2450. Comparison of 72 Hours versus 12-24 Hours Intravenous Terlipressin in Patients With Acute Esophageal Variceal Bleeding: A Systemic Review and Meta-analysis

P2458. Gastrointestinal Bleed: A Simulation Case for Medical Students

P2506. Not Just Another Cause of Melena: Blue Rubber Bleb Nevus Syndrome

P2544. Model-Informed Dosing Interval Extension of Infliximab in Patients With Inflammatory Bowel Diseases: Six Months Interim Analysis of the MODIFI Trial

P2573. Comparative Effectiveness of Bile Acid Sequestrants and Antibiotics in the Management of Pouchitis: A Matched Cohort Study From the United States

P2574. Patients With Crohn’s Disease and Ileostomy Can Achieve Remission With Upadacitinib

P2598. Time is of the Essence: An Analysis of IBD Advanced Therapy Initiation in a Large Community Practice

P2629. Clinical Validation of a Novel Software Tool to Guide the Intravenous-to-Subcutaneous Switching of Infliximab in Patients With Inflammatory Bowel Diseases

P2633. Impact of Mild Endoscopic Disease Activity on Short-Term Clinical Outcomes in Older Adults With Inflammatory Bowel Disease

P2683. Demographic Distribution and Disparities in Mortality of Ulcerative Colitis and Crohn's Disease: A 21-Year Longitudinal Analysis Using the CDC WONDER Database (1999-2020)

P2686. Timing of Index Ileocolic Resection is Associated With Radiographic Recurrence in Patients With Crohn’s Disease

P2702. Risankizumab Effectiveness in Perianal Crohn’s Disease: A Single Tertiary Care Center Case Series

P2707. Integrin Inhibition and Collagen Dynamics: Unraveling a Unique Case of Collagenous Colitis in a Patient With Ulcerative Colitis

P2723. A Diagnostic Dilemma: Abdominal Tuberculosis Mimicking Suspected Crohn’s Disease or Latent Tuberculosis Activated by Biologic Therapy

P2740. Eye Opener: Orbital Myositis Unveiling Crohn's Disease

P2789. Endoscopic Ultrasound Functionality for a Standard Upper Endoscope: Initial U.S. Experience

P2800. Bile Duct Obstruction Caused by Portal Vein Cavernous Transformation

P2806. Partial Endoscopic Sleeve Gastroplasty for Management of Gastric Perforation During Intragastric Balloon Placement

P2818. Therapeutic Utility of Endoscopic Cecostomy in Acute Colonic Pseudo-Obstruction

P2830. Endoscopic Ultrasound-Guided Gastric Remnant Access in a Patient With Massive Upper Gastrointestinal Bleeding and a History of a Rouxen-Y Gastric Bypass After Failed IR Embolization of a Bleeding Duodenal Ulcer

P2851. Circumferential Endoscopic Submucosal Dissection (ESD) of 15-cm Long Segment Barrett’s Esophagus With Multi-Focal Intramucosal Adenocarcinoma

P2912. Trends in Mortality Caused by Viral Hepatitis in the United States Population: A Retrospective Cross-Sectional Study Using the CDC WONDER Database

P2953. Role of Pre-Operative TIPS in Patients Undergoing Surgery

P2968. Elevated Rates of Liver and Intrahepatic Bile Duct Cancer in Native American and Alaskan Native Females vs to Males When Compared to Their White Counterparts: A 5-Year Regional Analysis

P2976. Deciphering Survival Disparities in Hepatocellular Carcinoma: A Multi-Omics Approach

P2993. Unveiling a Tropical Disease as a Cause of Liver Injury and Pancreatitis: Icterohemorrhagic Leptospirosis

P3000. Cyclical Right Upper Quadrant Pain: A Rare Presentation of Hepatic Endometriosis

P3074. The Importance of Genetic Testing in a Case of Oral Contraceptive Induced Jaundice as First Manifestation of Benign Recurrent Intrahepatic Cholestasis

P3077. Telomere Biology Disorders: An Under-Recognized Cause of Liver Disease

P3082. Congenital Intrahepatic Portosystemic Shunt: A Rare Cause of Altered Mental Status

P3101. Left Ventricular Assist Device as a Possible Instrument for Reversing Liver Fibrosis

P3122. Bile Duct Ballet: Dancing With Von Meyenburg Complexes and Liver Enzyme Riddles - Diagnostic Dilemma

P3127. Copy Cat: Inflammatory Pseudotumors of the Liver

P3135. Liver Meets Legs: Unraveling Hepatic Myelopathy

P3138. Too Much of a Good Thing? Kombucha-Induced Liver Injury

P3158. Endoscopic Sleeve Gastroplasty Improves Atherosclerotic Cardiovascular Disease Risk Factors and Pooled Cohort Equations Risk Score: A Prospective Cohort Study

P3162. Racial and Ethnic Disparities and Their Association With Obesity Phenotypes: A Prospective Single-Center Registry

P3177. Semaglutide-Linked Dry Beriberi: A Rare Adverse Reaction

P3187. Patient Outcomes and Natural History of 222 Patients with Sclerosing Mesenteritis

P3190. Delayed Gastric Emptying, but not Colonic Transit, Is Associated With SIBO Defined By Breath Test and Aspirate

P3191. Ileal Aspirates for Study: A Novel Sample for Diagnosis of Intestinal Tuberculosis

P3202. Risk of Small Intestine Cancer in Inflammatory Bowel Disease: Results From A Large Multi-Center Database

P3207. IL-15 Neutralizing Antibody Inhibits Cytotoxic T Cell-Mediated Tissue Damages and Increases TGF-Beta Expression in Celiac Disease

P3208. Quality Improvement Initiative Improves Pneumococcal Vaccination Rates in Adult Patients with Celiac Disease

P3210. Deep Learning and Capsule Endoscopy: Automatic Panendoscopic Detection of Pleomorphic Protruding Lesions

P3228. A Rare Case of Collagenous Duodenitis

P3229. Beyond the Usual Suspects: Gastrointestinal Histoplasmosis as a Marker of Undiagnosed of Common Variable Immunodeficiency

P3241. When Gluten isn't to Blame: Mycophenolate Mofetil Induced Celiac Like Enteropathy in Liver Transplant Patient

P3259. Splenic Marginal Zone Lymphoma Manifesting as Acquired Angioedema of the Small Intestine

P3262. Pregnancy Outcomes Following Triple Organ (Small Bowel, Liver, and Pancreas) Transplantation

P3273. Jejunal Diverticulosis as a Rare Cause of GI Bleeding

P3285. Gastrointestinal Bleeding Due to IgA Vasculitis in an Elderly Individual – Recognition of Radiologic Features

P3291. A Rare Case of Segmental Ileal Dilatation Causing Severe Malnutrition in a Young Woman

P3323. Impact of Proton Pump Inhibitor Use on Stool H. pylori Antigen Tests: A Cochrane Diagnostic Meta-Analysis

P3324. Predictive Value of Gastric Myoelectrical Activity in Patient Satisfaction after Gastric Per-Oral Myotomy

P3339. Addressing an Emerging Clinical Need: Nasal Metoclopramide's Impact on Diabetic Gastroparesis in Patients Taking GLP-1 Agonists

P3341. Mesenteroaxial Volvulus Complicated by Gastric Perforation in an Elderly Patient With Bochdalek Hernia

P3357. Resolution of Gastric Adenocarcinoma After H. Pylori Eradication Alone

P3378. Equity, Heredity and Cancer Risk: Delayed Diagnosis of Gastric Cancer and Lynch Syndrome in an Uninsured Patient

P3416. When Nivolumab Turns Nasty: A Rare Case of Hemorrhagic Gastritis

P3422. A Rare Case of Gastric Lymphangioma Masquerading as a Malignancy

Tuesday, October 29

Poster viewing time:

10:30 am – 4:00 pm

P3432. Dexamethasone-Eluting and Self-Expanding Biodegradable Stents Effectively Reduce Fibrosis in Cases of Biliary Stricture

P3439. Impact of Elective Cholecystectomy Following ERCP on Readmission Rate in Pregnant Patients With Choledocholithiasis: A Nationwide Analysis

P3477. Assessing the Ability of ChatGPT 4.0 as an Educational Tool for Patients With Pancreatic Cysts

P3492. Stabilization of Enhanced Liver Fibrosis and Liver Stiffness Measures in the Open-Label Extension of the Phase 3 POISE Trial of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis

P3523. GLP-1 Agonist Therapy: Culprit or Coincidence in Acute Pancreatitis? A Case Report

P3530. Life-Threatening Gastrointestinal Bleeding due to Hemorrhagic Necrotizing Pancreatitis Complicated by a Colopancreatic Fistula

P3535. Acute Myeloid Leukemia Presenting With Leukemic Infiltration of the Liver and Bile Ducts

P3548. Leser-Trélat Sign Revealing Pancreatic Adenocarcinoma: A Case Report and Diagnostic Insight

P3557. Segmental Arterial Mediolysis With Hepatic Artery Aneurysm Causing Biliary Obstruction and Arterio-Biliary Fistula: Rare Presentation of a Rare Disease

P3580. Cloaked Identity, Early T-Cell Precursor Lymphoblastic Leukemia (ETP-ALL) Masquerading as Autoimmune Pancreatitis

P3586. A Veinous Twist: A Rare Case of Fistulization from Pancreatic Pseudocyst into Inferior Vena Cava Leading to Hemosuccus Pancreaticus

P3614. The Dual Assault of COVID-19: Hepatitis and Pancreatitis

P3615. A Rare Ca(u)se of Metastatic Renal Cell Carcinoma in the Biliary Tree

P3634. Prognostication of Metastatic Colorectal Cancer by Circulating Tumor DNA Levels in Serum as a Predictor of Response to Chemotherapy

P3639. Interoperable Artificial Intelligence for High-Resolution Anoscopy: A Transatlantic Collaborative Study in Anal Cancer Precursor Detection and Differentiation

P3653. Randomized Clinical Trial of Infliximab Versus Vedolizumab for Immune Checkpoint Inhibitor Related Colitis

P3667. Efficacy and Safety of the 1 Liter NER1006 Bowel Preparation for Colonoscopy in Adults With Comorbid Conditions That May Impact Prep Quality

P3672. Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk

P3709. Endoscopic Ultrasound-Guided Diagnosis of A Rare Cecal/Appendiceal Subepithelial Lesion: An Intramural Pseudocyst

P3736. Barium Contrast Induced Bowel Obstruction Treated With Endoscopic Retrieval

P3745. A Case of Atypical Endometriosis Presenting as a Malignant Appearing Colonic Mass

P3767. Pneumatosis Intestinalis: An Unusual Complication of Pseudomembranous Clostridioides difficile Colitis

P3828. Impact of Neighborhood-Level Transportation Insecurity on Colorectal Cancer Screening in the United States

P3871. Test Performance and Lesion Characteristics in a Large Clinical Validation Study of a Blood-Based Screening Test for the Early Detection of Colorectal Cancer

P3901. Efficacy of Dupilumab on Facilitated Food Introduction in Eosinophilic Esophagitis

P3909. Timing and Durability of Dysphagia Symptom Response to Dupilumab in Patients With Eosinophilic Esophagitis: Post-Hoc Analysis of Part C of the LIBERTY EoE TREET Study

P3910. Improvements In Histologic, Symptomatic, and Endoscopic Aspects of Eosinophilic Esophagitis are Maintained, or Continue to Improve, With Long-Term Dupilumab Treatment Regardless of Prior Esophageal Dilation

P3924. Risk-Aligned Management Guided by the Tissue Systems Pathology Test Can Improve Health Outcomes in Barrett’s Esophagus and Reduce Healthcare-Associated Costs

P3937. Cendakimab Exhibits Robust Anti-Fibrotic Effects by Inhibiting IL-13Rα2 Signaling

P3959. Metastatic Esophageal Adenocarcinoma in a Healthy 19-Year-Old Female

P4012. Acute Phlegmonous Esophagitis: A Rare Case Report

P4014. Kommerell Diverticulum as a Rare Cause of Adult Esophageal Dysphagia

P4043. Evaluating Equity in Clinical Trial Accessibility: A Systematic Review of Demographic, Socioeconomic, and Educational Disparities in IBS Drug Trials

P4047. Pilot Study of Crofelemer for Functional Diarrhea

P4068. Global Insights: Glucagon-Like Peptide-1 Receptor Agonists are Linked to Gastrointestinal Functional Disorders

P4081. Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

P4130. Recognizing and Managing Artifact Arrhythmias in the Endoscopy Suite: A Case of New Onset Atrial Flutter During Time out for EGD in a Patient with Celiac Disease and Deep Brain Stimulator for Parkinson’s Disease

P4148. Endoscopic Use of New Short Bend ESD Colonoscope in Patients With Failed Colonoscopy: A Pilot Study

P4161. Diagnosis of GI Tract Cancers in New Onset Iron Deficiency Anemia in a National Retrospective Cohort (2005-2019)

P4167. Management and Outcomes of Gastric Varices: A Retrospective Study

P4204. Bean Bleeding: A Case of Blue Rubber Bleb Nevus Syndrome

P4227. Bleeding in the Shadows: Isolated Jejunal Varices Treated with Push Enteroscopy Sclerotherapy

P4235. A Rare Case of Gastrointestinal Bleeding Following Atrial Fibrillation Ablation

P4267. Identification of New Therapeutic Targets in IBD Using a Transcriptomic Foundation Model

P4275. Single Ascending Dose Results From a Phase 1 Clinical Trial of BT-600, a Combination Product of the NaviCap Targeted Oral Delivery Platform and Tofacitinib

P4276. Impact of GLP-1RA on MACE in Patients With IBD

P4303. Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel Disease

P4364. Exploring the Role and Association of Metabolic Risk Factors With Cardiovascular Diseases in Patients With Crohn’s Disease: A National Inpatient Database Study

P4373. Understanding Patient Preferences at the Time of Treatment Escalation to First Line Advanced Therapies in Ulcerative Colitis: A Discrete Choice Experiment in Five European Countries

P4391. Pathogenic Crossroads: Viral Defense Genes as Modulators of Crohn's Disease Activity

P4401. Geographic Disparity in Access to Specialist Care for Ulcerative Colitis and Crohn’s Disease in the US

P4406. Psychosocial Factors in Young IBD Patients Contribute to CRC Development

P4422. Unmasking Intestinal Plasmablastic Lymphoma in an Immunocompetent Crohn’s Disease Patient

P4437. Ixekizumab-Induced Ulcerative Colitis With Resultant Total Colectomy

P4442. A Challenging Diagnosis of Goblet Cell Adenocarcinoma of the Appendix in a Patient With Ulcerative Colitis

P4447. A Case of Peristomal PG: Novel Combination Therapy With IVIG and Risankizumab

P4452. Dramatic Changes in Thiopurine Metabolite Levels in a Patient with Inflammatory Bowel Disease Treated with Tirzepatide for Weight Loss: A Case Report

P4507. A Rare Cause of Post-ERCP Epigastric Pain: Fatty-Falciform Ligament Appendage Torsion

P4509. ERCP, Stent, and Beyond: A Rare Sequence of Events Post-Cholecystectomy Leading to Pneumoperitoneum

P4541. Neuroendocrine Tumor of the Ampulla of Vater: A Rare Cause of Biliary Obstruction

P4545. Does Endoscopic Sleeve Gastroplasty Worsen Esophageal Motility?

P4550. Dual Endoscopic Myotomy for Concurrent Achalasia and Esophageal Diverticulum: An Innovative Approach

P4551. Unique Approach to Managing Hepatojejunal Anastomosis Stricture in a Patient with Long Rouxen-Y Limb

P4559. Endoscopic Intraluminal Electrohydraulic Lithotripsy for the Treatment of a Giant Rectal Fecalith

P4566. Efficacy and Safety of Bulevirtide Monotherapy for Chronic Hepatitis Delta in Patients With and Without Cirrhosis: Results From the Week 96 Interim Analysis of a Phase 3 Randomized Study

P4573. The Evolving Landscape of Drug Induced Liver Injury (DILI): Tracking New Drug Culprits

P4576. Breaking Boundaries: A Comparative Study of Hepatitis C Mortality Rates in Oklahoma Against the Nation, 1999-2020

P4605. Non-English Primary Language Linked to Increased Complications and Reduced Transplant Rates in Cirrhosis Patients: Insights From Population-Based Multi-Network Analysis

P4609. Patient Advocates Increase Compliance with Hepatocellular Carcinoma Screening in Medicaid Patients with Cirrhosis

P4612. Plasma High-Resolution Metabolomics Identifies Differences in Linoleic Acid and Vitamin A Metabolism Between Adults with Steatosis and Steatohepatitis

P4627. Elucidating the Oncogenic Roles of Extrachromosomal Circular DNA (eccDNA) in Hepatitis B Virus-Associated Liver Cirrhosis and Hepatocellular Carcinoma: Implications for Early Diagnostic Markers

P4649. Cholangiocyte Response to Seladelpar Treatment

P4717. Cardiac Clot or Cancer? A Presentation of Metastatic HCC

P4721. Complicated Portal Vein Thrombosis Requiring Creation of a Surgical Shunt

P4756. Rescue PAATO/CAATO for Recurrent Peristomal Variceal Bleeding Secondary to Hepatic Metastases Causing Portal Hypertension

P4783. Spontaneous Portosystemic Shunt in a Non-Cirrhotic Adult Patient

P4787. A Case of Successful Treatment of High-Grade Immune-Mediated Hepatobiliary Toxicity With Oral Budesonide: Shifting the Paradigm Away From Systemic Steroids

P4801. Booch or Hooch: Excessive Kombucha Intake Mimicking Alcoholic Hepatitis

P4807. Rare Hepatic Manifestation in Influenza A H1N1: A Case Report of Acute Liver Failure

P4822. Unmasking Kratom: A Helpful Opioid-Substitute or Harmful Hepatotoxic Supplement?

P4835. Post-COVID-19 Cholangiopathy: Vigilance and Diligence Required - A Case Report

P4844. Perplexing “Pseudotumoral” Findings in Acute Alcohol-Associated Hepatitis

P4853. A Rare Case of Banti Syndrome: A Review of Literature

P4881. Gender Disparities in the Impact of Bariatric Surgery in Metabolic Associated Steatohepatitis Disease (MASLD) Patients: Propensity Matched Analysis of a Large Multi-Institutional Cohort

P4929. Bridging Healthcare Gaps: Improving Access to Gastroenterology Services in Hard-to-Reach Areas Using an Integrated Care Approach

P4938. Updated Analysis on a Call for Early Wireless Capsule Enteroscopy in Suspected Small Bowel Bleed: A Single Tertiary Care Referral Center Experience

P4961. Isolated Jejunal Varices: A Hidden Source of Gastrointestinal Bleeding in Patient With Extrahepatic Portal Hypertension and Altered Anatomy

P5045. The Efficacy and Safety of Vonoprazan-Based Regimens for Helicobacter pylori Eradication Treatment: A Systemic Review and Network Meta-Analysis

P5055. New Endoscopic Approaches Versus Conventional Surgical Interventions in the Management of Refractory Gastroparesis: A Network Meta-Analysis

P5061. Open Label Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis

P5062. Exposure-Response Analysis of Open Label Tradipitant in Idiopathic and Diabetic Gastroparesis in Study VP-VLY-686-3301

P5133. Hidden Hairball Hazard: A Case of Gastric Perforation With Purulent Peritonitis Due to an Insidious Trichobezoar

P5136. The Use of Blenderized Tube Feeds in Gastroparesis to Improve Enteral Feeding Tolerance and Metabolic Parameters

OUTSTANDING POSTER PRESENTER

Recognition

The College is pleased to once again provide recognition for “Outstanding Poster Presenter” at this year’s Annual Scientific Meeting. ACG hopes to cultivate the ability of clinical GI researchers to use critical storytelling and presentation skills essential for a career as a clinical investigator and scientific communicator.

During the daily Poster Rounds with the experts, poster presenters may be invited to give a succinct and informative two-minute briefing on their research, followed by one minute of Q&A with a faculty judge. Each judge will select one or more presenters within a poster category who are best able to communicate their key findings, the significance of their data, and articulate the potential impact of their work for clinicians and patients, to receive an “Outstanding Poster Presenter” distinction. Recipients of this designation will be recognized with a red ribbon and will receive a certificate.

Poster Rounds with the experts will take place on Sunday (5:15 pm - 6:30 pm), Monday (1:00 pm - 2:15 pm), and Tuesday (1:00 pm - 2:15 pm). Attendees who wish to attend these rounds can join the Experts at the Poster Counter in the Exhibit Hall 10 minutes before the start time.

2024 Samuel Weiss Award to IRVING M. PIKE, MD, MACG

Highest Honor to Dr. Pike for Unwavering Dedication and Exceptional Commitment to ACG

For his steadfast dedication to the ACG, its mission, and its future; his commitment as a leader and educator; and his pioneering contributions to quality and endoscopic practices across the nation, Irving M. Pike, MD, MACG, is the 2024 recipient of the prestigious ACG Samuel S. Weiss Award. This award in commemoration of ACG’s founding father, Dr. Samuel Weiss, is presented periodically, and not necessarily annually, to a Fellow of the College in recognition of outstanding career service to ACG.

Recognized for his tremendous positive impact on gastroenterology, patient care, and the direction of the ACG, Dr. Pike transformed the future of endoscopy care across the United States in his role as the driving force and visionary leader behind the establishment of the Gastroenterology Quality Improvement Consortium, Ltd., (GIQuIC) for which he served as the Founding Director and President from 2009 to 2017. Today, the GIQuIC is the largest national clinical data registry for gastroenterology and approximately one-third of all gastroenterologists in the country participate.

Named an ACG Trustee in 2006, Dr. Pike’s dedicated service to the College included the ACG Presidency from 2017-2018. After his tenure as Past President, Dr. Pike remained on the Board in 2020 as Trustee for Administrative Affairs. This appointment continues over a five-year tenure, reflecting his vibrant and ongoing commitment to the College and the Board of Trustees’ respect and admiration for his abilities and achievements.

Dr. Pike is widely heralded as “a man of genuine empathy and kindness,” a tribute noted by one of his nominators. Another wrote, “I often tap Irving for advice and have found his integrity to be impeccable, his wisdom to be invaluable, and his loyalty and dedication to the ACG to be unwavering.”

ABOUT DR. PIKE

Irving M. Pike, MD, MACG, is a 1973 graduate of Emory University and received his medical school education at the Medical College of Georgia in 1978. His postgraduate training was completed in Dallas, Texas, at the University of Texas Southwestern Health Science Center, Parkland Hospital and Dallas VA Medical Center, Internal Medicine Residency (1981), and Gastroenterology Fellowship (1983).

Following his training he entered private practice in Virginia Beach, Virginia.

While practicing in Virginia Beach, Dr. Pike helped the community of gastroenterologists form Gastrointestinal and Liver Specialists of Tidewater, PLLC, a practice of over 40 physicians and providers. He served as a community faculty member for the Eastern Virginia Medical School. Dr. Pike served as Chief of Staff of Sentara Bayside Hospital and President of the Virginia Beach Medical Society. In 1986, his practice introduced office-based endoscopy to the Commonwealth of Virginia, which is now the predominant form of ambulatory endoscopy in Virginia.

Dr. Pike has served on the ACG’s Practice Management Committee, Archives Committee, Credentials Committee, Finance and Budget Committee, and Nominating Committee. He was chair of the Practice Management Committee, Finance and Budget Committee, and Nominating Committee. He served as Co-Chair of the 2005 ACG/ASGE Task Force for the Development of Quality Indicators for Gastrointestinal Endoscopy and again as Co-Chair of the Task Force in 2015 for the update of these indicators. In 2007, Dr. Pike started a grass roots Benchmarking Advisory Committee which became the prototype for the GI Quality Improvement Consortium (GIQuIC), a gastroenterology quality registry (2010) which has grown to become a resource for establishing important national quality metrics in gastroenterology and a source for important clinical research, while being a tool to support the improvement of performance by the over 4,700 gastroenterologists utilizing the registry.

Dr. Pike has been a presenter at many regional and ACG Annual Scientific Meetings. He is honored to

OCTOBER 26 | 5:15 PM – 7:00 PM | ROOM 120AB

have presented the Emily Couric Memorial Lecture (2015). He has been the author of numerous GI quality articles, as well as articles and chapters related to practice management. Dr. Pike served three terms as Trustee for the College and served in each elected officer position, including President from 2017-2018. Dr. Pike currently serves as ACG Trustee for Administrative Affairs.

During his time practicing in Virginia Beach, Dr. Pike began working in administrative part-time roles for Sentara Health Care, eventually serving as Vice President of Medical Affairs for the hospital where he was practicing. In 2012, Dr. Pike moved to Alamo, California, to accept the role of John Muir Health’s first Sr. VP and Chief Medical Officer. Dr. Pike retired from this role in the summer of 2021. He currently is Co-Director of the University of California San Francisco Network Physician Leadership Academy. He and Randy, his wife of 51 years, continue to reside in Alamo near their adult children and their spouses and their four grandchildren.

 ABOUT THE SAMUEL S. WEISS AWARD

The Samuel S. Weiss Award was established as a service award in commemoration of the founding father of the ACG, Samuel S. Weiss, MD, whose efforts and initiative resulted in the establishment of the College in 1932. Since its inception in 1972, it has been presented periodically (not always annually) to a Fellow of the College in recognition of outstanding career service to the American College of Gastroenterology. Nominations are solicited and reviewed by the Awards Committee and the recipients must be approved by the ACG Board of Trustees.

DISTINGUISHED MENTORSHIP & TEACHING AWARD

JEAN-PAUL ACHKAR, MD, FACG; DAVID A. JOHNSON, MD, MACG; AND LAWRENCE R. SCHILLER, MD, MACG

2024 HONOREES

Three renowned gastroenterologists are the recipients of this year's Distinguished Mentorship and Teaching Award: Jean-Paul Achkar, MD, FACG; David A. Johnson, MD, MACG; and Lawrence R. Schiller, MD, MACG. Among their many contributions to the field of gastroenterology, these three stand out for the breadth of their interests and the numbers of GI trainees who benefited from their mentorship.

JEAN-PAUL ACHKAR, MD, FACG

Jean-Paul (JP) Achkar, MD, FACG, has had a longstanding commitment to education and mentorship during his 26-year tenure at the Cleveland Clinic in Cleveland, Ohio, and as part of his involvement with the American College of Gastroenterology.

He has served as the Gastroenterology Fellowship Program Director at the Cleveland Clinic for 18 years and is currently the longest serving program director at the institution. During that time, Dr. Achkar has helped teach and mentor close to 100 GI fellows who have graduated from the program and have been successful in their own careers. He has also worked with and taught many internal medicine residents and medical students. He has been recognized with several teaching awards, including being selected multiple times each for Gastroenterology Teacher of the Year and Senior Fellows Mentorship Awards.

Dr. Achkar has also brought his passion for education and research to his work with ACG. He served on and chaired both the ACG Educational Affairs Committee (2001-2010) and the ACG Research Committee (20112018). He has worked to help define quality metrics for inflammatory bowel disease as part of the GIQuIC IBD Subcommittee which he has chaired for the past two years. He also Co-Chairs the ACG-Crohn’s and Colitis Foundation IBD Circle with Dr. Sunanda V. Kane, an online platform for discussion and teaching of challenging cases and interesting topics. In addition, he has served on the ACG Board of Trustees from 2018-2024.

DAVID A. JOHNSON, MD, MACG

David A. Johnson, MD, MACG, is Professor of Medicine/Chief of GI at Eastern VA Medical School (EVMS). He has published extensively, contributing over 700 articles/chapters/invited reviews and edited/ co-edited seven books. His focus has been GERD, GI microbiome, sleep disorders, and CRC screening. He more recently edited the books “Gut Microbiome: New Understanding and Translational Opportunities for Disease” (2015) and “Esophageal Disease and the Role of the Microbiome” (2023). He co-directs the ongoing 2020 VA Catalyst grant on prebiotic treatment of microbial GERD effects.

Dr. Johnson served three terms as Trustee for the American College of Gastroenterology (ACG) and served in each elected officer position, including President (2006-2007). He has also served the College

as Governor for Virginia, Chair of the Quality Council Task Force, and member of the Awards, Educational Affairs, Publications, Credentials, Constitution and Bylaws (Chair), and Nominating (Chair) Committees. Additionally, he was on the executive committee and Treasurer of the ACG/ASGE GIQuIC and the executive committee of the GI Political Action Committee (GIPAC). He co-chaired the ACG North American Conference of GI Fellows meeting for 17 years (1991-2008) and was co-director for the ACG Annual Postgraduate Course in 1994. He co-founded the National Medicare Carrier Advisory Committee and co-chaired that committee for 10 years. From 2000-2018, he served on the GI Multi-Society CRC Screening Task Force and ACG guidelines committee for CRC screening and has co-authored these screening national guidelines and other ongoing national guideline publications from 2000-present (17 total).

Dr. Johnson has always prided himself on and prioritized being an educator. ACG named lectures delivered include: Emily Couric (2013), AJG (2009), Berk Fise (2016), David Sun (2018) and David Graham. Major ACG awards: Master (2013), Berk/ Fise (2013), William D. Carey Governors (2015) and Samuel Weiss (2021). Additional awards include: 2022 ACP Community Education Award, 2019 ACP Master, 2012 National Institutes of Health “Great Teacher” (first non-NIH GI physician), 2016 AGA “Distinguished Educator”, Virginia GI Society “Master of Gastroenterology” (2001) and “Presidential Award” (2000), EVMS Distinguished Internal Medicine Faculty (1999), Dean’s Outstanding Faculty (2010) and the Distinguished Community Faculty Awards (2022). He served on the American Board of Internal Medicine (Gastroenterology) Board of Examiners (20122017) and was reappointed to the Maintenance of Certification ABIM Board 2020-2021. He is the past co-editor of Reviews in Gastroenterological Disorders, Journal Medicine and section editor for The American Journal of Gastroenterology. He is the past co-editor of the American College of Gastroenterology Education Universe (2009-2015), GI section editor (2000present) for Medscape Gastroenterology, Medscape GI Viewpoints, and Medscape GI Consultant Corner, and was the esophageal section editor for Journal Watch Gastroenterology (New England Journal of Medicine) (2000-2018).

Dr. Johnson directed the first CRC trial on colonoscopy (1988) and led, with VA State Senator Emily Couric, the effort to pass the historic first legislation to mandate CRC colonoscopy screening as the preferred standard. This set the model for other states which followed with similar legislation mandating CRC screening. He has always prioritized and valued mentoring three to five students/trainees per year over his 40+ year career, as well as many established peers.

LAWRENCE R. SCHILLER, MD, MACG

Lawrence R. Schiller, MD, MACG, was born in Philadelphia and attended Pennsylvania State University and Jefferson Medical College of Philadelphia. He completed his internal medicine training at Temple University Hospital in Philadelphia and then served as Chief Resident there. He spent the next two years in Belgium as a Major in the U.S. Army Medical Corps, where he was decorated with the U.S. Army Commendation

Medal. Dr. Schiller then moved to Texas for training in gastroenterology at Southwestern Medical School and the Dallas VA Medical Center. He stayed on the faculty at the medical school and was an attending physician at the Dallas VA Hospital for five years.

He moved to Baylor University Medical Center, Dallas in 1985 to continue research activities with Dr. John Fordtran, and has been there ever since, lately as an Attending Physician and Chairman of the Institutional Review Board for Human Subject Protection at Baylor Scott & White Health. Dr. Schiller has published 110 papers and 73 book chapters dealing with gastric physiology, intestinal transport, diarrheal diseases, and motility disorders. He was involved with patient care until his retirement in 2016 as a founding partner of Digestive Health Associates of Texas, at one time one of the largest single-specialty private gastroenterology practices in America.

Since his retirement from direct patient care, he has continued to be involved in the education of medical students, residents, and fellows as Clinical Professor in the Department of Medical Education at Texas A&M University School of Medicine, Dallas Campus. He served as Program Director of the Gastroenterology Fellowship Program at Baylor University Medical Center, Dallas for 24 years and trained 38 fellows who have gone on to successful careers. Dr. Schiller has won three fellow teaching awards at UT Southwestern and Baylor, and the prestigious Ralph Thompsett Award for Excellence in Medical Education at Baylor. He has been elected to fellowship in the American College of Physicians and mastership in the American College of Gastroenterology (ACG). He has served as President of the Texas Society for Gastroenterology and Endoscopy and President of the ACG.

 ABOUT THE DISTINGUISHED MENTORSHIP AND TEACHING AWARD

In 2021, the College established a new Distinguished Mentorship and Teaching Award to recognize ACG members who have provided meaningful and sustained contributions to trainees/ colleagues in gastroenterology. The vision for this award is to celebrate mentorship or teaching that helps develop the mentees’ overall scientific growth and career or life planning; supports their practice of high-level clinical gastroenterology; imparts skills to perform high quality clinical research; encourages those skills necessary to present and publish results of clinical research or quality improvement; and inspires mentees’ involvement in professional society, healthcare organization, or leadership development.

The spirit of the award is to honor those mentors and teachers who have made contributions over a significant period of time in gastroenterology. Such contributions may be via academic affiliation as well as in private practice or an integrated (government or non-government) health system. Recognizably, each of these specific pathways has provided impactful mentorship to many individuals, hence any of these backgrounds would be suitable for this award. The decision to grant any award within a given year, as well as the selection of the award winner, is at the discretion and recommendation of the ACG Awards Committee, and upon approval of the ACG Board of Trustees. This award is not necessarily given annually.

News from the ACG Institute

Promoting education, supporting clinical science, and raising public awareness for the prevention and treatment of digestive disease.

Learn how the ACG Institute for Clinical Research and Education supports clinical GI investigators, leadership development, and education for physicians and patients in the Institute in Focus. This booklet shares important application deadlines and opportunities for leadership training, clinical research, and educational growth for you and your colleagues.

 GI.ORG/ACG-INSTITUTE/ABOUT

ACG CLINICAL RESEARCH AWARDS

The ACG Institute supports a robust clinical research program in gastroenterology and hepatology. This upcoming year, the ACG Institute is funding eight different award types, supporting researchers throughout their careers, from medical school to established investigators. Notably, the Established Investigator Bridge Funding Award eligibility criteria was updated to increase the number of years elapsed after funding to three years, allow K-awards and Career Development Awards as prior funding, and the required percentage of protected time reduced to 30%. Also of note, Nurse Practitioners and Physician Assistants are eligible to apply for the Clinical Research Award and Clinical Research Pilot Award.

 Junior Faculty Development Award ($450,000 total / $150,000 per year)

 Established Investigator Bridge Funding Award ($300,000 total / $150,000 per year)

 ACG/ASGE Epidemiologic Award in Gastrointestinal Endoscopy ($50,000 / 1- or 2-year)

• NOTE: Deadline Friday, December 6, 2024

 ACG Leonidas Berry Health Equity Research Award ($75,000 / $50,000 year-one, $25,000 year-two based on progress)

 Clinical Research Award ($50,000 / 1-year)

 Pilot Research Award ($15,000 / 1-year)

 Resident Clinical Research Award ($10,000 / 1-year / travel to ACG 2025)

 Medical Student Research Award ($5,000 / 6-10 weeks / travel to ACG 2025)

Deadline for all awards:

MONDAY, DECEMBER 2, 2024



THE ACG INSTITUTE CENTER FOR LEADERSHIP, ETHICS & EQUITY (THE LE&E CENTER)

The LE&E Center addresses the contemporary need for leadership training, equitable delivery of care, and ethically based decision-making with a suite of training programs and activities to provide transformational tools and experiences to GI clinicians. The programs under the LE&E Center include:

 NEW for 2025! The ACG Institute and The LE&E Center support four distinct leadership programs under Leadership YOU, with each program being tailored to a distinct career stage. Leadership YOU provides an opportunity for participants in all four cohorts to network and engage in shared learning sessions, in addition to cohort-specific professional development over one weekend, June 6-8, 2025, in Washington, DC

APPLICATION DEADLINE: NOVEMBER 15, 2024

 Emerging Leadership Program (3rd and 4th year of GI fellowship training)

 Early Career Leadership Program (1-5 years post-fellowship completion)

 Advanced Leadership Program (10-20 years post-fellowship completion)

 Clinical Research Leadership Program (clinical investigators with recent funding, 2-15 years post-fellowship completion)

Additional LE&E Center Programs:

• The ACG Leonidas Berry Health Equity Research Award

• The ACG Visiting Scholar in Equity, Diversity & Ethical Care

• Scholarships for High School Students through the Prescriptions for Success: Careers in Medicine High School Visit  LEARN MORE: GI.ORG/LEECENTER

THE LE&E CENTER EMERGING LEADERSHIP PROGRAM

The program provides leadership training for fellows-in-training who are U.S.-based ACG member physicians (in their 3rd or 4th year of GI fellowship training) to explore their leadership potential. This program will reach fellows-in-training to develop, build, and maintain success as future leaders. Participants are immersed in coursework covering the skills needed as they look ahead to their career post-fellowship and begin to take on more leadership roles.

The program includes a mix of lectures, Q&A, breakout and role-playing exercises, and networking.

“I learned so many new ideas and perspectives from the talks, faculty, and members of the cohort. I really enjoyed the opportunity to speak with other fellows in different programs - we truly are going through the same trials and experiences, and it's nice to know you are not the only one. I appreciated the candidness and vulnerability the faculty displayed - everyone's journey is different, and the various perspectives bring richness and diversity to personal and professional work.”

—Siri Urquhart, MD (ELP 2023)

Course Directors: Andrew Moon, MD, MPH, FACG; Divya Bhatt, MD; Olufemi Kassim, MD; and Josh Steinberg, MD

THE LE&E CENTER EARLY CAREER LEADERSHIP PROGRAM

The LE&E Center Early Career Leadership Program develops future leaders in clinical gastroenterology by providing leadership and policy training to earlycareer U.S.-based ACG member physicians (1-5 years post-fellowship completion).

Participants will begin by participating in the ACG Governors' Washington, DC, Fly-in April 2025, followed by pre-course learning, and coursework covering effective leadership, impactful networking, emotional intelligence, negotiation, group dynamics, and team building in June 2025. The ACG Institute is excited to welcome the seventh cohort of the Early Career Leadership Program in 2025.

“It was incredibly impactful hearing from senior leadership, what approaches helped them, and listening to the unique perspectives of various participants who are navigating leadership roles in their early careers.”

—Hassan Siddiki, MD, MS, MEd (ECLP 2023)

Course Directors:

Andy Tau, MD, and Judy A. Trieu, MD, MPH

THE LE&E CENTER ADVANCED LEADERSHIP PROGRAM

The LE&E Center Advanced Leadership Program aims to develop a cohesive group of peer leaders who will serve as problem-solving consultants for each other and the College. This program offers mid-career U.S.-based ACG member physicians (10-20 years post-fellowship completion) the opportunity to develop comprehensive leadership skills.

“Our GI societies offer lots of phenomenal educational opportunities for GI conditions, but very few on leadership. The ALP is a game-changer – it offers insight into leadership skills and emotional intelligence that will be a useful asset at work and in life.”

—Bryan Sauer, MD, MSc, FACG (ALP 2023)

Course Directors:

Neena S. Abraham, MD, MSc (Epid), MACG, and Patrick E. Young, MD, FACG

THE LE&E CENTER CLINICAL RESEARCH LEADERSHIP PROGRAM

The goal of the LE&E Center Clinical Research Leadership Program is to provide leadership training for early to mid-career clinical investigators who are U.S.-based ACG member physicians (between 2-15 years out of fellowship training) and have active or recent funding as a Principal Investigator or Co-Principal Investigator. The program will help train clinical investigators as scientific leaders, team managers, financial stewards of research dollars, and mentors. This unique interactive program will provide funded ACG clinician investigators with the skill set to start, grow, and successfully maintain an independent research program.

“The candid advice and guidance given at the CRLP will undoubtedly shape my career in GI and clinical research. The program demonstrates the ACG’s commitment to fostering excellence within our research community, opening opportunities for young investigators and providing mentoring circles with faculty who lift us up in this wild ride.”

—Joy Chang, MD, MS (CRLP 2024)

Course Directors:

Millie D. Long, MD, MPH, FACG, and Brennan Spiegel, MD, MSHS, FACG

 LEARN MORE: GI.ORG/CRLP

ACG EDGAR ACHKAR VISITING PROFESSORSHIPS AND VISITING

SCHOLAR IN EQUITY, DIVERSITY & ETHICAL CARE

This program, which honors former ACG Institute Director Edgar Achkar, MD, MACG, enables GI fellowship programs to host high-quality visiting professors to enhance the training program by providing lectures, small group discussions, and one-on-one visits with trainees and faculty. Additionally, this program allows community gastroenterologists to learn from an expert through an evening event or medical grand rounds.

The ACG Visiting Scholars in Equity, Diversity, and Ethical Care are an initiative of the LE&E Center, which helps institutions create awareness around the issues and challenges of delivering equitable care, respecting diversity, and instilling ethical decision-making. These visits provide an impactful learning opportunity for fellows, faculty, leadership, and Diversity, Equity, and Inclusion (DEI) leadership, as physicians seek to improve care and communication for their diverse patient populations. Topics to date have included DEI & colorectal cancer screening; hepatology/ ethical issues in the care of patients

with liver diseases; LGBTQ digestive health considerations, understanding the impact of social determinants of health; a path to liver health equity; how implicit bias affects healthcare outcomes, health disparities in GI, and diversity in GI; and neurogastroenterology and motility principles in high-need communities. The LE&E Center supported six ACG Visiting Scholars in Equity, Diversity, and Ethical Care in 2024.

 LEARN MORE: GI.ORG/EAVP

SCHOLARSHIPS FOR HIGH SCHOOL STUDENTS

The LE&E Center supports scholarships to local high school students interested in the field of medicine, supporting the pipeline of future healthcare providers. The high school students are invited to apply after participating in the ACG DEI Committee’s Prescriptions for Success high school visit, held with the ACG Annual Scientific Meeting at a local high school.

SUPPORTING THE WORK OF THE INSTITUTETHE G.U.T. FUND

The Fund Grows, Uplifts & Transforms Clinical GI

The G.U.T. Fund is the ongoing campaign that makes possible innovative Institute programs such as the ACG Visiting Scholar in Equity, Diversity & Ethical Care, Junior Faculty Development Awards, the Emerging Leadership Program, the Early Career Leadership Program, the Advanced Leadership Program, the Clinical Research Leadership Program, scholarships for high school students through the Prescriptions for Success high school visit initiative, and much more.

The G.U.T. Fund is supported by the ACG community, individual and legacy gifts, and industry contributions. Thousands of ACG members and supporters annually make philanthropic gifts that take the programs of the ACG Institute from GOOD to GREAT.

To learn more about the ACG Institute programs or to support the work of the Institute through the G.U.T. fund, please visit: gi.org/acg-institute to read the new report - Institute in Focus.

Deadline: Monday, December 2, 2024

ACG Junior Faculty Development Award $150,000 a year for three years

Established Investigator Bridge Funding Award up to $150,000 a year for two years

Leonidas Berry Health Equity Research Award up to $75,000

($50,000 year-one, $25,000 year-two based on progress)

ACG/ASGE Epidemiologic Research Award in Gastrointestinal Endoscopy up to $50,000 for research utilizing the GIQuIC database

NOTE: Deadline is Friday, December 6, 2024

Clinical Research Award up to $50,000 for clinical research

Clinical Research Pilot Award up to $15,000 for pilot projects

Resident Clinical Research Award up to $10,000

Medical Student Research Award up to $5,000 for 6–10 week summer project

Learn more about ACG 2025 Clinical Research Opportunities and Submit Your Application:

GI.ORG/RESEARCH-AWARDS

ANNUAL SCIENTIFIC MEETING & POSTGRADUATE COURSE

PHOENIX, ARIZONA | OCTOBER 24–29, 2025

ACG GOVERNORS AWARD WINNERS and NEW ACG GOVERNORS Congratulations

2024 ACG Governor Awards

JUNIOR GOVERNOR’S AWARD

Kunjali T. Padhya, MD, FACG

Kunjali T. Padhya, MD, FACG, is currently serving as the American College of Gastroenterology (ACG) Governor for Washington State. She is the Medical Director of Endoscopy at Providence Swedish Medical Center in Seattle, Washington. Dr. Padhya completed medical school at the University of Illinois College of Medicine at Peoria (UICOMP), an internal medicine residency at the University of Michigan, and a gastroenterology fellowship at the University of Texas Southwestern Medical School in Dallas. Her clinical interests include quality in endoscopy and optimizing the use of the electronic health record.

Dr. Padhya currently serves on the ACG Credentials Committee and as an abstract and poster reviewer for the Annual Scientific Meeting. She enjoys participating in the annual ACG Governors Fly-In and working to advance the College’s platforms with local, state, and national leaders.

Dr. Padhya is on the Board of the Pacific Northwest Gastroenterology Society and co-director of several educational courses around the region. She enjoys Pilates, indoor cycling, paddleboarding, and cooking. She is looking forward to serving ACG in many more capacities in the future.

SENIOR GOVERNOR’S

AWARD

Ronald K. Hsu, MD, FACG

Ronald K. Hsu, MD, FACG, is a Clinical Professor at the University of California Davis School of Medicine. He serves as the American College of Gastroenterology Governor for Northern California, Regional Councilor for the Board of Governors, and the U.S. Regional Advisor for the Royal College of Physicians, Edinburgh, United Kingdom. After graduating from the University of Wales College of Medicine, UK, he obtained his gastroenterology and advanced therapeutic endoscopy fellowship at the University of California, Davis Medical Center, where he served as the Director of Endoscopy for the GI Fellowship Program and is the current Medical Director of the Sutter Roseville Endoscopy Center.

As ACG Governor, Ron initiated the Bridging Medicine and Music - Colon Cancer Awareness outreach program during the COVID-19 pandemic in

2022, a project that brought together professionals and community members. His collaboration with Angelo Moreno, Davis Senior High School Director of Orchestras, was endorsed by world-class violinist Rachel Barton Pine. In 2024, Ron performed with Trans-Siberian Orchestra original string master Mark Wood at the CRC Outreach and Rock & Roll Concert, a program supported by the Davis Joint Unified School District Music Program. Multiple ACG experts participated, and 350 young musicians performed for a live audience of over a thousand at a concert live-streamed to ACG members.

Dr. Hsu's dedication is highlighted at the annual ACG DC Fly-in Advocacy Day and his work with esteemed advocacy groups, including the California Colorectal Cancer Coalition, Fight Colon Cancer, and the American Cancer Society Cancer Action Network. Together, they hosted the first Light the Capitol Blue Colorectal Cancer Awareness Rally at the California State Capitol in 2023. In 2024, California legislation proposed the joint resolution SCR109: Declaration of March as Colorectal Cancer Awareness Month.

Dr. Hsu spearheads the inaugural joint ACG, Scottish Society of Gastroenterology, and Royal College of Physicians Edinburgh Symposium— Gastroenterology: A Global Perspective to be held in Scotland in November 2024. He promoted ACG’s mission in education, research, and advocacy at the Northern California Society for Clinical Gastroenterology annual conference and meetings with Northern California GI groups. Ron has been the program director of the annual Crohn’s and Colitis Foundation Professional IBD Symposium in Northern California since its inception in 2020 and directed the ACG Hands-on Workshop (HOW) in Endoscopy sessions at five regional postgraduate courses. He is Co-Director of the Endoscopy School Hands-On Workshop Center at ACG 2024. He has served on the Patient Care Committee, Educational Affairs Committee, SelfAssessment Test sub-section editor, abstract and poster reviewer, Practice Management Committee, Legislative and Public Policy Council, Membership Committee, and International Relations Committee.

In 2024, Dr. Hsu received numerous accolades and recognitions, including the Walter Trudeau Excellence in Teaching Award, the Dean's Award for Excellence in Team Inclusion from the UC Davis School of Medicine, the ACG Community Service Award in 2023, and has received the ACG SCOPY Award for nine consecutive years.

THE WILLIAM D. CAREY AWARD

March Seabrook, MD, FACG

March Seabrook, MD, FACG, has been an active member of the American College of Gastroenterology (ACG) for over three decades. During this time, he has had the privilege of serving in multiple positions within the organization. He served as the Governor of South Carolina from 2006-2012 and was recognized with both the Freshman Governor and Senior Governor Awards. He is a past member of the Nominating Committee and Public Relations Committee and has served as Chairman of the National Affairs Committee. He is currently a member of the Legislative and Public Policy Council and the Delegate from the ACG to the American Medical Association (AMA).

Dr. Seabrook completed his undergraduate education at Wofford College and then graduated from the University of South Carolina School of Medicine. After completing his internal medicine and gastroenterology training in 1991, he became a founding member of Consultants in Gastroenterology in West Columbia, South Carolina. The practice has grown to be one of the largest in the state and is committed to continued organic growth and maintaining its independent nature. His son is now a physician in the practice.

Early in his career, Dr. Seabrook developed a passion for colorectal cancer screening and prevention after his best friend’s father died of the disease. Working with the University of South Carolina's Center for Colorectal Cancer Research, he was instrumental in developing a statewide screening program for the uninsured. This collaboration has been recognized nationally for its outreach and results. He credits the gastroenterologists from around the state who continue to participate in this vital program. He was recognized with an ACG SCOPY Award and the ACG Community Service Award for these efforts.

Dr. Seabrook helped to develop the South Carolina Gastroenterology Association in 2000 and was its first President. This organization continues to grow and expand. He has also served as the President of the South Carolina Medical Association and currently serves on the Board of Directors of the Physicians Foundation.

2024 New ACG Governors

EASTERN PENNSYLVANIA

Adam Ehrlich, MD, MPH, FACG

KENTUCKY

Gerald Dryden, MD, FACG

MAINE

Noemi Baffy, MD, MPH, FACG

MARYLAND

Raymond Cross, MD, MS, FACG

MISSOURI

Sheetal Sharma, MD, FACG

NORTHERN FLORIDA

Samuel Giday, MD, FACG

NORTHERN TEXAS

Neha Patel, MD, FACG

SOUTH DAKOTA

Lee Austin, MD, FACG

SOUTHERN FLORIDA

Adam Lessne, MD, FACG

SOUTHERN TEXAS

Asif Zamir, MD, FACG

UNITED KINGDOM

Jimmy Limdi, MD, FACG

IOWA

Kenneth Adams, MD, FACG

MILITARY

Anish Patel, DO, FACG

NEW HAMPSHIRE

Francis MacMillan, MD, FACG

NEW MEXICO

Antoine Jakiche, MD, FACG

ONTARIO PROVINCES

Mohammad Yaghoobi, MD, FACG, FRCPC

RHODE ISLAND

William Chen, MD, FACG

VERMONT

David Schwartz, MD, FACG

Meet the 2024–2025 ACGCRJ EDITORIAL BOARD

Prateek Harne, MBBS, MD Editor-in-Chief University Hospitals, Allegheny Health Network Pittsburgh, PA

Muhammad Nadeem Yousaf, MD Editor-in-Chief University of Missouri Columbia, MO

Daniyal Abbas, MD

Associate Editor Harlem Hospital Center New York, NY

Dushyant Dahiya, MD

Associate Editor University of Kansas Kansas City, KS

Daniel Marino, MD, MBA

Associate Editor NYU Langone New York, NY

ACGCRJ is a fully open access journal. View all published case reports for free. acgcasereports.com

Thanks to outgoing ACGCRJ Editorial Board members! We thank the outgoing members of the Editorial Board for their outstanding service to the Journal and wish them continued success in their careers.

Vibhu Chittajallu, MD

Khushboo Gala, MBBS

Smit Deliwala, MD

Banreet Dhindsa, MD

Yue-Sai Jao, MD

Sonya Bhaskar, MD

Associate Editor University of South Florida Tampa, FL

Umer Farooq, MD

Associate Editor St. Louis University St. Louis, MO

Krystal Mills, MD

Associate Editor Mayo Clinic Rochester Rochester, MN

Tina Boortalary, MD

Associate Editor Thomas Jefferson University Philadelphia, PA

Abel Joseph, MD

Associate Editor Stanford University Stanford, CA

Ahmed Telbany, MD, MPH

Associate Editor University of New Mexico Albuquerque, NM

Robert J. Pattison, MD, MPH

Nicholas Placone, MD

Shazia Rashid, MD

Achintya Singh, MD

Gianna Stoleru, MD

Vaishnavi Boppana, MD

Associate Editor

University of New Mexico Albuquerque, NM

Rahul Karna, MD

Associate Editor University of Minnesota Minneapolis, MN

Himesh Zaver, MD

Associate Editor

University of Virginia Charlottesville, VA

Arif Nawaz, MD, FACG

Earns

the International Leadership Award

For his work promoting international grants, improving the experience for international meeting attendees, and increasing communication among international ACG governors, Dr. Nawaz is the recipient of the 2024 the International Leadership Award.

Arif Nawaz, MD, FACG, is a graduate of the Aga Khan University, Karachi, Pakistan, and completed his GI training at the State University of New York, Stony Brook. He is board-certified in gastroenterology. Since his return to Pakistan in 2000, he has worked at the FMH College of Medicine and Dentistry, Lahore, Pakistan, in various capacities, including Head of the Department of Gastroenterology and Associate Dean.

Dr. Nawaz is an active member of various GI societies in Pakistan. Since 2021, he has served as the ACG Governor for Pakistan. During this period, he has effectively advocated for his constituency on several issues including membership, dues rationalization, as well as challenges of access to meetings. His efforts have led to enhanced cooperation between ACG and the GI societies of Pakistan. As a result of his efforts,

ACG now regularly sends speakers to the major GI meetings of Pakistan. As a result of the increased exposure of ACG to the GI community of Pakistan, the number of ACG International members from this country has nearly doubled over his tenure. As a member of the ACG International Relations Committee and co-chair of the international attendee reception subcommittee, he has been instrumental in planning several new activities for ACG's international members. In recognition of his service, he has received several awards including the ACG Board of Governors Distinguished Service Award and the Pakistan Society of Hepatology Distinguished Service Award. He hopes to continue to enhance cooperation between the ACG and the GI community of Pakistan to create unprecedented professional growth opportunities for his constituency.



ABOUT THE INTERNATIONAL LEADERSHIP AWARD

The International Leadership Award is given to a Fellow or Master of the ACG in recognition of outstanding and substantial contributions to gastroenterology, to the College, and to the international gastroenterology community. Substantial contributions internationally may include, but are not limited to the following: The training of individuals from other countries who have gone on to become leaders in gastroenterology in their community; leadership in international organizations that has resulted in improvement in the care of patients; and participation in humanitarian efforts.

10th Annual #ACG2024 #IRL In Real Life Social Media & Ceremony Meetup Reception

DATE: MONDAY, OCTOBER 28, 2024

TIME: 5:00 PM – 6:00 PM

LOCATION: ROOM 121BC

SIRIUSXM'S “DOCTOR RADIO ” Broadcast Live from Philadelphia

Dr.

Mark Pochapin to Host Live Broadcast Sunday, October 27th

SIRIUSXM’S DOCTOR RADIO WILL BROADCAST LIVE FROM THE ACG ANNUAL SCIENTIFIC MEETING. ACG Past President Mark B. Pochapin, MD, FACG will host a two-hour radio show from 5:00 pm to 7:00 pm ET on Sunday, October 27, from a studio set up in the Exhibit Hall near the Endoscopy School Hands-On Workshop Center and across from Booth 101. The broadcast is happening concurrently with the Opening Welcome Reception. The program will feature Dr. Pochapin in conversation with ACG leaders, special lecturers, noteworthy clinical investigators, and other special guests.

ON THE AIR FOR 2024!

SiriusXM "Doctor Radio Live from ACG" returns to the ACG Annual Scientific Meeting with vibrant conversations and special guests. Dr. Pochapin and his producers at SiriusXM have partnered with the College to update listeners on GI health topics and share breaking news during live broadcasts from the ACG Annual Scientific Meeting starting in 2017.

Doctor Radio always offers an engaging take on critical topics important to GI and liver health, touching on key science presented at the ACG meeting. The College is grateful to SiriusXM and Doctor Radio for their partnership and support. SiriusXM subscribers can listen to the show online via SiriusXM On Demand and on Doctor Radio (Channel 110). Guests for 2024 include:

• Colorectal Cancer Screening Options & Getting Younger Americans Screened

Renee L. Williams, MD, MHPE, FACG

Carol A. Burke, MD, MACG

Aasma Shaukat, MD, MPH, FACG

Seth A. Gross, MD, FACG

• How to Address Abdominal Pain

Lin Chang, MD, FACG

Lavanya Viswanathan, MD, MS, FACG

Linda Anh B. Nguyen, MD, FACG

• Liver Health and New ACG Alcohol-Associated Liver Disease Guidelines

Jasmohan S. Bajaj, MD, MS, FACG

Atoosa Rabiee, MD, FACG

Paul Martin, MD, FACG

Nancy S. Reau, MD, FACG

• Abdominal Distention: Dysmotility, Dysbiosis or Diet?

Baharak “Baha” Moshiree, MD, MSc, FACG

Brooks D. Cash, MD, FACG

Amy S. Oxentenko, MD,

FACG

Left to Right: Darren M. Brenner, MD, FACG; Linda Anh B. Nguyen, MD, FACG; Mark B. Pochapin, MD, FACG; David J. Hass, MD, FACG; and Lin Chang, MD, FACG

Left to Right: William K. Oelsner, MD; Anthony J. Lembo, MD, FACG; Dr. Pochapin; Claire JanssonKnodell, MD; and Jasmohan S. Bajaj, MD, MS, FACG

Left to Right: Baharak Moshiree, MD, MSc, FACG; Shelby A. Sullivan, MD, FACG; Dr. Pochapin; Jennifer Phan, MD; Cynthia A. Moylan, MD, MHS

Left to Right: David A. Greenwald, MD, FACG; Evan S. Dellon, MD, MPH, FACG; Dr. Pochapin; Prasad G. Iyer, MD, MSc, FACG; and Rena H. Yadlapati, MD, FACG

THE BERK/FISE AWARD: MARK B. POCHAPIN, MD, FACG

A Superb Clinical Gastroenterologist, Educator, and Innovative Servant Leader

For his excellence in patient care, research, teaching, and mentoring, along with his singular achievement of leading the College with skill, empathy, and vision during the worst days of the COVID-19 pandemic, the 2024 Berk/Fise Clinical Achievement Awardee is Mark B. Pochapin, MD, FACG. Dr. Pochapin is an astute clinician, inspiring teacher, and respected colleague who is a staunch champion of colorectal cancer screening, colonoscopy, reducing disparities, and promoting a diverse workforce. Dr. Pochapin’s distinguished career fully embodies the attributes of the Berk/Fise Clinical Achievement Award, which recognizes not only clinical excellence but also contributions in patient care, clinical science, clinical education, technological innovation, and public and community service.

During his tenure as ACG President during the COVID-19 pandemic in 2020, Dr. Pochapin was exemplary for his steady and reassuring servant leadership and his commitment to supporting ACG members during that unprecedented era. He led his own GI division and institution on the front line of the pandemic outbreak in New York City and was able to translate this experience into effective leadership of the broader community of gastroenterologists.

One nominator wrote of Dr. Pochapin’s time as President, “I am not sure there was anyone in our history of great leadership of the College who would have had the personality, interpersonal skills, organizational skills, tolerance, and integrative skills to lead us all through some of the darkest times we have had in medicine. He was instrumental in making sure the members all had the best information, much less a resilient and brilliant broad plan of approach to provide education and information to GI practitioners at all levels.”

His leadership of the College during those dark, uncertain days was nothing short of inspirational. One nominator described how during his ACG presidency Dr. Pochapin “coined the term ‘beacon’ related to what to he thought the College should be for others but, appropriately, we immediately recognized that Mark's shining example of leadership and eternal optimism most represented that symbol.”

Noted by his nominators for his relentless energy, ambition, creativity, and innovative nature, Dr. Pochapin is described as a “a wonderful communicator who exudes honesty and sincerity.” He is recognized as a leader who “inspires and motivates all in his presence,” and who has a “dedicated interest in developing and coaching people to help them become the best versions of themselves.”

ABOUT DR. POCHAPIN

Mark B. Pochapin, MD, FACG, is the Sholtz-Leeds Professor of Gastroenterology; Director of the Division of Gastroenterology and Hepatology; and Vice Chair of Clinical Affairs in the Department of Medicine at NYU Grossman School of Medicine/NYU Langone Health. Dr. Pochapin graduated from the University of Pennsylvania with a Bachelor of Science and Engineering degree and received his medical degree from Cornell University Medical College. He completed his residency and chief residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center and a fellowship in gastroenterology at Montefiore Medical Center/Albert Einstein College of Medicine.

In his clinical and research efforts, Dr. Pochapin has been dedicated to the prevention, early detection, and treatment of gastrointestinal cancers and to quality in endoscopy. Dr. Pochapin was one of the first to use linear EUS with FNA in New York and helped establish its use as a procedure

in the assessment of pancreatic lesions. Moreover, for over 25 years, Dr. Pochapin has been a leader in the national effort to increase colorectal cancer screening and promote quality in endoscopy. He served as a founding member of the Board of Directors of the GI Quality Improvement Consortium (GIQuIC); held leadership positions with the National Colorectal Cancer Roundtable (NCCRT) and New York Citywide Coalition for Colon Cancer Control (C5); and worked nationally and internationally through media outreach and collaborations to raise public awareness.

Throughout his career, Dr. Pochapin has been committed to teaching the next generation of physicians. As an educator, Dr. Pochapin has received over 30 teaching awards, including the Physician of the Year Award, Humanism in Medicine Award, and twice the Elliot Hochstein Teaching Award, the distinguished honor given at Weill Cornell Medical College by vote of the graduating class. He is also dedicated to public health education, and currently hosts two alternating weekly U.S. national radio broadcasts called “Chief's Rounds” and “Medicine Grand Rounds” on SiriusXM Doctor Radio, connecting the public with leaders in science and medicine.

Dr. Pochapin is perhaps most of all esteemed for his role as master clinician and leader in medicine. Among the honors he has received in recognition of his contributions are the 2019 Master Clinician Award and 2021 Clinical Faculty Mentor of the Year Award, from NYU Langone Health; 2022 Special Alumni Achievement Award from Weill Cornell Medicine for “notable achievements in medicine that significantly advance healthcare and medical science;” and 2022 Healio Lifetime Disruptor Award in Gastroenterology, by vote of his peers nationally.

Dr. Pochapin has been a longtime active member of the American College of Gastroenterology, playing a key role in the development and launch of its Young Physician Leadership Scholars Program. For his leadership and service as President during the COVID-19 pandemic in 2020, the College presented him with the “Beacon Award for Outstanding Leadership in Extraordinary Times.”

 ABOUT THE BERK/FISE CLINICAL ACHIEVEMENT AWARD

The Berk/Fise Clinical Achievement Award, formerly the ACG Clinical Achievement Award, is presented to no more than one member/Fellow of the College in any year, and is made in recognition of distinguished contributions to clinical gastroenterology over a significant period of time. In addition to a career of distinguished clinical practice of gastroenterology, specific criteria include contributions in patient care, clinical science, clinical education, technological innovation, and public and community service.

DISPLAY INTRODUCES UPDATED

ACG STRATEGIC PLAN

A History of Commitment, Collegiality, Connection & Clinical Excellence…and a Bold Vision for the Future

An update to the College’s Strategic Plan is an ideal opportunity to look back at the College’s history, showcase today’s vibrant programs and publications, and celebrate ACG’s members. With a timeline of select milestones featuring historical photos from ACG’s archives, viewers are invited to explore ACG’s storied past and appreciate the strides and achievements of its long history.

 EXPLORE: The 2024 Strategic Plan Display is prominently located in the Terrace Ballroom Foyer at the Pennsylvania Convention Center.

By showcasing ACG’s advocacy on behalf of clinical GI, educational programs, publications, and many resources for clinicians at every career stage, the display aims to communicate how the College helps its members navigate their professional lives. A major goal is to strengthen a sense of community by featuring recent photos. Looking ahead, highlights of the Strategic Plan offer a vision for ACG’s future.

BRIEF SUMMARY: Before prescribing, please see Full Prescribing Information and Medication Guide for SUTAB® (sodium sulfate, magnesium sulfate, potassium chloride) tablets for oral use. INDICATIONS AND USAGE: An osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults. DOSAGE AND ADMINISTRATION: Split Dose (2-Day) Regimen: Day 1, Dose 1 – On the Evening Prior to Colonoscopy: A low residue breakfast may be consumed. After breakfast, only clear liquids may be consumed until after the colonoscopy. Early in the evening prior to colonoscopy, open one bottle of 12 tablets. Remove and discard the desiccant. Remove and discard the desiccant from the second bottle and close the bottle. Use the second bottle for the second dose on the morning of the colonoscopy. Fill the provided container with 16 ounces of water (up to the fill line). Swallow each tablet with a sip of water and drink the entire amount over 15 to 20 minutes. Approximately one hour after the last tablet is ingested, fill the provided container a second time with 16 ounces of water (up to the fill line) and drink the entire amount over 30 minutes. Approximately 30 minutes after finishing the second container of water, fill the provided container with 16 ounces of water (up to the fill line) and drink the entire amount over 30 minutes. Day 2, Dose 2 – The Morning of the Colonoscopy: (5 to 8 hours prior to the colonoscopy and no sooner than 4 hours from starting Dose 1). Continue to consume only clear liquids until after the colonoscopy. The morning of colonoscopy, open the second bottle of 12 tablets. Fill the provided container with 16 ounces of water (up to the fill line). Swallow each tablet with a sip of water and drink the entire amount over 15 to 20 minutes. Approximately one hour after the last tablet is ingested, fill the provided container a second time with 16 ounces of water (up to the fill line) and drink the entire amount over 30 minutes. Approximately 30 minutes after finishing the second container of water, fill the provided container with 16 ounces of water (up to the fill line) and drink the entire amount over 30 minutes. If patients experience preparation-related symptoms (e.g., nausea, bloating, cramping), pause or slow the rate of drinking the additional water until symptoms diminish. Complete all SUTAB tablets and required water at least 2 hours before colonoscopy. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention, hypersensitivity to any ingredient in SUTAB. WARNINGS AND PRECAUTIONS: Serious Fluid and Electrolyte Abnormalities: Advise all patients to hydrate adequately before, during, and after the use of SUTAB. If a patient develops significant vomiting or signs of dehydration after taking SUTAB, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN). Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment. Correct fluid and electrolyte abnormalities before treatment with SUTAB. Use SUTAB with caution in patients with conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and renal impairment; Cardiac arrhythmias: Use caution when prescribing SUTAB for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias; Seizures: Use caution when prescribing SUTAB for patients with a history of seizures and in patients at increased risk of seizure, such as patients taking medications that lower the seizure threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected hyponatremia; Use in Patients with Risk of Renal Injury: Use SUTAB with caution in patients with impaired renal function or patients taking concomitant medications that may a ect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs). These patients may be at risk for renal injury. Advise these patients of the importance of adequate hydration with SUTAB and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients; Colonic Mucosal Ulcerations and Ischemic Colitis: Osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Concurrent use of stimulant laxatives and SUTAB may increase these risks. Consider the potential for mucosal ulcerations resulting from the bowel preparation when interpreting colonoscopy findings in patients with known or suspect inflammatory bowel disease (IBD); Use in Patients with Significant Gastrointestinal Disease: If gastrointestinal obstruction or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering SUTAB. Use with caution in patients with severe active ulcerative colitis. Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylaxis, angioedema, dyspnea, rash, pruritis and urticaria have been reported with SUTAB. Inform patients of the signs and symptoms of anaphylaxis and instruct them to seek immediate medical care should signs and symptoms occur. Risk of Gastrointestinal Complications with Ingestion of Desiccant: Postmarketing reports of ingestion of the desiccant along with SUTAB tablets has been reported and may be associated with risk of gastrointestinal complications and/or choking. ADVERSE REACTIONS: Most common gastrointestinal adverse reactions are: nausea, abdominal distension, vomiting and upper abdominal pain. Postmarketing Experience: Gastrointestinal: gastric ulceration, gastritis; Hypersensitivity: anaphylaxis, angioedema, dyspnea, rash, pruritus, urticaria. POTENTIAL FOR DRUG ABSORPTION: SUTAB can reduce the absorption of other co-administered drugs. Administer oral medications at least one hour before starting each dose of SUTAB. Administer tetracycline and fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of each dose of SUTAB to avoid chelation with magnesium. Pregnancy: There are no available data on SUTAB use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. No reproduction or developmental studies in animals have been conducted with sodium sulfate, magnesium sulfate, and potassium chloride (SUTAB). Lactation: There are no available data on the presence of SUTAB in human or animal milk, the e ects on the breastfed child, or the e ects on milk production. Pediatric Use: Safety and e ectiveness in pediatric patients has not been established. Geriatric Use: Of the 471 patients who received SUTAB in pivotal clinical trials, 150 (32%) were 65 years of age or older, and 25 (5%) were 75 years of age or older. No di erences in safety or e ectiveness of SUTAB were observed between geriatric patients and younger patients. Elderly patients are more likely to have decreased hepatic, renal or cardiac function and may be more susceptible to adverse reactions resulting from fluid and electrolyte abnormalities.

STORAGE: Store at 20° to 25°C (68° to 77°F). Excursions permitted between 15° to 30°C (59° to 86°F). See USP controlled room temperature. Rx only. Manufactured by Braintree Laboratories, Inc. Braintree, MA 02185

See Full Prescribing Information and Medication Guide at SUTAB.com.

Tablets and packaging not shown actual size.

BRIEF SUMMARY: Before prescribing, please see Full Prescribing Information and Medication Guide for SUFLAVE™ (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution).

INDICATIONS AND USAGE: An osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults.

Packaging not shown actual size.

DOSAGE AND ADMINISTRATION:Split Dose (2-Day) Recommended Dosage: Dose 1 – On the day prior to colonoscopy: A low residue breakfast may be consumed. After breakfast, only consume clear liquids until after the colonoscopy. Day 1, Dose 1Early in the Evening Prior to Colonoscopy: Open 1 flavor enhancing packet and pour the contents into one bottle. Fill the provided container (bottle) with lukewarm water up to the fill line. After capping the bottle, gently shake the bottle until all the powder has dissolved. For best taste, refrigerate the solution for an hour before drinking. Do not freeze. Use within 24 hours. Drink 8 ounces of solution every 15 minutes until the bottle is empty. Drink an additional 16 ounces of water during the evening. If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish. Day 2, Dose 2 – The Morning of the Colonoscopy: (5 to 8 hours prior to the colonoscopy and no sooner than 4 hours from starting Dose 1): Continue to consume only clear liquids until after the colonoscopy. Repeat Step 1 to Step 3 from Day 1, Dose 1. Drink an additional 16 ounces of water during the morning. Stop drinking liquids at least 2 hours prior to colonoscopy. If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention, hypersensitivity to any ingredient in SUFLAVE. WARNINGS AND PRECAUTIONS: Serious Fluid and Electrolyte Abnormalities: Advise all patients to hydrate adequately before, during, and after the use of SUFLAVE. If a patient develops significant vomiting or signs of dehydration after taking SUFLAVE, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN). Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment. Correct fluid and electrolyte abnormalities before treatment with SUFLAVE. Use SUFLAVE with caution in patients with conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and renal impairment; Cardiac arrhythmias: Use caution when prescribing SUFLAVE for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias; Seizures: Use caution when prescribing SUFLAVE for patients with a history of seizures and in patients at increased risk of seizure, such as patients taking medications that lower the seizure threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected hyponatremia; Use in Patients with Risk of Renal Injury: Use SUFLAVE with caution in patients with impaired renal function or patients taking concomitant medications that may a ect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs). These patients may be at risk for renal injury. Advise these patients of the importance of adequate hydration with SUFLAVE and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients; Colonic Mucosal Ulcerations and Ischemic Colitis: Osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Concurrent use of stimulant laxatives and SUFLAVE may increase these risks. Consider the potential for mucosal ulcerations resulting from the bowel preparation when interpreting colonoscopy findings in patients with known or suspect inflammatory bowel disease; Use in Patients with Significant Gastrointestinal Disease: If gastrointestinal obstruction or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering SUFLAVE. Use with caution in patients with severe active ulcerative colitis. Aspiration: Patients with impaired gag reflex or other swallowing abnormalities are at risk for regurgitation or aspiration of SUFLAVE. Do not combine SUFLAVE with starch-based thickeners. Observe these patients during administration of SUFLAVE. Hypersensitivity reactions, including anaphylaxis: SUFLAVE contains polyethylene glycol (PEG) and other ingredients that may cause serious hypersensitivity reactions including anaphylaxis, angioedema, rash, urticaria, and pruritus. Inform patients of the signs and symptoms of anaphylaxis, and instruct them to seek immediate medical care should signs and symptoms occur. ADVERSE REACTIONS: Most common adverse reactions are: nausea, abdominal distension, vomiting, abdominal pain, and headache. POTENTIAL FOR DRUG ABSORPTION: SUFLAVE can reduce the absorption of other co-administered drugs. Administer oral medications at least one hour before starting each dose of SUFLAVE. Administer tetracycline and fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of each dose of SUFLAVE to avoid chelation with magnesium. Pregnancy: There are no available data on the use of SUFLAVE during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies have not been conducted with polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride (SUFLAVE). Lactation: There are no available data on the presence of SUFLAVE in human or animal milk, the e ects on the breastfed child, or the e ects on milk production. Pediatric Use: Safety and e ectiveness in pediatric patients have not been established. Geriatric Use: Of the 460 patients who received SUFLAVE in pivotal clinical trials, 125 (27%) were 65 years of age or older. No di erences in e ectiveness of SUFLAVE were observed between geriatric patients and younger adult patients. In geriatric patients, decreases in blood pressure on the day of colonoscopy were reported more frequently in SUFLAVE patients than with the active comparator in Study 1 (6% vs 0%) and Study 2 (3% vs 0%). Geriatric patients are more likely to have decreased hepatic, renal or cardiac function and may be more susceptible to adverse reactions resulting from fluid and electrolyte abnormalities. STORAGE: Store SUFLAVE at room temperature between 20°C to 25°C (68°F to 77°F). Excursions permitted from 15°C to 30°C (59°F to 86°F). See USP controlled room temperature. Rx only. Manufactured by Braintree Laboratories, Inc. Braintree, MA 02185

See Full Prescribing Information and Medication Guide at SUFLAVE.com.

please call 1-800-874-6756, or visit